data_2lp1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lp1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.444 0.164 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.8 tt -57.34 -37.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.533 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 17.1 mt -69.18 -38.44 77.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.312 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.77 -45.55 64.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.04 -29.19 68.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.788 -0.206 . . . . 0.0 110.701 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 3.9 mmt -70.9 -51.28 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.49 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.04 -40.15 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.543 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.37 -6.77 87.97 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.53 5.25 78.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.03 -35.29 63.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.614 0.245 . . . . 0.0 110.688 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.8 -38.02 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.371 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.51 -32.52 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.491 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.48 -53.12 61.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 35.0 p -64.32 -30.67 71.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.26 -49.8 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.438 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.87 -33.87 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.329 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 78.0 t -72.27 -45.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.433 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.9 mm -54.57 -41.3 54.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 15.7 m -65.87 -36.34 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.537 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -28.95 69.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.634 -176.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.74 -47.52 88.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.413 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 57.6 mtt -77.26 -29.35 53.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.486 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.775 177.283 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.371 0.129 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 12.9 mm -58.16 -31.95 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.6 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.65 -43.02 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.373 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.51 -31.41 56.71 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.2 -25.48 66.94 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.839 -0.213 . . . . 0.0 110.834 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -30.54 69.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.96 -48.3 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.524 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -84.43 -3.22 88.71 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.16 11.34 55.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.53 -42.91 55.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.492 0.187 . . . . 0.0 110.538 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.99 -45.65 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.372 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.0 -34.92 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.91 -51.13 70.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.533 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 45.6 p -62.93 -36.77 84.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.619 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.77 -54.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.502 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.62 -38.36 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.362 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 56.3 t -66.38 -42.17 90.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.507 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.12 -29.63 46.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.512 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -34.78 68.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.52 -31.2 72.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.515 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.0 t -61.12 -38.12 78.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 5.4 mmt -76.54 -28.14 56.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.571 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.778 178.152 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.68 -29.91 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 4.4 mm -63.44 -50.86 76.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.89 -34.77 29.73 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.79 -29.11 70.46 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.825 -0.22 . . . . 0.0 110.964 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -30.54 71.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.658 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.79 -40.51 85.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.59 1.62 64.11 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.73 14.06 32.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -46.99 67.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.564 0.221 . . . . 0.0 110.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.76 -42.24 85.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 8.3 mt -66.47 -36.86 78.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.517 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.41 70.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -38.73 83.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.707 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 88.3 t -63.06 -50.4 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.477 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -36.83 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.32 -42.42 81.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.446 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.93 -29.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.548 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -71.44 -36.16 71.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.578 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.74 -30.69 71.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.5 -36.65 65.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.505 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -32.74 68.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.537 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 177.247 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.496 0.188 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.58 -33.78 49.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.496 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 703' ' ' ILE . 15.3 mm -66.58 -36.54 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.368 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.11 -31.97 41.01 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -70.93 -21.14 62.39 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.781 -0.246 . . . . 0.0 110.941 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.5 ttm -66.13 -25.8 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.17 -42.05 95.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.99 80.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.17 11.58 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.65 -37.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.589 0.233 . . . . 0.0 110.609 -174.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -37.87 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.42 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.14 -28.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.4 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.45 -54.29 42.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.573 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.47 -37.46 75.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.8 -52.7 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.356 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 45.0 mt -66.85 -37.81 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.485 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.44 -40.29 77.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.408 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 42.3 mt -63.72 -32.95 58.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.44 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.5 m -69.73 -32.38 70.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -69.28 -29.43 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.07 -34.88 71.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.464 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 -37.09 86.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.707 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.431 -179.426 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.419 0.152 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.8 mm -55.48 -39.2 52.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.61 -43.82 95.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.36 -37.09 37.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.12 -25.4 67.75 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.842 -0.21 . . . . 0.0 110.989 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.48 -28.72 69.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -42.83 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.35 -3.22 88.52 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.99 24.49 7.85 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.79 -34.39 7.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.633 0.254 . . . . 0.0 110.6 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.51 -42.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.468 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -26.07 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.14 -51.55 67.4 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 2.2 p -61.04 -33.75 73.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.703 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.17 -46.45 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 82.8 mt -73.86 -31.23 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.19 -42.83 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.391 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.7 mt -61.89 -37.6 78.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 10.7 p -72.22 -30.63 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.598 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.1 t -60.39 -33.89 55.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.514 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.2 mmt -73.03 -32.84 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.746 176.184 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.032 0 CA-C-O 120.479 0.18 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 20.4 mt -55.75 -41.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.513 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.33 -48.36 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -67.08 -28.24 73.71 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.24 -21.55 39.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.118 . . . . 0.0 110.717 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 11.3 tpt -67.31 -49.12 65.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.362 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.79 -33.82 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.1 5.89 82.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.86 17.24 42.12 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.65 -43.59 61.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.643 0.258 . . . . 0.0 110.416 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.45 -42.51 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 8.1 tt -75.82 -26.58 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.49 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.5 -46.94 88.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.8 m -67.85 -35.54 78.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.61 -43.82 91.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.536 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.7 mm -69.75 -38.15 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.482 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.18 -46.24 94.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.444 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.35 -28.78 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.415 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 3.9 m -75.69 -38.52 58.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.441 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -31.33 72.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.0 -28.85 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.571 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -81.12 -24.47 37.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.495 0.188 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.2 tt -53.98 -33.77 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.84 -40.58 88.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.317 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.21 62.67 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.19 -31.05 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.602 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.3 ttm -72.18 -50.94 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.81 -34.46 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.435 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.37 -4.29 86.18 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.24 18.01 30.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.3 m -76.53 -34.06 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.93 -45.91 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.545 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.28 -25.38 31.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.14 -51.23 68.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 37.0 p -64.0 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.596 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.88 -45.12 84.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.46 -36.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.456 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 82.2 t -70.97 -47.77 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.393 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.12 -26.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.483 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 68.9 m -70.01 -46.1 65.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.594 171.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.03 -32.74 74.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.58 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.51 -40.33 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.508 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.3 mmm -79.56 -27.99 41.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.484 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 177.228 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.52 0.2 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 5.8 tt -55.9 -36.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.575 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.96 -36.86 78.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.41 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -71.28 -33.63 64.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.02 -32.11 63.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.503 0.192 . . . . 0.0 110.77 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 13.5 tpp -71.79 -51.71 21.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.05 -37.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.428 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.97 -2.25 90.66 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -80.46 2.82 76.23 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 20.9 m -65.39 -40.15 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.404 0.145 . . . . 0.0 110.707 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -41.28 36.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.503 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 68.6 mt -71.12 -30.17 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.73 72.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -39.51 94.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.49 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.4 -51.15 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.516 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.16 -36.92 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 56.8 t -58.49 -46.99 89.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.457 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.48 -32.0 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -43.2 82.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.63 -29.48 66.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.599 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.02 -41.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.406 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.0 tpt -75.21 -31.82 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.475 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.092 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.34 0.114 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.03 -32.46 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 -173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.53 -48.03 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.623 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.29 66.98 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.48 -24.16 65.57 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 122.944 -0.151 . . . . 0.0 110.778 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 26.4 ttm -65.58 -30.53 71.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.11 -40.24 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.14 0.48 75.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.25 12.34 45.29 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -49.0 75.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 110.664 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.01 -46.51 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.37 -36.0 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.588 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.59 -47.89 83.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 18.5 m -64.3 -36.77 85.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.6 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.25 -31.69 53.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.525 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 73.8 mt -80.16 -30.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.68 -39.27 85.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.58 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.1 pt -65.23 -26.07 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 1.1 m -79.92 -30.48 40.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.33 -29.23 70.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -31.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -26.14 60.48 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.568 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.711 175.865 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.566 0.222 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.12 -26.62 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -42.26 84.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.2 98.37 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.16 -22.76 59.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.835 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -47.65 69.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.339 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.04 -37.6 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.323 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.65 7.98 60.51 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.66 12.52 56.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.1 m -68.31 -39.9 81.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.504 0.192 . . . . 0.0 110.678 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -43.19 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.63 -31.05 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.362 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.09 62.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.615 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -39.59 82.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.4 -51.6 71.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.495 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.21 -35.15 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.339 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.46 -36.34 76.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.438 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.96 -26.94 31.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -25.83 48.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.698 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.37 -20.83 62.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.22 -26.53 36.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.423 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 tpt -70.41 -37.21 74.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.437 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.646 174.664 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.037 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 46.0 mt -57.07 -31.49 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.482 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 9.9 mm -68.22 -44.69 83.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.85 41.45 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.94 -24.37 67.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.222 . . . . 0.0 111.045 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 25.4 ttm -61.96 -28.74 69.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.49 -40.25 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -88.19 -1.95 81.01 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.47 14.9 48.89 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.91 -49.57 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.632 0.254 . . . . 0.0 110.445 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.26 -47.39 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.519 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.27 -34.37 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.535 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.14 -48.98 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.39 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -33.17 74.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.527 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.3 -46.4 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.363 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 11.9 mm -72.21 -31.76 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 45.6 t -74.33 -45.91 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.429 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.8 -41.28 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.406 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 32.2 p -73.42 -27.53 61.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.697 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.86 -31.13 69.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.32 -28.74 45.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 722' ' ' MET . 0.9 OUTLIER -82.28 -24.85 34.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.706 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.444 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.359 0.124 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -59.09 -31.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.674 -175.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.47 -47.41 86.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.555 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.05 -37.61 37.54 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.29 -26.01 68.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.496 0.189 . . . . 0.0 110.705 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 14.2 ttp -60.54 -32.5 71.55 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.28 -46.01 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.504 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.86 -3.53 85.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.77 13.57 47.32 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.71 -36.41 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 110.658 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.7 -40.15 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.452 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 3.5 mm -65.9 -36.77 78.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.87 63.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -35.45 78.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.736 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.49 -51.4 71.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.471 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 95.7 mt -68.14 -37.08 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.4 -41.05 85.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.444 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.3 mt -63.51 -26.09 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.84 -27.48 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.671 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -27.61 69.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.81 -21.17 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.511 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 12.9 mtt -78.68 -22.57 46.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.659 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.802 176.096 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.646 0.26 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.9 mt -63.2 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -22.65 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.347 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.21 38.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.844 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -63.01 -46.78 86.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.618 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.54 -31.7 43.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.33 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.66 13.38 66.84 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.45 37.27 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.95 -39.86 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.551 0.215 . . . . 0.0 110.656 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 33.7 t -75.82 -42.71 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.4 -27.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.438 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.94 75.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.584 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 88.0 m -62.09 -41.2 97.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 91.5 t -56.8 -42.19 77.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.462 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -74.24 -35.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.12 -47.64 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.28 -30.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.452 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 5.3 m -72.64 -39.1 67.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.528 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 -30.51 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -32.21 56.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.402 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.67 -32.36 57.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 -172.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.808 178.526 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.087 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 26.1 mt -54.69 -34.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.31 -47.57 80.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.582 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.42 59.47 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.66 -26.74 68.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.425 -0.11 . . . . 0.0 110.823 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -27.64 66.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.01 -43.35 99.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.513 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.11 -2.99 90.71 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -87.79 24.74 9.79 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.89 -47.04 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.56 0.219 . . . . 0.0 110.465 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.87 -44.25 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.6 -28.23 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.08 78.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.541 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -30.72 70.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.467 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 89.7 t -76.37 -49.09 25.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.405 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.92 -23.58 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.703 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 16.2 t -66.6 -44.93 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.72 -36.75 62.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.539 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -41.5 97.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.447 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -31.14 69.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.759 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 -31.71 55.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 14.8 ttm -80.28 -26.04 39.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.661 177.109 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.388 0.137 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.23 -27.95 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.483 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.3 mt -70.34 -44.03 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.21 -35.33 49.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.0 mt -71.28 -34.75 70.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.89 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.1 tpp -62.89 -55.17 28.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.392 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.87 -38.57 50.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.458 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.54 -5.98 79.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.49 16.69 17.32 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.55 -40.96 82.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.64 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.8 -38.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.512 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.6 -26.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.503 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.83 72.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 67.7 p -63.66 -34.75 78.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.579 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.03 -48.18 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.54 -36.86 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.458 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.47 -44.12 77.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.406 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.28 -38.49 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.5 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 20.8 m -68.16 -32.86 73.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.599 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.61 -32.24 73.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.606 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.66 -41.24 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.476 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.08 -31.2 55.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.524 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 178.184 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 120.433 0.158 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.58 -30.69 22.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.652 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.39 -42.11 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.493 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.72 -43.68 17.7 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.61 -34.43 69.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.379 0.133 . . . . 0.0 110.89 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.8 ttt -64.9 -53.08 52.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.405 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.87 -42.28 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.49 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.85 -6.61 82.43 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.53 18.74 40.5 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.76 -35.34 30.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 91.1 t -71.14 -49.14 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 18.5 pt -67.73 -27.41 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.59 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.35 -50.81 72.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.594 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -37.44 85.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.547 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.93 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.569 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.63 -29.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.553 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.25 -40.38 88.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.463 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.4 -26.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.475 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 16.0 m -78.96 -29.13 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.617 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -26.86 67.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -173.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 3.2 m -62.6 -26.11 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.481 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.87 -35.43 69.78 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.53 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 174.191 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.557 0.217 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.3 tt -55.57 -37.03 44.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.16 -39.7 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.67 12.95 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.52 -36.28 69.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.511 0.196 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 18.8 ttp -63.56 -54.67 32.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.411 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.87 -43.49 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.35 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.59 -4.94 62.53 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.27 16.13 35.8 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.46 -47.61 64.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 110.579 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -44.44 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.604 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.44 HD13 HG22 ' A' ' 712' ' ' ILE . 15.1 mm -71.64 -25.22 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.14 -53.12 61.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 76.5 p -61.71 -33.37 73.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.65 -46.18 86.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.518 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 -32.02 36.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 81.0 t -73.52 -41.33 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.36 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.22 -44.17 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 13.4 p -64.26 -31.96 73.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.607 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -31.73 73.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.683 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.87 -46.53 93.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 10.8 ttt -67.91 -36.71 80.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.781 -176.491 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' A' ' 705' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 110.832 -0.062 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.75 -42.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.449 -173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.65 -30.21 37.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.591 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.5 -24.5 72.67 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 701' ' ' ALA . 80.4 mt -61.4 -34.03 74.68 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.936 -0.155 . . . . 0.0 110.933 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.18 -38.4 35.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.55 -54.25 37.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.349 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -83.79 -29.63 31.52 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -65.27 -33.06 85.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.69 -47.15 87.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 110.632 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.96 -48.68 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.506 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 28.7 mt -62.66 -30.77 50.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.649 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -56.41 -53.51 56.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.443 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 66.8 p -61.47 -33.25 73.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.625 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.69 -51.89 29.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.416 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.35 -33.33 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.416 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.26 -43.97 98.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.303 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.88 -32.09 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.464 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -29.59 55.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.61 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -32.63 74.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.623 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.18 -35.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.428 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 ttm -72.0 -33.39 68.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.723 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.564 177.478 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.692 0.282 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.04 -32.93 51.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.581 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.36 -43.95 91.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.89 -40.9 24.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 47.3 mt -72.49 -21.64 61.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.792 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -25.74 62.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.47 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.57 -40.76 87.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.412 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.23 1.99 83.15 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.14 26.23 8.03 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -43.09 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.729 0.3 . . . . 0.0 110.64 173.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.98 -38.38 63.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.449 -174.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 8.2 tt -78.22 -25.02 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.516 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.41 73.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.515 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.43 -38.44 80.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.64 -51.0 67.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.459 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.45 -37.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.579 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.53 -39.01 77.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.32 -175.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.9 mt -65.91 -33.85 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.346 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -34.51 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.775 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.3 -31.73 72.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.654 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.47 -27.23 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.531 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 6.3 mmt -80.52 -31.65 37.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.514 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.423 175.902 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.466 0.174 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.3 pt -58.89 -28.28 37.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.492 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.93 -46.94 81.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.426 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.73 -33.99 59.95 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.86 -21.42 51.4 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.839 -0.212 . . . . 0.0 110.997 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.29 -43.08 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.67 -29.27 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -101.32 9.13 57.46 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.52 12.3 40.83 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.7 -30.4 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.686 0.279 . . . . 0.0 110.724 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 64.8 t -76.81 -46.46 30.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 22.3 pt -67.41 -25.85 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.594 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.58 62.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 6.1 p -62.19 -31.98 72.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.666 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.28 -46.83 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 34.9 mt -71.67 -33.5 49.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.54 -40.27 81.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.66 -32.93 57.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -23.82 41.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.787 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.37 -24.75 64.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.703 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.87 -26.12 39.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -69.48 -36.68 76.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.893 176.788 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.475 0.179 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -54.6 -32.79 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.589 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.88 -31.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -178.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.68 -39.37 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.85 -43.56 95.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.587 0.232 . . . . 0.0 110.781 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.0 ttt -62.17 -53.64 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.412 -174.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.51 -44.06 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.405 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.22 3.44 46.75 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.17 20.07 23.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.5 -49.97 78.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 110.601 174.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.86 -43.91 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.445 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.2 -23.73 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.411 -176.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -63.3 -49.99 71.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.562 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 70.8 p -66.14 -30.27 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.417 -175.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.02 -34.91 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.641 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 70.2 mt -77.49 -32.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.75 -47.27 89.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.437 -176.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 39.4 pt -67.27 -28.96 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.629 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 28.1 m -71.78 -36.26 70.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 176.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -25.2 59.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.586 -178.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.64 -47.83 87.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 722' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 722' ' ' MET . 0.0 OUTLIER -81.98 -23.22 36.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.41 -176.569 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.705 175.342 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.483 0.182 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -53.5 -26.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.779 -173.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.97 -46.53 78.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.561 177.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.78 -32.55 32.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.35 -25.06 64.9 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.895 -0.179 . . . . 0.0 111.091 177.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 ttt -63.55 -30.91 71.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.719 -179.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.72 -44.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.58 2.88 78.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.43 23.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -177.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 3.1 m -86.65 -35.87 9.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -45.46 78.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.443 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.4 pt -70.37 -26.63 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 -179.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.37 73.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.47 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 3.0 m -61.67 -36.31 80.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.572 -178.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.44 -48.72 79.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.08 -38.34 79.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.414 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.24 -47.19 82.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.362 -176.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 43.2 mt -56.67 -42.29 76.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.524 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 93.5 m -67.13 -37.16 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.79 -30.11 69.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.656 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.35 -40.77 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 176.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 21.0 mtp -74.29 -24.71 59.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.9 -179.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.408 -178.896 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -65.7 -26.08 38.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.43 -177.66 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.08 -29.22 45.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.684 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -84.4 -33.2 20.52 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.82 -21.32 51.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.852 174.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.9 tpp -71.26 -47.96 53.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.497 -174.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 22.1 m -68.32 -31.11 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.652 174.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -89.83 11.28 70.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 177.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.32 13.88 56.2 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.52 -43.83 96.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.456 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.23 -40.21 50.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.57 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.2 mt -73.73 -28.68 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.579 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -33.3 75.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.544 -176.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.92 -45.28 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.541 178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.33 -36.92 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.424 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.73 -47.98 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 -176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 tp -69.4 -26.42 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.42 -174.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 57.0 m -75.67 -41.87 52.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.553 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.71 -35.68 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.486 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.4 mtt -78.7 -30.1 45.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.5 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.644 176.886 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.03 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.99 -32.56 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.632 -174.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.57 -44.79 93.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 175.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.74 -29.39 57.63 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 75.2 mt -68.02 -24.62 65.13 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.911 -0.17 . . . . 0.0 110.923 177.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.2 ttm -66.57 -29.27 69.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.705 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.45 -38.67 81.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.89 -0.91 71.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.7 12.86 39.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -175.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -46.37 79.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.625 -178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.43 -47.49 80.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.66 -40.29 78.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.669 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -38.71 87.21 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.485 -178.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.89 -52.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.44 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.49 -39.29 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.562 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 73.6 t -68.34 -41.72 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.356 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.99 -36.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -72.98 -32.55 65.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.04 -33.41 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.01 -42.19 78.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 176.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -36.66 76.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.649 177.406 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 3.4 mm -60.36 -24.4 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.576 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 12.3 tt -57.51 -31.59 39.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -86.29 -33.07 14.99 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.45 -23.38 66.27 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.827 -0.219 . . . . 0.0 110.86 174.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.6 ttm -68.55 -25.57 64.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.719 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.0 -39.19 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.605 176.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.6 -7.14 88.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.38 23.18 10.31 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.35 -37.8 14.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.715 0.293 . . . . 0.0 110.489 175.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -41.0 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.373 -174.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.4 -26.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.681 177.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.14 -51.84 67.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.9 p -61.9 -34.37 75.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.76 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.31 -51.46 58.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 178.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.1 -39.98 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.452 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.32 -45.18 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 -174.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.47 -40.68 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.504 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.1 m -67.27 -39.29 86.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.479 176.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.614 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.15 -44.54 95.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.453 177.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 52.7 mmm -70.83 -33.85 71.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.481 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.681 177.842 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.594 0.235 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 9.7 mm -51.02 -33.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.602 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.17 -47.01 89.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.422 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.13 -36.48 24.41 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -176.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.99 -28.64 69.17 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.53 0.205 . . . . 0.0 110.857 176.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -31.12 70.46 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -46.19 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.44 -5.63 89.37 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 178.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.91 12.19 54.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 71.6 t -71.57 -46.49 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.758 0.313 . . . . 0.0 110.536 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.52 -42.34 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.407 -176.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.38 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.648 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.5 65.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 178.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 69.7 p -62.94 -33.63 75.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.653 -177.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.35 -49.04 80.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.54 -31.82 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.49 -178.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.8 t -73.21 -39.6 56.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.442 -178.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.07 -32.22 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.426 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -45.38 90.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 174.387 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.48 -30.26 70.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.778 -176.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.607 176.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.3 tpt -82.65 -22.43 34.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 175.581 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.506 0.193 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.01 -34.53 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.544 176.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 20.0 mt -70.29 -48.87 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.233 179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.92 -25.62 75.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 177.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.25 -43.85 80.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.4 mmt -70.04 -31.19 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.408 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.13 -48.45 78.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.9 1.95 78.87 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 178.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -93.22 16.93 59.4 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.81 -33.58 16.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.517 0.198 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -43.64 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.66 -25.58 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.08 -54.11 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 178.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 714' ' ' THR . . . . . 0.464 ' H ' ' HG1' ' A' ' 714' ' ' THR . 1.4 p -57.74 -36.64 72.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.84 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.81 -49.54 76.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -65.36 -40.48 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.4 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.92 -42.22 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.68 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 90.4 m -65.58 -31.24 72.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -25.95 64.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.733 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.27 -33.87 65.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 176.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.32 -29.13 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.423 -178.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.852 177.677 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.594 0.235 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.4 tp -65.58 -21.43 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.641 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.22 -24.7 35.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -178.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.88 -35.22 19.49 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.69 -24.23 63.56 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 122.877 -0.19 . . . . 0.0 110.714 178.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 9.4 ttp -67.63 -25.7 65.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.24 -41.51 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -87.16 -0.83 84.88 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.42 9.38 55.22 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -44.75 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 -177.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.99 -36.96 59.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.45 -176.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.15 -27.94 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.529 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.14 -54.2 47.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.555 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 28.0 p -62.29 -29.17 70.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.629 -175.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.17 -48.3 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.49 177.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.44 -30.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.469 -178.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.81 -39.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.292 -177.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.78 -42.18 93.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.321 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.7 p -72.62 -29.39 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.579 -177.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 37.8 tp -67.46 -34.81 77.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.606 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.89 -31.13 52.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.3 ttt -72.63 -31.17 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.613 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.762 178.031 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.79 -29.11 25.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.02 -48.65 78.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.495 -179.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.66 -34.76 48.28 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.67 -33.61 75.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.025 -179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.4 ttm -50.66 -25.14 3.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.91 -50.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.564 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.83 -4.25 85.05 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.67 13.37 56.27 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.06 -49.18 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.457 -177.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.26 -47.29 94.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.471 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 712' ' ' ILE . 17.2 mm -68.25 -34.13 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.465 -176.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.5 64.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 175.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -33.06 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.589 -176.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.11 -51.54 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.404 179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.4 -38.17 81.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.449 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.89 -43.55 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.457 -175.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.01 -34.28 52.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.559 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.3 m -70.61 -36.32 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.451 178.079 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 -30.16 70.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.685 -176.234 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.33 -39.67 81.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 2.8 ttt -73.71 -30.39 62.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.559 -176.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.758 174.65 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.073 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.6 mm -57.18 -32.92 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.635 -178.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 703' ' ' ILE . 8.6 mm -69.88 -43.32 79.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.524 178.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -78.67 -21.66 68.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.55 -24.71 49.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 174.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -21.51 66.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.522 -173.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 4.8 m -68.79 -31.31 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.17 0.16 63.83 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.32 13.39 33.85 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.18 -50.25 37.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.626 0.25 . . . . 0.0 110.489 -178.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -48.14 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.593 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.471 -178.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.82 72.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.577 177.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 85.2 m -60.24 -35.7 76.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.645 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.31 -45.7 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.65 -29.16 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.521 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.2 -42.27 31.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.414 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.12 -43.51 89.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.491 176.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 39.5 p -68.03 -31.31 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.545 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -28.9 67.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.578 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.47 -34.98 70.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 9.0 mtm -79.36 -15.98 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.618 -177.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.53 0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.638 174.005 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.55 0.214 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . 0.428 ' CG ' ' H ' ' A' ' 685' ' ' HIS . 5.0 t-80 -96.51 -179.52 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.614 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . 0.428 ' H ' ' CG ' ' A' ' 684' ' ' HIS . 32.3 p-80 -119.48 176.13 5.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.03 77.89 1.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.09 19.48 11.63 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.32 -15.52 62.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.33 -0.34 4.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.861 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -71.76 -27.98 63.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -82.88 8.88 11.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.799 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.22 61.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.51 -3.43 14.63 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.16 -16.32 62.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.46 -21.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -72.18 -156.73 3.03 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 53.1 m -137.45 -85.96 0.3 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.455 0.169 . . . . 0.0 110.608 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . 0.484 ' CG ' ' H ' ' A' ' 699' ' ' LYS . 14.6 p-10 -151.54 -111.34 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 698' ' ' ASN . 0.4 OUTLIER -54.28 -40.93 68.31 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.918 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.24 -18.4 71.21 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.08 60.72 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.805 -0.233 . . . . 0.0 110.895 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.8 tt -57.34 -37.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.533 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 17.1 mt -69.18 -38.44 77.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.312 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.77 -45.55 64.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.04 -29.19 68.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.788 -0.206 . . . . 0.0 110.701 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 3.9 mmt -70.9 -51.28 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.49 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.04 -40.15 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.543 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.37 -6.77 87.97 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.53 5.25 78.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.03 -35.29 63.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.614 0.245 . . . . 0.0 110.688 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.8 -38.02 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.371 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.51 -32.52 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.491 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.48 -53.12 61.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 35.0 p -64.32 -30.67 71.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.26 -49.8 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.438 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.87 -33.87 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.329 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 78.0 t -72.27 -45.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.433 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.9 mm -54.57 -41.3 54.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 15.7 m -65.87 -36.34 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.537 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -28.95 69.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.634 -176.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.74 -47.52 88.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.413 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 57.6 mtt -77.26 -29.35 53.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.486 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.41 -16.26 56.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.775 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.2 pttp 26.29 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.604 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -60.68 130.28 45.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.749 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 45.4 mttt 51.81 68.67 0.77 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.802 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 54.48 -141.67 0.85 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.443 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.577 172.19 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.706 0.289 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -98.79 -156.41 0.54 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.653 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.26 95.23 10.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -91.09 12.99 18.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.13 -165.28 1.16 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.37 5.35 4.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.944 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 83.9 t -75.79 -6.08 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.564 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -30.39 12.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.466 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.76 -56.13 3.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.306 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.36 -17.2 64.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.54 -17.89 63.28 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.773 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 92.3 t -60.32 -39.12 79.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 64.49 -129.35 36.64 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.63 -50.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.79 171.29 11.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.447 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . 0.47 ' HZ2' ' N ' ' A' ' 700' ' ' GLY . 0.0 OUTLIER -52.5 -47.21 66.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.755 175.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.47 ' N ' ' HZ2' ' A' ' 699' ' ' LYS . . . -69.26 -24.34 76.03 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.87 96.04 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.789 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 12.9 mm -58.16 -31.95 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.6 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.65 -43.02 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.373 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.51 -31.41 56.71 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.2 -25.48 66.94 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.839 -0.213 . . . . 0.0 110.834 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -30.54 69.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.96 -48.3 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.524 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -84.43 -3.22 88.71 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.16 11.34 55.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.53 -42.91 55.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.492 0.187 . . . . 0.0 110.538 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.99 -45.65 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.372 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.0 -34.92 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.91 -51.13 70.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.533 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 45.6 p -62.93 -36.77 84.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.619 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.77 -54.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.502 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.62 -38.36 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.362 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 56.3 t -66.38 -42.17 90.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.507 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.12 -29.63 46.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.512 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -34.78 68.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.52 -31.2 72.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.515 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.0 t -61.12 -38.12 78.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 5.4 mmt -76.54 -28.14 56.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.571 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.45 -24.8 67.74 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.778 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt 71.95 155.5 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -148.19 -72.01 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.447 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -166.7 97.14 0.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.445 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . 0.441 HE21 ' H ' ' A' ' 728' ' ' TYR . 0.1 OUTLIER -167.34 -102.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.435 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . 0.441 ' H ' HE21 ' A' ' 727' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.477 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.703 0.287 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 64.83 19.04 11.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -102.14 -62.82 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -168.96 144.6 3.35 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.534 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -101.93 103.23 13.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.502 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.17 -16.41 4.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.2 -13.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.758 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -54.63 44.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.679 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -75.42 -31.69 60.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.612 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.3 61.07 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -60.24 -17.5 42.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.08 -10.61 59.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.918 -171.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.25 -4.56 4.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.805 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -51.28 143.24 16.53 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' SER . . . . . 0.443 ' HG ' ' H ' ' A' ' 698' ' ' ASN . 7.6 t -128.68 -165.38 1.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . 0.443 ' H ' ' HG ' ' A' ' 697' ' ' SER . 0.4 OUTLIER 70.18 146.58 0.06 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -50.56 7.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.491 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -64.98 -13.67 57.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.48 -24.97 68.05 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.788 -0.242 . . . . 0.0 110.966 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.68 -29.91 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 4.4 mm -63.44 -50.86 76.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.89 -34.77 29.73 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.79 -29.11 70.46 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.825 -0.22 . . . . 0.0 110.964 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -30.54 71.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.658 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.79 -40.51 85.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.59 1.62 64.11 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.73 14.06 32.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -46.99 67.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.564 0.221 . . . . 0.0 110.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.76 -42.24 85.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 8.3 mt -66.47 -36.86 78.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.517 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.41 70.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -38.73 83.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.707 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 88.3 t -63.06 -50.4 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.477 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -36.83 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.32 -42.42 81.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.446 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.93 -29.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.548 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -71.44 -36.16 71.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.578 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.74 -30.69 71.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.5 -36.65 65.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.505 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -32.74 68.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.537 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.8 -37.62 70.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -68.54 154.42 41.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 35.3 mttm 55.99 90.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.762 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.6 -54.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.439 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -79.18 161.21 26.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.642 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.482 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -91.41 171.84 8.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.525 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -71.35 -88.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.486 -168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 51.15 -113.14 0.69 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.798 164.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -116.06 176.34 5.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.587 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.76 -48.32 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.542 173.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.28 -44.85 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -34.28 78.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.582 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -96.05 21.08 9.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.409 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.65 58.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.81 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.07 -27.16 65.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -53.81 15.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.569 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.63 -54.62 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 92.1 59.62 1.3 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 1.1 p -94.34 175.06 6.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.662 0.268 . . . . 0.0 110.575 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -130.44 172.76 11.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.742 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -34.83 75.0 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.653 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.04 -32.24 76.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -73.54 -30.78 63.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.496 0.188 . . . . 0.0 110.651 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.58 -33.78 49.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.496 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 703' ' ' ILE . 15.3 mm -66.58 -36.54 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.368 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.11 -31.97 41.01 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -70.93 -21.14 62.39 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.781 -0.246 . . . . 0.0 110.941 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.5 ttm -66.13 -25.8 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.17 -42.05 95.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.99 80.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.17 11.58 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.65 -37.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.589 0.233 . . . . 0.0 110.609 -174.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -37.87 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.42 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.14 -28.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.4 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.45 -54.29 42.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.573 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.47 -37.46 75.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.8 -52.7 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.356 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 45.0 mt -66.85 -37.81 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.485 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.44 -40.29 77.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.408 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 42.3 mt -63.72 -32.95 58.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.44 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.5 m -69.73 -32.38 70.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -69.28 -29.43 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.07 -34.88 71.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.464 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 -37.09 86.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.707 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.27 -60.59 3.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.431 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -133.99 151.29 51.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -76.1 -174.33 2.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.531 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -60.69 -72.93 0.1 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.505 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -165.41 83.53 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.348 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.562 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--O 1.232 0.18 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.44 25.97 0.4 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.57 158.05 18.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.387 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -83.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.515 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -133.27 -152.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.07 -4.79 1.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.838 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.11 -0.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -52.45 65.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.58 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.6 -26.37 41.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.503 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -69.95 -9.17 54.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -78.52 -17.32 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.93 -6.94 53.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 21.3 m -65.77 -12.24 13.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.067 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -48.03 121.27 6.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 75.2 p -128.21 -155.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.31 116.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.802 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -34.69 66.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.743 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -61.34 -53.01 47.86 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.04 -32.95 72.81 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.841 -0.211 . . . . 0.0 110.642 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.8 mm -55.48 -39.2 52.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.61 -43.82 95.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.36 -37.09 37.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.12 -25.4 67.75 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.842 -0.21 . . . . 0.0 110.989 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.48 -28.72 69.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -42.83 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.35 -3.22 88.52 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.99 24.49 7.85 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.79 -34.39 7.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.633 0.254 . . . . 0.0 110.6 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.51 -42.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.468 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -26.07 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.14 -51.55 67.4 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 2.2 p -61.04 -33.75 73.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.703 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.17 -46.45 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 82.8 mt -73.86 -31.23 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.19 -42.83 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.391 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.7 mt -61.89 -37.6 78.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 10.7 p -72.22 -30.63 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.598 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.1 t -60.39 -33.89 55.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.514 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.2 mmt -73.03 -32.84 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.0 -30.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.746 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.7 pttt 35.17 37.16 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.594 0.559 . . . . 0.0 111.482 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm 44.13 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.086 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 11.5 tttp 68.28 104.11 0.05 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 -44.23 0.15 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.661 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.462 0.153 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.465 176.521 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.552 0.215 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -102.04 -87.52 0.4 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.495 -174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 20.9 m80 52.62 -161.23 0.1 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.794 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 74.45 -67.02 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.672 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -101.67 165.95 10.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.2 tp 70.3 1.25 3.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.874 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.89 -11.73 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -8.22 43.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.929 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -83.86 39.02 0.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.667 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -75.01 -10.95 59.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.724 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.43 -30.39 71.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.701 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.74 -55.8 6.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 35.7 m -74.32 0.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -69.8 -166.17 5.28 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 1.1 p 63.28 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.569 0.223 . . . . 0.0 110.857 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -172.16 103.61 0.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.479 173.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -67.66 -41.47 83.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.58 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.34 96.88 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.34 97.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.636 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 20.4 mt -55.75 -41.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.513 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.33 -48.36 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -67.08 -28.24 73.71 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.24 -21.55 39.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.118 . . . . 0.0 110.717 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 11.3 tpt -67.31 -49.12 65.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.362 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.79 -33.82 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.1 5.89 82.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.86 17.24 42.12 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.65 -43.59 61.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.643 0.258 . . . . 0.0 110.416 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.45 -42.51 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 8.1 tt -75.82 -26.58 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.49 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.5 -46.94 88.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.8 m -67.85 -35.54 78.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.61 -43.82 91.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.536 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.7 mm -69.75 -38.15 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.482 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.18 -46.24 94.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.444 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.35 -28.78 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.415 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 3.9 m -75.69 -38.52 58.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.441 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -31.33 72.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.0 -28.85 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.571 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -81.12 -24.47 37.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.89 -18.68 57.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -74.87 -40.96 60.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 17.8 tttt 69.9 102.24 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.64 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -100.07 -60.25 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.587 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -135.32 -39.96 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.448 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.506 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.546 0.212 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -81.96 164.87 21.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.92 75.07 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.388 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 150.33 26.37 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.463 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 689' ' ' VAL . 19.2 mttp -96.87 -168.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.41 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.91 -12.49 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.849 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 687' ' ' LYS . 12.2 p -69.5 -13.15 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.499 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -64.6 -61.06 2.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.687 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -71.97 -32.74 67.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.79 -16.03 62.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.69 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.2 -25.43 59.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.729 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -8.62 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.8 -41.56 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.593 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 66.57 -147.93 50.2 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.7 m -168.05 -90.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -109.75 -164.97 0.97 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -46.05 60.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.488 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.5 -19.72 69.11 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.09 62.35 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.679 -0.307 . . . . 0.0 110.819 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.2 tt -53.98 -33.77 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.84 -40.58 88.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.317 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.21 62.67 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.19 -31.05 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.602 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.3 ttm -72.18 -50.94 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.81 -34.46 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.435 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.37 -4.29 86.18 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.24 18.01 30.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.3 m -76.53 -34.06 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.93 -45.91 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.545 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.28 -25.38 31.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.14 -51.23 68.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 37.0 p -64.0 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.596 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.88 -45.12 84.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.46 -36.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.456 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 82.2 t -70.97 -47.77 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.393 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.12 -26.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.483 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 68.9 m -70.01 -46.1 65.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.594 171.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.03 -32.74 74.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.58 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.51 -40.33 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.508 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.3 mmm -79.56 -27.99 41.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.484 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.04 -20.95 65.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -88.77 25.61 1.72 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 173.4 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.653 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -140.36 107.1 5.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.418 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -55.55 102.61 0.07 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.526 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 -174.584 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.595 0.236 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.13 -9.47 0.16 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -68.89 -7.4 34.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.592 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -61.27 -82.76 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.663 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -76.2 95.82 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.1 -43.48 1.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.093 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.69 -33.7 26.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.619 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.87 -24.16 59.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.542 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.71 16.31 26.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.595 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.73 44.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.667 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -7.58 14.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -15.28 63.58 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.61 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.97 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.077 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -90.65 157.89 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.42 168.3 22.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.853 0.358 . . . . 0.0 110.948 172.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 699' ' ' LYS . 4.9 t30 64.82 -175.33 0.17 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.679 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . 0.479 ' H ' ' ND2' ' A' ' 698' ' ' ASN . 0.1 OUTLIER -61.98 -30.88 71.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.743 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.6 65.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.21 65.8 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.798 -0.237 . . . . 0.0 110.912 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 5.8 tt -55.9 -36.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.575 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.96 -36.86 78.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.41 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -71.28 -33.63 64.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.02 -32.11 63.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.503 0.192 . . . . 0.0 110.77 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 13.5 tpp -71.79 -51.71 21.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.05 -37.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.428 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.97 -2.25 90.66 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -80.46 2.82 76.23 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 20.9 m -65.39 -40.15 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.404 0.145 . . . . 0.0 110.707 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -41.28 36.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.503 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 68.6 mt -71.12 -30.17 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.73 72.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -39.51 94.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.49 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.4 -51.15 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.516 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.16 -36.92 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 56.8 t -58.49 -46.99 89.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.457 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.48 -32.0 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -43.2 82.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.63 -29.48 66.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.599 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.02 -41.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.406 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.0 tpt -75.21 -31.82 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.475 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.91 -65.94 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.0 tttp 69.98 -53.62 0.62 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.79 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -62.76 142.69 58.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.571 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 155.35 46.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.84 -125.85 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.415 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 41.7 t80 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.936 0.398 . . . . 0.0 110.622 178.047 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.647 0.26 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -67.06 119.44 12.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -151.85 -40.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.953 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -57.95 -22.24 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -136.06 -171.64 2.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.665 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 80.15 -45.4 0.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.24 -25.08 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -72.09 -44.52 63.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -73.63 -49.57 25.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.74 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.02 51.38 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -54.55 -21.7 11.0 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -19.4 62.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.603 -168.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.92 -25.16 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.78 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 71.73 -143.86 35.89 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 27.6 t -169.23 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.604 0.24 . . . . 0.0 110.374 169.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.67 149.36 14.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.123 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -54.62 -40.07 68.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.55 -42.5 93.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.53 89.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.722 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.03 -32.46 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 -173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.53 -48.03 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.623 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.29 66.98 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.48 -24.16 65.57 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 122.944 -0.151 . . . . 0.0 110.778 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 26.4 ttm -65.58 -30.53 71.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.11 -40.24 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.14 0.48 75.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.25 12.34 45.29 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -49.0 75.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 110.664 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.01 -46.51 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.37 -36.0 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.588 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.59 -47.89 83.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 18.5 m -64.3 -36.77 85.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.6 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.25 -31.69 53.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.525 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 73.8 mt -80.16 -30.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.68 -39.27 85.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.58 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.1 pt -65.23 -26.07 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 1.1 m -79.92 -30.48 40.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.33 -29.23 70.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -31.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -26.14 60.48 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.568 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.21 -10.85 60.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.711 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 36.3 tttp 72.03 129.1 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -161.96 109.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.353 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt 53.96 61.78 2.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.703 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -159.33 111.05 2.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.344 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.539 179.306 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.492 0.187 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -125.6 -79.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -162.77 169.17 20.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.787 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -87.11 178.1 7.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.454 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -146.16 -77.54 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.251 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.94 -67.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.114 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.44 -12.04 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -72.24 -55.32 7.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.542 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.35 -10.51 59.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.701 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.01 -30.3 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.83 -39.08 73.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.576 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.92 -52.19 66.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.556 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.23 -57.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.416 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 77.64 27.26 59.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -10.41 59.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.9 159.94 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.709 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -76.83 -9.03 58.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.697 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.65 -22.33 76.67 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -72.88 -13.42 61.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.566 0.222 . . . . 0.0 110.78 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.12 -26.62 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -42.26 84.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.2 98.37 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.16 -22.76 59.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.835 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -47.65 69.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.339 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.04 -37.6 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.323 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.65 7.98 60.51 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.66 12.52 56.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.1 m -68.31 -39.9 81.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.504 0.192 . . . . 0.0 110.678 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -43.19 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.63 -31.05 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.362 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.09 62.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.615 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -39.59 82.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.4 -51.6 71.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.495 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.21 -35.15 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.339 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 78.4 t -67.46 -36.34 76.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.438 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 52.0 mt -69.96 -26.94 31.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -25.83 48.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.698 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.37 -20.83 62.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.22 -26.53 36.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.423 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 tpt -70.41 -37.21 74.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.437 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.04 -37.64 54.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.646 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.2 tttt 56.21 -170.8 0.08 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.687 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -132.54 172.28 12.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.497 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.11 143.54 39.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.672 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 65.84 170.08 0.22 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.855 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.676 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 111.77 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.1 78.46 8.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 -176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -103.57 100.81 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.57 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 51.66 79.78 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.35 -13.95 44.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.644 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 33.3 m -83.46 -30.4 8.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.767 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.78 -24.39 67.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -92.39 41.45 1.07 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.717 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -82.18 7.25 14.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.667 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.23 -20.58 51.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -33.78 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 10.6 m -76.7 -6.99 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -60.9 63.12 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 37.5 m -105.82 151.78 24.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.803 -0.199 . . . . 0.0 110.528 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 111.91 0.02 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -26.72 67.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.522 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.2 -37.01 80.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -62.03 -41.43 98.09 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.584 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 46.0 mt -57.07 -31.49 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.482 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 9.9 mm -68.22 -44.69 83.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.85 41.45 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.94 -24.37 67.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.222 . . . . 0.0 111.045 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 25.4 ttm -61.96 -28.74 69.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.49 -40.25 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -88.19 -1.95 81.01 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.47 14.9 48.89 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.91 -49.57 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.632 0.254 . . . . 0.0 110.445 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.26 -47.39 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.519 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.27 -34.37 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.535 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.14 -48.98 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.39 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -33.17 74.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.527 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.3 -46.4 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.363 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 11.9 mm -72.21 -31.76 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 45.6 t -74.33 -45.91 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.429 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.8 -41.28 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.406 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 32.2 p -73.42 -27.53 61.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.697 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.86 -31.13 69.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.32 -28.74 45.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 722' ' ' MET . 0.9 OUTLIER -82.28 -24.85 34.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.706 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.5 -55.46 30.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.444 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -102.63 179.92 4.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.489 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.37 174.83 10.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.466 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -77.77 -119.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.541 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -137.64 16.2 2.91 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.445 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.685 0.278 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 116.86 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.365 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -133.49 148.35 51.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.541 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -70.47 145.82 50.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.644 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.47 172.43 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.091 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.4 tp 75.64 -11.32 1.13 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.928 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.3 t -86.7 9.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.445 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.03 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.36 35.7 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -75.01 -13.89 60.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.15 -38.65 80.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.608 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -77.95 -45.18 24.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.574 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.21 -34.15 52.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.567 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -64.42 102.99 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 92.7 p -140.48 -49.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.234 . . . . 0.0 110.455 -175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -69.71 120.23 15.16 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.575 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -75.22 -43.25 52.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.577 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.22 -30.68 78.39 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.93 70.8 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.815 -0.226 . . . . 0.0 110.798 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -59.09 -31.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.674 -175.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.47 -47.41 86.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.555 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.05 -37.61 37.54 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.29 -26.01 68.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.496 0.189 . . . . 0.0 110.705 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 14.2 ttp -60.54 -32.5 71.55 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.28 -46.01 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.504 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.86 -3.53 85.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.77 13.57 47.32 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.71 -36.41 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 110.658 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.7 -40.15 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.452 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 3.5 mm -65.9 -36.77 78.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.87 63.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -35.45 78.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.736 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.49 -51.4 71.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.471 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 95.7 mt -68.14 -37.08 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.4 -41.05 85.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.444 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.3 mt -63.51 -26.09 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.84 -27.48 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.671 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -27.61 69.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 2.7 m -65.81 -21.17 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.511 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 12.9 mtt -78.68 -22.57 46.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.659 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.67 -4.37 19.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.802 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -76.19 45.89 0.38 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.574 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -145.73 82.11 1.62 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.345 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 123.67 26.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.682 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -138.8 149.41 44.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.467 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.164 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.7 0.286 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -97.88 144.41 27.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -79.96 91.89 5.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.402 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -56.68 129.4 40.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.633 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.77 57.88 1.71 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.469 -175.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 9.9 mp -95.76 -20.32 18.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.499 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.95 -11.05 11.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.86 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.58 -33.58 10.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.77 -49.83 6.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.633 -173.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.39 -6.72 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.8 -11.02 60.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.934 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -64.61 -18.69 65.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.19 -32.71 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -92.23 99.04 2.49 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 22.0 t -142.75 -123.28 0.09 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.36 125.78 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.855 0.359 . . . . 0.0 110.637 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -58.64 -26.44 63.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.12 38.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -73.67 -21.03 60.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.646 0.26 . . . . 0.0 110.749 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.9 mt -63.2 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -22.65 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.347 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.21 38.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.844 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -63.01 -46.78 86.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.618 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.54 -31.7 43.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.33 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.66 13.38 66.84 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.45 37.27 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.95 -39.86 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.551 0.215 . . . . 0.0 110.656 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 33.7 t -75.82 -42.71 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.4 -27.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.438 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.94 75.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.584 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 88.0 m -62.09 -41.2 97.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 91.5 t -56.8 -42.19 77.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.462 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -74.24 -35.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.12 -47.64 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.28 -30.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.452 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 5.3 m -72.64 -39.1 67.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.528 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 -30.51 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -32.21 56.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.402 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.67 -32.36 57.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 -172.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.43 -40.47 71.56 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.808 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm 59.21 162.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.5 tttt 63.56 92.45 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.807 174.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -101.15 126.94 47.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 63.58 159.23 0.08 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.859 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 174.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -152.02 101.51 2.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.3 -68.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.433 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.43 104.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.873 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -139.13 156.8 46.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.683 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 2.1 tt -166.65 -39.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.245 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.11 -18.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.819 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -80.54 -48.17 13.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.643 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.91 -29.73 44.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.25 -10.07 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.63 -7.4 38.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.17 -8.94 57.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.838 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.24 -24.33 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -73.37 97.47 0.86 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.3 p -138.35 94.63 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.554 0.216 . . . . 0.0 110.489 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.53 136.36 3.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.352 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -59.48 -38.52 81.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.21 -44.1 77.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.73 84.51 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 121.391 -0.123 . . . . 0.0 110.697 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 26.1 mt -54.69 -34.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.31 -47.57 80.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.582 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.42 59.47 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.66 -26.74 68.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.425 -0.11 . . . . 0.0 110.823 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -27.64 66.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.01 -43.35 99.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.513 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.11 -2.99 90.71 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -87.79 24.74 9.79 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.89 -47.04 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.56 0.219 . . . . 0.0 110.465 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.87 -44.25 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.6 -28.23 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.08 78.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.541 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -30.72 70.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.467 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 89.7 t -76.37 -49.09 25.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.405 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.92 -23.58 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.703 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 16.2 t -66.6 -44.93 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.72 -36.75 62.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.539 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -41.5 97.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.447 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -31.14 69.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.759 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 -31.71 55.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 14.8 ttm -80.28 -26.04 39.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.95 -64.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.661 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -145.01 -92.48 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.118 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.6 tttm 44.22 65.5 1.03 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.637 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -61.95 100.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.489 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -73.47 177.35 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.614 0.245 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -89.11 -27.36 20.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 11.2 m170 58.94 -179.26 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -143.15 25.5 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.614 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 689' ' ' VAL . 4.3 tptp -69.02 -58.81 3.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.496 177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 71.56 -41.67 0.51 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.967 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.447 ' H ' ' C ' ' A' ' 687' ' ' LYS . 2.8 t -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.564 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.44 -54.15 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -79.55 -37.87 35.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.604 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -63.81 -15.73 59.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.708 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.05 -29.84 62.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.759 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -15.66 59.09 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.95 -45.38 98.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.759 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . 0.428 ' HA3' HD13 ' A' ' 705' ' ' LEU . . . 73.53 -156.24 50.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' SER . . . . . 0.403 ' HG ' ' ND2' ' A' ' 698' ' ' ASN . 31.0 t -168.15 -111.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -165.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . 0.403 ' ND2' ' HG ' ' A' ' 697' ' ' SER . 4.4 m-80 -80.46 -162.17 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.434 -173.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -61.53 -42.91 99.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.737 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.17 -11.4 58.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -68.43 -18.3 64.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.822 -0.189 . . . . 0.0 110.894 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.23 -27.95 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.483 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.3 mt -70.34 -44.03 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.21 -35.33 49.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.428 HD13 ' HA3' ' A' ' 696' ' ' GLY . 94.0 mt -71.28 -34.75 70.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.89 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.1 tpp -62.89 -55.17 28.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.392 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.87 -38.57 50.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.458 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.54 -5.98 79.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.49 16.69 17.32 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.55 -40.96 82.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.64 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.8 -38.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.512 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.6 -26.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.503 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.83 72.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 67.7 p -63.66 -34.75 78.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.579 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.03 -48.18 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.54 -36.86 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.458 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.47 -44.12 77.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.406 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.28 -38.49 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.5 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 20.8 m -68.16 -32.86 73.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.599 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.61 -32.24 73.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.606 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.66 -41.24 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.476 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.08 -31.2 55.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.524 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.92 -12.52 58.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -109.45 144.14 38.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.469 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -76.35 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.561 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -71.77 168.65 17.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.67 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.96 -143.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.6 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -59.93 -31.51 69.91 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -75.08 128.11 34.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.589 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -167.28 165.03 15.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.437 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -156.2 27.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.57 -30.77 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.527 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.52 -10.43 13.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.714 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.46 -60.23 3.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.703 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -82.12 -27.21 32.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.72 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.76 -23.12 64.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.774 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -75.12 -16.52 60.54 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.51 14.28 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.261 176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.4 -62.91 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.625 162.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 71.41 178.21 28.43 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 66.2 m -152.44 162.55 41.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.455 0.169 . . . . 0.0 110.901 173.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.47 165.86 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -62.17 -25.61 67.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.94 -18.61 66.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.53 -23.62 67.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 122.866 -0.197 . . . . 0.0 110.837 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.58 -30.69 22.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.652 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.39 -42.11 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.493 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.72 -43.68 17.7 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.61 -34.43 69.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.379 0.133 . . . . 0.0 110.89 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.8 ttt -64.9 -53.08 52.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.405 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.87 -42.28 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.49 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.85 -6.61 82.43 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.53 18.74 40.5 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 55.2 t -75.76 -35.34 30.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 91.1 t -71.14 -49.14 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 18.5 pt -67.73 -27.41 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.59 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.35 -50.81 72.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.594 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -37.44 85.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.547 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.93 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.569 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.63 -29.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.553 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.25 -40.38 88.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.463 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.4 -26.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.475 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 16.0 m -78.96 -29.13 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.617 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -26.86 67.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -173.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 3.2 m -62.6 -26.11 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.481 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.87 -35.43 69.78 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.53 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.0 mt -80.45 -53.96 6.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -156.88 144.81 19.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.546 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -72.97 -50.81 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.533 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -101.08 177.32 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.607 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -104.47 -93.84 0.34 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.5 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.145 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.52 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.603 0.239 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 14.3 m80 63.09 176.57 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.755 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . 0.487 ' H ' ' HZ3' ' A' ' 687' ' ' LYS . 5.0 m-70 -117.51 -150.01 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.288 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.49 -69.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.671 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.487 ' HZ3' ' H ' ' A' ' 685' ' ' HIS . 20.8 mttp 49.07 -105.49 0.16 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.773 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.5 mp -52.37 -23.68 6.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.047 -174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.76 2.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 1.0 OUTLIER -91.31 -39.71 11.89 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.487 174.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . 0.468 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 21.5 t80 -76.78 -55.21 5.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.357 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.81 -9.72 40.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.819 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.31 -23.37 56.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -60.79 -15.81 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.109 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.84 -49.46 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 170.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 66.91 -150.54 52.02 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 4.0 m -166.16 -96.06 0.02 OUTLIER 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -164.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 -157.42 0.61 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.485 -172.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -57.27 -45.28 84.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.772 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.78 -18.0 67.88 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.87 62.08 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.745 -0.268 . . . . 0.0 110.843 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.3 tt -55.57 -37.03 44.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.16 -39.7 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.67 12.95 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.52 -36.28 69.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.511 0.196 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 18.8 ttp -63.56 -54.67 32.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.411 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.87 -43.49 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.35 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.59 -4.94 62.53 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.27 16.13 35.8 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.46 -47.61 64.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 110.579 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -44.44 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.604 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.44 HD13 HG22 ' A' ' 712' ' ' ILE . 15.1 mm -71.64 -25.22 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.14 -53.12 61.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 76.5 p -61.71 -33.37 73.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.65 -46.18 86.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.518 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 -32.02 36.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 81.0 t -73.52 -41.33 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.36 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.22 -44.17 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 13.4 p -64.26 -31.96 73.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.607 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -31.73 73.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.683 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.87 -46.53 93.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 10.8 ttt -67.91 -36.71 80.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.66 3.66 31.98 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.781 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -142.67 112.22 6.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.39 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -164.45 140.48 6.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -77.63 80.29 4.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.425 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -89.43 122.33 32.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.498 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -171.396 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.607 0.241 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . 0.409 ' CG ' ' H ' ' A' ' 685' ' ' HIS . 1.3 t-80 54.03 -148.86 0.44 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.61 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . 0.409 ' H ' ' CG ' ' A' ' 684' ' ' HIS . 5.8 m-70 57.06 37.47 28.69 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 -175.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -69.79 -45.4 68.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.53 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -86.52 -117.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.562 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.6 -50.05 0.7 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.883 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.58 -9.39 11.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -70.13 -59.32 2.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.627 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 175.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.72 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.572 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.22 -38.67 75.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.86 -33.75 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.629 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.64 -25.78 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.552 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 161.72 -89.59 0.11 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 38.2 t -165.12 172.68 12.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.832 0.348 . . . . 0.0 110.661 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -35.65 64.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.713 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -57.76 -32.83 67.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.758 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.56 -40.72 96.22 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . 0.413 ' O ' ' HG ' ' A' ' 705' ' ' LEU . . . -60.31 -36.79 78.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.75 -42.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.449 -173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.65 -30.21 37.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.591 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.5 -24.5 72.67 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 701' ' ' ALA . 80.4 mt -61.4 -34.03 74.68 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.936 -0.155 . . . . 0.0 110.933 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.18 -38.4 35.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.55 -54.25 37.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.349 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -83.79 -29.63 31.52 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -65.27 -33.06 85.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.69 -47.15 87.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 110.632 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.96 -48.68 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.506 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 28.7 mt -62.66 -30.77 50.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.649 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -56.41 -53.51 56.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.443 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 66.8 p -61.47 -33.25 73.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.625 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.69 -51.89 29.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.416 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.35 -33.33 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.416 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.26 -43.97 98.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.303 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.88 -32.09 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.464 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -29.59 55.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.61 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -32.63 74.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.623 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.18 -35.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.428 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 ttm -72.0 -33.39 68.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.723 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.68 -62.06 1.99 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.564 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.08 144.62 5.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.21 -56.43 2.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.562 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -76.59 -84.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -73.42 131.54 41.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.526 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.521 -170.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -29.79 66.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.618 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.6 t60 68.52 112.68 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.649 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -68.76 101.42 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.434 -172.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -66.78 122.62 18.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.661 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.16 -58.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.339 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -29.68 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.462 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.2 -26.48 64.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.616 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -47.14 4.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 172.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -88.77 1.51 55.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.885 -163.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.47 -22.96 64.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -66.69 -24.7 66.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.444 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.59 -37.49 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.568 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -179.64 161.03 26.66 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 9.3 t -154.17 8.92 0.35 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.618 0.246 . . . . 0.0 110.477 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.52 138.39 46.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.48 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.676 -176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.8 -23.04 65.02 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -67.03 -22.63 65.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.692 0.282 . . . . 0.0 110.79 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.04 -32.93 51.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.581 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.36 -43.95 91.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.89 -40.9 24.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 47.3 mt -72.49 -21.64 61.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.792 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -25.74 62.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.47 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.57 -40.76 87.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.412 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.23 1.99 83.15 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.14 26.23 8.03 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -43.09 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.729 0.3 . . . . 0.0 110.64 173.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.98 -38.38 63.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.449 -174.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 8.2 tt -78.22 -25.02 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.516 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.41 73.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.515 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.43 -38.44 80.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.64 -51.0 67.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.459 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.45 -37.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.579 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.53 -39.01 77.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.32 -175.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.9 mt -65.91 -33.85 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.346 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -34.51 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.775 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.3 -31.73 72.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.654 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.47 -27.23 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.531 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 6.3 mmt -80.52 -31.65 37.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.514 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.68 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.423 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -97.81 176.96 5.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.762 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.02 144.64 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -86.04 166.65 15.69 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.668 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.32 -52.24 12.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.447 -170.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.589 0.233 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -90.47 -175.11 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.391 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -14.09 0.98 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.605 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.61 -53.59 5.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.545 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -101.13 119.86 39.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.543 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 23.5 mt -100.05 -27.53 13.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.363 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.69 21.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.68 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -61.77 -35.58 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.556 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -95.03 39.36 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.662 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -86.79 24.11 1.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -86.32 -30.69 22.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.628 166.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.09 -29.7 15.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.528 -167.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.1 m -72.46 -8.41 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.537 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -54.41 77.73 0.01 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 83.9 p -82.05 -130.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.3 127.96 33.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.698 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -21.18 62.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.643 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.49 -11.21 40.18 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -64.97 -22.18 66.96 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.466 0.174 . . . . 0.0 110.924 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.3 pt -58.89 -28.28 37.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.492 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.93 -46.94 81.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.426 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.73 -33.99 59.95 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.86 -21.42 51.4 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.839 -0.212 . . . . 0.0 110.997 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.29 -43.08 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.67 -29.27 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -101.32 9.13 57.46 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.52 12.3 40.83 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.7 -30.4 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.686 0.279 . . . . 0.0 110.724 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 64.8 t -76.81 -46.46 30.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 22.3 pt -67.41 -25.85 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.594 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -62.52 -52.58 62.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 6.1 p -62.19 -31.98 72.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.666 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.28 -46.83 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 34.9 mt -71.67 -33.5 49.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.54 -40.27 81.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.66 -32.93 57.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -23.82 41.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.787 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.37 -24.75 64.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.703 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.87 -26.12 39.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -69.48 -36.68 76.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt -74.11 -43.73 56.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.893 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -67.34 122.42 17.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm 54.61 87.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.876 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -90.22 -0.41 57.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.731 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -97.46 169.26 9.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.63 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 179.593 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.509 0.195 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -175.07 5.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -132.78 117.73 18.15 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.78 143.66 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 178.033 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 689' ' ' VAL . 23.3 mttp -78.0 -81.64 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.9 tp 73.54 -12.08 0.86 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.001 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 687' ' ' LYS . 84.9 t -71.35 -12.11 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.392 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -56.99 -57.28 13.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.69 176.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -76.85 -31.49 56.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.613 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.61 -17.19 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.708 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -19.4 58.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.891 175.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.59 11.12 3.29 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.303 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.3 t -82.77 -40.89 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.617 164.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 72.3 -144.12 35.45 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 46.8 t -172.92 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.9 -0.177 . . . . 0.0 110.528 -166.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -93.21 -161.6 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.46 -170.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -59.51 -43.75 93.3 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -59.87 -22.26 57.11 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -177.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -72.68 -16.12 61.69 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.682 -0.305 . . . . 0.0 110.955 -174.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -54.6 -32.79 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.589 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.88 -31.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -178.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.68 -39.37 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.85 -43.56 95.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.587 0.232 . . . . 0.0 110.781 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.0 ttt -62.17 -53.64 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.412 -174.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.51 -44.06 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.405 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.22 3.44 46.75 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.17 20.07 23.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.5 -49.97 78.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 110.601 174.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.86 -43.91 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.445 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.2 -23.73 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.411 -176.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -63.3 -49.99 71.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.562 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 70.8 p -66.14 -30.27 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.417 -175.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.02 -34.91 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.641 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 70.2 mt -77.49 -32.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.75 -47.27 89.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.437 -176.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 39.4 pt -67.27 -28.96 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.629 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 28.1 m -71.78 -36.26 70.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 176.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -25.2 59.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.586 -178.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.64 -47.83 87.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 722' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 722' ' ' MET . 0.0 OUTLIER -81.98 -23.22 36.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.41 -176.569 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 98.6 mt -88.84 3.85 49.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.705 175.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.66 -75.52 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.545 -170.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 53.02 -173.58 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -104.44 170.43 7.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.635 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -73.78 139.11 44.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.828 179.157 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 9.7 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.49 164.47 29.66 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 110.65 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.82 166.64 27.9 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.518 -178.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -157.11 161.03 39.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.472 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -165.06 15.98 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -8.9 9.13 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.499 -175.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 10.1 p -68.72 -12.38 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.72 177.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.15 -68.94 0.16 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.29 -40.15 85.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 176.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.51 -12.3 56.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -174.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.99 -13.28 24.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.937 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -8.75 57.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -171.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.15 -4.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.834 177.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -50.49 97.02 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 87.0 p -83.15 -168.49 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.608 0.242 . . . . 0.0 110.676 -175.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.53 144.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.7 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -81.42 -51.75 7.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.493 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.36 -10.04 56.27 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -175.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.86 69.31 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.76 -0.259 . . . . 0.0 110.939 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -53.5 -26.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.779 -173.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.97 -46.53 78.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.561 177.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.78 -32.55 32.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.35 -25.06 64.9 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.895 -0.179 . . . . 0.0 111.091 177.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 ttt -63.55 -30.91 71.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.719 -179.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.72 -44.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.58 2.88 78.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.43 23.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -177.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 3.1 m -86.65 -35.87 9.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -45.46 78.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.443 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.4 pt -70.37 -26.63 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 -179.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.37 73.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.47 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 3.0 m -61.67 -36.31 80.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.572 -178.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.44 -48.72 79.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.08 -38.34 79.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.414 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.24 -47.19 82.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.362 -176.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 43.2 mt -56.67 -42.29 76.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.524 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 93.5 m -67.13 -37.16 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.79 -30.11 69.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.656 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.35 -40.77 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 176.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 21.0 mtp -74.29 -24.71 59.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.9 -179.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.44 -41.69 97.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.408 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -159.04 -67.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.641 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -69.29 95.6 0.79 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.16 -166.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -83.71 131.09 34.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.55 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.32 -118.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 172.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.803 0.335 . . . . 0.0 110.74 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.706 0.289 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -139.09 15.78 2.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.603 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -73.31 -9.44 58.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.443 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -141.9 103.09 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -87.65 155.86 19.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.36 -21.2 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.07 -10.43 9.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.751 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.84 -13.43 62.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.815 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -90.45 34.27 0.89 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.657 176.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.49 55.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 176.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -65.41 -20.88 66.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.756 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.66 -38.7 64.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.781 178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.09 -62.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.415 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 60.6 -157.55 29.49 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 174.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 19.9 m 55.06 42.62 30.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 165.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -126.36 9.69 7.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.458 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -48.93 77.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.568 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.62 92.41 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.41 -11.29 60.82 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.771 -0.252 . . . . 0.0 110.801 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -65.7 -26.08 38.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.43 -177.66 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.08 -29.22 45.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.684 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -84.4 -33.2 20.52 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.82 -21.32 51.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.852 174.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.9 tpp -71.26 -47.96 53.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.497 -174.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 22.1 m -68.32 -31.11 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.652 174.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -89.83 11.28 70.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 177.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.32 13.88 56.2 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.52 -43.83 96.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.456 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.23 -40.21 50.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.57 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.2 mt -73.73 -28.68 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.579 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -33.3 75.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.544 -176.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.92 -45.28 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.541 178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.33 -36.92 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.424 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.73 -47.98 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 -176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 tp -69.4 -26.42 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.42 -174.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 57.0 m -75.67 -41.87 52.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.553 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.71 -35.68 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.486 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.4 mtt -78.7 -30.1 45.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.5 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.55 -49.83 36.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.644 176.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -103.11 120.76 41.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.626 -176.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.15 108.59 5.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.342 -175.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -98.47 39.54 1.24 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.593 -177.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 52.23 71.27 0.48 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.61 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.74 0.305 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -147.84 -173.3 4.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 2.3 m80 59.27 102.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.35 -67.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.476 -170.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -84.57 -157.05 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.383 172.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 17.1 mt 70.8 -2.21 2.36 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.91 -16.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -49.87 75.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.63 -21.68 35.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.709 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -74.73 -1.08 20.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.62 -14.23 62.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 173.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -65.57 -16.24 63.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.739 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.88 -40.9 74.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.639 174.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -83.71 118.83 4.76 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.87 107.06 2.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.575 0.226 . . . . 0.0 110.509 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.58 142.86 6.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 175.229 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -62.86 -35.67 80.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.662 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.26 -47.95 74.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 175.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.33 83.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.823 -0.222 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.99 -32.56 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.632 -174.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.57 -44.79 93.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 175.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.74 -29.39 57.63 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 75.2 mt -68.02 -24.62 65.13 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.911 -0.17 . . . . 0.0 110.923 177.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.2 ttm -66.57 -29.27 69.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.705 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.45 -38.67 81.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.89 -0.91 71.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.7 12.86 39.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -175.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -46.37 79.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.625 -178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.43 -47.49 80.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.66 -40.29 78.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.669 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -38.71 87.21 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.485 -178.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 65.3 t -61.89 -52.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.44 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.49 -39.29 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.562 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 73.6 t -68.34 -41.72 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.356 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.99 -36.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -72.98 -32.55 65.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.04 -33.41 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.01 -42.19 78.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 176.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -36.66 76.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.44 -39.76 77.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.649 177.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 725' ' ' LYS . 2.7 tptm -90.96 -160.4 0.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 724' ' ' LYS . 39.9 pttt -163.02 -20.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.356 -172.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -97.46 99.35 10.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.91 138.87 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.614 176.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.425 173.332 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.516 0.198 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.35 144.4 49.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.649 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -97.09 70.08 2.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.425 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.43 -19.16 24.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.65 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -76.17 158.76 31.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.43 -31.22 2.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.436 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.72 -28.95 41.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.47 -54.6 26.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 -175.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -61.99 -30.0 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.644 175.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.25 73.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.654 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.36 -35.68 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.38 -39.64 85.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.587 -171.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.72 -12.66 8.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.677 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 97.3 -48.66 1.54 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 172.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 17.5 t -161.83 96.09 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.604 -0.35 . . . . 0.0 110.449 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.61 -30.17 13.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.862 176.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -59.68 -28.09 66.98 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.554 -167.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -60.13 -62.13 6.39 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.67 -21.52 63.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.771 0.319 . . . . 0.0 110.737 -171.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 3.4 mm -60.36 -24.4 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.576 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 12.3 tt -57.51 -31.59 39.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -86.29 -33.07 14.99 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.45 -23.38 66.27 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.827 -0.219 . . . . 0.0 110.86 174.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.6 ttm -68.55 -25.57 64.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.719 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.0 -39.19 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.605 176.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.6 -7.14 88.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.38 23.18 10.31 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.35 -37.8 14.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.715 0.293 . . . . 0.0 110.489 175.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -41.0 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.373 -174.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.4 -26.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.681 177.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.14 -51.84 67.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.9 p -61.9 -34.37 75.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.76 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.31 -51.46 58.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 178.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.1 -39.98 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.452 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.32 -45.18 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 -174.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.47 -40.68 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.504 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.1 m -67.27 -39.29 86.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.479 176.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.614 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.15 -44.54 95.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.453 177.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 52.7 mmm -70.83 -33.85 71.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.481 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.89 -28.77 60.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.681 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 100.32 6.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.388 -175.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -133.31 -41.63 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.523 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 20.3 mttt 55.77 30.78 16.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.98 -178.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -143.82 -71.13 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.371 -178.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -178.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.837 0.351 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 128.92 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 -176.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.82 174.65 7.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.617 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -93.01 -179.7 5.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.67 178.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.49 56.15 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.546 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.6 -15.41 6.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.538 178.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.6 -10.67 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 -178.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 0.0 OUTLIER -77.74 -53.5 7.45 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.346 177.527 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . 0.402 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 66.1 t80 -74.16 -39.72 63.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.474 -177.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.36 -13.16 49.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.891 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.0 -19.91 63.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.745 175.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -65.26 -12.11 48.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 -176.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.95 -48.98 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 171.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 73.37 -149.87 42.8 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 99.3 p -161.99 -127.45 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.468 0.175 . . . . 0.0 110.555 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.56 -179.88 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.906 -177.199 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -77.07 -50.18 13.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.607 -177.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.32 -21.88 62.61 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.25 64.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.594 0.235 . . . . 0.0 110.788 177.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 9.7 mm -51.02 -33.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.602 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.17 -47.01 89.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.422 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.13 -36.48 24.41 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -176.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.99 -28.64 69.17 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.53 0.205 . . . . 0.0 110.857 176.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -31.12 70.46 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -46.19 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.44 -5.63 89.37 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 178.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.91 12.19 54.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 71.6 t -71.57 -46.49 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.758 0.313 . . . . 0.0 110.536 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.52 -42.34 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.407 -176.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.38 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.648 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.59 -52.5 65.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 178.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 69.7 p -62.94 -33.63 75.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.653 -177.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.35 -49.04 80.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.54 -31.82 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.49 -178.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.8 t -73.21 -39.6 56.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.442 -178.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.07 -32.22 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.426 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -45.38 90.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 174.387 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.48 -30.26 70.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.778 -176.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.607 176.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.3 tpt -82.65 -22.43 34.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.94 4.23 5.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 175.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -54.54 158.51 2.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.897 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -98.49 41.05 1.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.55 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 10.0 tttp 67.26 161.47 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.868 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 54.7 -148.53 0.47 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.589 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.274 178.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.925 0.393 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -100.32 135.7 41.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.565 178.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . 0.422 ' CG ' ' N ' ' A' ' 686' ' ' GLN . 14.1 p-80 -146.66 -125.61 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.337 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . 0.422 ' N ' ' CG ' ' A' ' 685' ' ' HIS . 4.2 tt0 71.6 49.67 0.28 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.042 0.449 . . . . 0.0 110.568 176.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -136.8 38.61 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.442 -174.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.75 -26.85 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.742 -176.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.74 9.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.701 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 0.0 OUTLIER -58.59 -54.96 41.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.63 177.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 7.4 t80 -81.23 -31.51 33.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 176.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -82.25 14.7 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.513 -178.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.68 -10.22 22.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.941 162.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.82 -11.58 56.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.545 -171.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 4.7 m -77.09 -0.33 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -61.48 148.53 46.89 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -173.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.0 m -127.92 -26.84 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.455 -0.373 . . . . 0.0 110.208 -160.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -57.61 155.49 9.72 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 178.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -58.97 -31.36 68.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 -173.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -76.96 -18.54 78.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.57 -13.97 62.31 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.828 -0.219 . . . . 0.0 110.923 176.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.01 -34.53 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.544 176.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 20.0 mt -70.29 -48.87 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.233 179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.92 -25.62 75.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 177.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.25 -43.85 80.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.4 mmt -70.04 -31.19 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.408 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.13 -48.45 78.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.9 1.95 78.87 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 178.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -93.22 16.93 59.4 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.81 -33.58 16.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.517 0.198 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -43.64 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.66 -25.58 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.08 -54.11 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 178.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 714' ' ' THR . . . . . 0.464 ' H ' ' HG1' ' A' ' 714' ' ' THR . 1.4 p -57.74 -36.64 72.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.84 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.81 -49.54 76.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -65.36 -40.48 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.4 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.92 -42.22 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.68 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 90.4 m -65.58 -31.24 72.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -25.95 64.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.733 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.27 -33.87 65.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 176.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.32 -29.13 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.423 -178.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.5 mt -70.42 -38.06 74.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.852 177.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -105.95 128.12 53.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.687 -175.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -176.99 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.634 -178.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -148.73 171.49 16.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.839 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -101.52 -63.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.421 -177.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.465 0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.916 176.837 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.485 0.183 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 152.26 25.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 -176.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.8 t60 50.53 54.29 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.581 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -94.37 -22.45 18.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.579 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -90.4 165.57 13.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.605 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.5 tp -117.13 -36.64 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.179 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.96 -18.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.59 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -78.47 -50.97 10.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.452 -175.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -13.81 62.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.66 177.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.99 67.34 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.82 -39.0 83.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.56 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.36 -47.08 24.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.467 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.55 -38.64 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 -176.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 137.64 -106.51 0.54 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 13.2 t -176.25 78.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 175.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -140.96 89.27 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -83.14 -19.39 36.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.94 -36.81 92.57 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 175.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.99 -8.8 52.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.594 0.235 . . . . 0.0 110.751 -170.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.4 tp -65.58 -21.43 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.641 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.22 -24.7 35.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -178.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.88 -35.22 19.49 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.69 -24.23 63.56 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 122.877 -0.19 . . . . 0.0 110.714 178.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 9.4 ttp -67.63 -25.7 65.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.24 -41.51 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -87.16 -0.83 84.88 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.42 9.38 55.22 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -44.75 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 -177.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.99 -36.96 59.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.45 -176.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.15 -27.94 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.529 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.14 -54.2 47.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.555 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 28.0 p -62.29 -29.17 70.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.629 -175.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.17 -48.3 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.49 177.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.44 -30.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.469 -178.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.81 -39.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.292 -177.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.78 -42.18 93.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.321 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.7 p -72.62 -29.39 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.579 -177.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 37.8 tp -67.46 -34.81 77.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.606 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.89 -31.13 52.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.3 ttt -72.63 -31.17 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.613 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.28 -16.2 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.762 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.3 tttp 66.72 132.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.746 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -143.0 165.87 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.722 -178.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -71.55 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.427 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -141.34 -63.39 0.46 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 -174.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.406 179.455 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -81.16 115.33 20.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.517 176.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -151.49 -9.83 0.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.586 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.49 77.68 1.94 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 -176.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 689' ' ' VAL . 36.1 mttp -132.07 -77.14 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.571 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.2 -47.2 0.62 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.926 -176.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 687' ' ' LYS . 2.7 t -57.39 -38.58 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 -177.278 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.51 -41.44 19.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.63 177.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -37.04 67.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -63.56 -30.51 71.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.748 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.24 -41.79 56.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -38.62 75.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.533 -171.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.07 -21.61 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 175.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -42.94 -38.66 3.4 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 172.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.73 140.94 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.741 170.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -77.8 169.2 18.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.821 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -60.09 -52.26 66.11 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.16 -23.86 64.55 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.55 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.764 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.79 -29.11 25.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.02 -48.65 78.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.495 -179.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.66 -34.76 48.28 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.67 -33.61 75.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.025 -179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.4 ttm -50.66 -25.14 3.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.91 -50.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.564 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.83 -4.25 85.05 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.67 13.37 56.27 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.06 -49.18 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.457 -177.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.26 -47.29 94.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.471 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 712' ' ' ILE . 17.2 mm -68.25 -34.13 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.465 -176.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.5 64.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 175.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -33.06 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.589 -176.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.11 -51.54 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.404 179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.4 -38.17 81.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.449 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.89 -43.55 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.457 -175.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.01 -34.28 52.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.559 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.3 m -70.61 -36.32 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.451 178.079 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 -30.16 70.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.685 -176.234 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.33 -39.67 81.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 2.8 ttt -73.71 -30.39 62.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.559 -176.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.89 -17.01 63.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.758 174.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.18 171.74 7.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -143.92 24.71 1.65 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.448 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 tttm 67.31 143.22 0.03 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.852 -178.127 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.57 133.44 39.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.677 174.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.49 171.088 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.618 0.247 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 70.3 1.79 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.371 -178.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -140.0 -61.24 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.518 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 52.68 -101.39 0.11 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt 49.88 -112.9 0.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.852 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 67.93 3.06 3.37 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.41 -17.63 20.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.439 176.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -78.31 -37.84 43.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.47 176.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -46.09 12.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.646 -178.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.7 -0.71 11.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.721 -177.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.01 -14.32 60.11 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 176.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.28 -7.16 59.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.68 -170.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.97 -18.83 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.02 176.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -133.81 83.26 0.29 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 174.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 35.0 p -111.0 57.03 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 175.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.49 132.56 37.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.504 177.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -56.36 -40.28 74.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.83 -36.14 81.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.75 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.733 178.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.6 mm -57.18 -32.92 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.635 -178.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 703' ' ' ILE . 8.6 mm -69.88 -43.32 79.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.524 178.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -78.67 -21.66 68.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.55 -24.71 49.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 174.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -21.51 66.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.522 -173.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 4.8 m -68.79 -31.31 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.17 0.16 63.83 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.32 13.39 33.85 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.18 -50.25 37.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.626 0.25 . . . . 0.0 110.489 -178.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -48.14 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.593 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.471 -178.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.82 72.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.577 177.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 85.2 m -60.24 -35.7 76.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.645 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.31 -45.7 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.65 -29.16 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.521 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.2 -42.27 31.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.414 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.12 -43.51 89.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.491 176.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 39.5 p -68.03 -31.31 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.545 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -28.9 67.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.578 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.47 -34.98 70.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 9.0 mtm -79.36 -15.98 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.618 -177.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.34 17.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.638 174.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -7.39 41.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.907 174.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 29.3 mttp 64.39 -167.3 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.726 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -98.4 -30.07 12.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -79.61 -2.91 44.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.642 177.688 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.444 0.164 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 703' ' ' ILE . 7.8 tt -57.34 -37.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.533 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 17.1 mt -69.18 -38.44 77.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.312 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.77 -45.55 64.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.04 -29.19 68.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.788 -0.206 . . . . 0.0 110.701 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 3.9 mmt -70.9 -51.28 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.49 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.04 -40.15 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.543 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.37 -6.77 87.97 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.53 5.25 78.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.03 -35.29 63.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.614 0.245 . . . . 0.0 110.688 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 715' ' ' VAL . 6.7 t -77.8 -38.02 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.371 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.51 -32.52 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.491 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.48 -53.12 61.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 35.0 p -64.32 -30.67 71.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.6 t -68.26 -49.8 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.87 -33.87 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.329 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.0 t -72.27 -45.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.433 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.9 mm -54.57 -41.3 54.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 15.7 m -65.87 -36.34 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.537 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -28.95 69.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.634 -176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.74 -47.52 88.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.413 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 57.6 mtt -77.26 -29.35 53.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.486 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.775 177.283 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.371 0.129 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 12.9 mm -58.16 -31.95 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.6 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 703' ' ' ILE . 1.8 mp -74.65 -43.02 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.373 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.51 -31.41 56.71 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.2 -25.48 66.94 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.839 -0.213 . . . . 0.0 110.834 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -30.54 69.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.96 -48.3 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.524 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -84.43 -3.22 88.71 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.16 11.34 55.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 714' ' ' THR . 7.7 p -73.53 -42.91 55.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.492 0.187 . . . . 0.0 110.538 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 715' ' ' VAL . 24.6 t -66.99 -45.65 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.372 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.0 -34.92 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.91 -51.13 70.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.533 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 710' ' ' VAL . 45.6 p -62.93 -36.77 84.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.619 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 711' ' ' VAL . 66.6 t -61.77 -54.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.502 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.62 -38.36 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.362 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.3 t -66.38 -42.17 90.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.507 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.12 -29.63 46.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.512 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -34.78 68.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 720' ' ' LEU . . . . . 0.488 HD13 HD12 ' A' ' 723' ' ' LEU . 1.6 mm? -65.52 -31.2 72.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.515 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.0 t -61.12 -38.12 78.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 5.4 mmt -76.54 -28.14 56.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.571 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 720' ' ' LEU . 84.4 mt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.778 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.68 -29.91 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 4.4 mm -63.44 -50.86 76.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.89 -34.77 29.73 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.79 -29.11 70.46 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.825 -0.22 . . . . 0.0 110.964 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -30.54 71.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.658 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.79 -40.51 85.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.59 1.62 64.11 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.73 14.06 32.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.1 OUTLIER -70.52 -46.99 67.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.564 0.221 . . . . 0.0 110.624 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -67.76 -42.24 85.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.467 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.3 mt -66.47 -36.86 78.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.517 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.55 -51.41 70.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -38.73 83.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.707 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 711' ' ' VAL . 88.3 t -63.06 -50.4 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.477 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -36.83 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 70.0 t -69.32 -42.42 81.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.446 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.93 -29.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.548 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -71.44 -36.16 71.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.578 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.74 -30.69 71.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.5 -36.65 65.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.505 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -32.74 68.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.537 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 177.247 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.496 0.188 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.58 -33.78 49.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.496 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 15.3 mm -66.58 -36.54 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.368 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.11 -31.97 41.01 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -70.93 -21.14 62.39 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.781 -0.246 . . . . 0.0 110.941 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.5 ttm -66.13 -25.8 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.17 -42.05 95.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.99 80.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.17 11.58 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.65 -37.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.589 0.233 . . . . 0.0 110.609 -174.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.8 OUTLIER -76.15 -37.87 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.42 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.14 -28.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.4 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.45 -54.29 42.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.573 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.47 -37.46 75.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 711' ' ' VAL . 94.1 t -63.8 -52.7 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.356 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 45.0 mt -66.85 -37.81 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.485 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -70.44 -40.29 77.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.408 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 42.3 mt -63.72 -32.95 58.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.44 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.5 m -69.73 -32.38 70.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -69.28 -29.43 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.07 -34.88 71.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.464 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 -37.09 86.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.707 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.431 -179.426 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.419 0.152 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.8 mm -55.48 -39.2 52.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.61 -43.82 95.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.36 -37.09 37.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.12 -25.4 67.75 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.842 -0.21 . . . . 0.0 110.989 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.48 -28.72 69.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -42.83 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.35 -3.22 88.52 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.99 24.49 7.85 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.79 -34.39 7.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.633 0.254 . . . . 0.0 110.6 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 715' ' ' VAL . 22.1 t -76.51 -42.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.468 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -26.07 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -62.14 -51.55 67.4 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 2.2 p -61.04 -33.75 73.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.703 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 711' ' ' VAL . 67.4 t -68.17 -46.45 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.43 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 82.8 mt -73.86 -31.23 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.4 t -74.19 -42.83 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.391 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.7 mt -61.89 -37.6 78.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 10.7 p -72.22 -30.63 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.598 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.1 t -60.39 -33.89 55.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.514 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.2 mmt -73.03 -32.84 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.746 176.184 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.032 0 CA-C-O 120.479 0.18 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 20.4 mt -55.75 -41.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.513 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.33 -48.36 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -67.08 -28.24 73.71 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.24 -21.55 39.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.118 . . . . 0.0 110.717 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 11.3 tpt -67.31 -49.12 65.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.362 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 707' ' ' VAL . 14.3 m -66.79 -33.82 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.1 5.89 82.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.86 17.24 42.12 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.65 -43.59 61.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.643 0.258 . . . . 0.0 110.416 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.4 p -69.45 -42.51 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.1 tt -75.82 -26.58 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.49 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.5 -46.94 88.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.8 m -67.85 -35.54 78.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.61 -43.82 91.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.536 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.7 mm -69.75 -38.15 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.482 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.6 t -60.18 -46.24 94.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.444 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.35 -28.78 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.415 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 3.9 m -75.69 -38.52 58.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.441 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 720' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -65.33 -31.33 72.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 717' ' ' VAL . 87.7 t -61.0 -28.85 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.571 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -81.12 -24.47 37.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 720' ' ' LEU . 85.5 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.495 0.188 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.2 tt -53.98 -33.77 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.84 -40.58 88.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.317 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.21 62.67 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.19 -31.05 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.602 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.3 ttm -72.18 -50.94 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.81 -34.46 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.435 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.37 -4.29 86.18 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 709' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.24 18.01 30.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.3 m -76.53 -34.06 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.93 -45.91 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.545 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.28 -25.38 31.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.14 -51.23 68.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 37.0 p -64.0 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.596 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.88 -45.12 84.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.46 -36.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.456 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.2 t -70.97 -47.77 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.393 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.12 -26.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.483 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 68.9 m -70.01 -46.1 65.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.594 171.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.03 -32.74 74.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.58 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.51 -40.33 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.508 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.3 mmm -79.56 -27.99 41.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.484 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 723' ' ' LEU . 89.8 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.52 0.2 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 5.8 tt -55.9 -36.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.575 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 707' ' ' VAL . 82.9 mt -64.96 -36.86 78.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.41 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -71.28 -33.63 64.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.02 -32.11 63.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.503 0.192 . . . . 0.0 110.77 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 13.5 tpp -71.79 -51.71 21.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 703' ' ' ILE . 12.4 p -73.05 -37.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.428 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 708' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -82.97 -2.25 90.66 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -80.46 2.82 76.23 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 20.9 m -65.39 -40.15 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.404 0.145 . . . . 0.0 110.707 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 711' ' ' VAL . 0.0 OUTLIER -76.28 -41.28 36.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.503 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 68.6 mt -71.12 -30.17 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.65 -50.73 72.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -39.51 94.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.49 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.4 -51.15 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.516 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.16 -36.92 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.8 t -58.49 -46.99 89.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.457 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.48 -32.0 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -43.2 82.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.63 -29.48 66.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.599 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.02 -41.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.406 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.0 tpt -75.21 -31.82 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.475 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.092 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.34 0.114 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.03 -32.46 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 -173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.53 -48.03 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.623 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.29 66.98 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.48 -24.16 65.57 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 122.944 -0.151 . . . . 0.0 110.778 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 26.4 ttm -65.58 -30.53 71.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.11 -40.24 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.14 0.48 75.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.25 12.34 45.29 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -67.47 -49.0 75.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 110.664 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 715' ' ' VAL . 93.7 t -65.01 -46.51 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.37 -36.0 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.588 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.59 -47.89 83.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 714' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 718' ' ' ILE . 18.5 m -64.3 -36.77 85.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.6 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 711' ' ' VAL . 86.0 t -63.25 -31.69 53.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.525 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 73.8 mt -80.16 -30.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 713' ' ' ALA . 62.3 t -64.68 -39.27 85.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.58 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 714' ' ' THR . 1.1 pt -65.23 -26.07 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 1.1 m -79.92 -30.48 40.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.33 -29.23 70.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -31.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -26.14 60.48 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.568 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.711 175.865 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.566 0.222 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.12 -26.62 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -42.26 84.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.2 98.37 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.16 -22.76 59.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.835 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -47.65 69.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.339 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 710' ' ' VAL . 61.2 t -67.04 -37.6 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.323 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.65 7.98 60.51 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.66 12.52 56.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 707' ' ' VAL . 29.1 m -68.31 -39.9 81.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.504 0.192 . . . . 0.0 110.678 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -75.0 -43.19 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.63 -31.05 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.362 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.97 -53.09 62.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.615 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -39.59 82.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 60.2 t -61.4 -51.6 71.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.495 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.21 -35.15 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.339 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.4 t -67.46 -36.34 76.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.438 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 721' ' ' VAL . 52.0 mt -69.96 -26.94 31.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -25.83 48.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.698 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.37 -20.83 62.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.4 m -67.22 -26.53 36.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 tpt -70.41 -37.21 74.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.437 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.646 174.664 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.037 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 46.0 mt -57.07 -31.49 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.482 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 9.9 mm -68.22 -44.69 83.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.85 41.45 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.94 -24.37 67.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.222 . . . . 0.0 111.045 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 25.4 ttm -61.96 -28.74 69.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.49 -40.25 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -88.19 -1.95 81.01 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.47 14.9 48.89 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.91 -49.57 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.632 0.254 . . . . 0.0 110.445 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 78.2 t -60.26 -47.39 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.519 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.27 -34.37 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.535 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.14 -48.98 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.39 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -33.17 74.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.527 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 57.3 t -70.3 -46.4 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.363 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 11.9 mm -72.21 -31.76 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 721' ' ' VAL . 45.6 t -74.33 -45.91 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.429 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.8 -41.28 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.406 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 32.2 p -73.42 -27.53 61.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.697 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.86 -31.13 69.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 717' ' ' VAL . 93.9 t -65.32 -28.74 45.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.558 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' MET . . . . . 0.478 ' SD ' ' N ' ' A' ' 722' ' ' MET . 0.9 OUTLIER -82.28 -24.85 34.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.706 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.444 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.359 0.124 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.473 ' O ' HD13 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -59.09 -31.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.674 -175.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.47 -47.41 86.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.555 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.05 -37.61 37.54 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.29 -26.01 68.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.496 0.189 . . . . 0.0 110.705 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 14.2 ttp -60.54 -32.5 71.55 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.28 -46.01 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.504 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.86 -3.53 85.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.77 13.57 47.32 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.71 -36.41 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 110.658 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 715' ' ' VAL . 35.2 m -73.7 -40.15 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.452 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 711' ' ' VAL . 3.5 mm -65.9 -36.77 78.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.92 -52.87 63.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -35.45 78.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.736 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 711' ' ' VAL . 92.0 t -63.49 -51.4 71.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.471 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 95.7 mt -68.14 -37.08 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.2 t -67.4 -41.05 85.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.444 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 718' ' ' ILE . . . . . 0.597 ' O ' HG22 ' A' ' 721' ' ' VAL . 36.3 mt -63.51 -26.09 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.84 -27.48 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.671 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' LEU . . . . . 1.002 HD13 HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -62.18 -27.61 69.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 718' ' ' ILE . 2.7 m -65.81 -21.17 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.511 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 12.9 mtt -78.68 -22.57 46.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.659 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 1.002 HD12 HD13 ' A' ' 720' ' ' LEU . 97.4 mt . . . . . 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.802 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.646 0.26 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.9 mt -63.2 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 703' ' ' ILE . 0.9 OUTLIER -63.03 -22.65 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.347 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.21 38.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.844 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -63.01 -46.78 86.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.618 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.54 -31.7 43.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.33 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.66 13.38 66.84 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.45 37.27 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 711' ' ' VAL . 7.1 p -67.95 -39.86 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.551 0.215 . . . . 0.0 110.656 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.476 HG23 HG13 ' A' ' 710' ' ' VAL . 33.7 t -75.82 -42.71 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.4 -27.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.438 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.81 -49.94 75.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.584 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 88.0 m -62.09 -41.2 97.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 91.5 t -56.8 -42.19 77.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.462 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -74.24 -35.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 713' ' ' ALA . 76.3 t -60.12 -47.64 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.28 -30.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.452 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 5.3 m -72.64 -39.1 67.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.528 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 720' ' ' LEU . . . . . 0.431 HD13 HD12 ' A' ' 723' ' ' LEU . 0.6 OUTLIER -64.83 -30.51 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -32.21 56.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.402 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.67 -32.36 57.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 -172.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 720' ' ' LEU . 85.6 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.808 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.087 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 26.1 mt -54.69 -34.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.31 -47.57 80.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.582 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.42 59.47 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.66 -26.74 68.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.425 -0.11 . . . . 0.0 110.823 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -27.64 66.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.01 -43.35 99.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.513 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.11 -2.99 90.71 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -87.79 24.74 9.79 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.89 -47.04 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.56 0.219 . . . . 0.0 110.465 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.1 p -62.87 -44.25 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -177.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.494 ' N ' HG13 ' A' ' 711' ' ' VAL . 17.7 tt -70.6 -28.23 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.24 -49.08 78.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.541 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -30.72 70.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.467 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.7 t -76.37 -49.09 25.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.405 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.92 -23.58 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.703 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 713' ' ' ALA . 16.2 t -66.6 -44.93 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.72 -36.75 62.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.539 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -41.5 97.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.447 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -31.14 69.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.759 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 -31.71 55.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 14.8 ttm -80.28 -26.04 39.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.661 177.109 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.388 0.137 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.23 -27.95 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.483 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.3 mt -70.34 -44.03 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.21 -35.33 49.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 705' ' ' LEU . 94.0 mt -71.28 -34.75 70.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.89 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.1 tpp -62.89 -55.17 28.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.392 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 708' ' ' GLY . 12.5 p -73.87 -38.57 50.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.458 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 708' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -75.54 -5.98 79.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.49 16.69 17.32 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 711' ' ' VAL . 7.9 p -68.55 -40.96 82.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.64 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 710' ' ' VAL . 7.4 p -75.8 -38.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.512 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.4 ' N ' HG13 ' A' ' 711' ' ' VAL . 7.3 mt -75.6 -26.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.19 -50.83 72.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.509 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 67.7 p -63.66 -34.75 78.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.579 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.03 -48.18 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.54 -36.86 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.458 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 713' ' ' ALA . 64.7 t -70.47 -44.12 77.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.406 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.28 -38.49 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.5 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 20.8 m -68.16 -32.86 73.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.599 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.61 -32.24 73.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.606 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.66 -41.24 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.476 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.08 -31.2 55.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.524 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 178.184 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 120.433 0.158 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.58 -30.69 22.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.652 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.39 -42.11 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.493 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.72 -43.68 17.7 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.61 -34.43 69.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.379 0.133 . . . . 0.0 110.89 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.8 ttt -64.9 -53.08 52.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.405 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 710' ' ' VAL . 39.7 t -73.87 -42.28 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.49 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.85 -6.61 82.43 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.53 18.74 40.5 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.2 t -75.76 -35.34 30.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 91.1 t -71.14 -49.14 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 18.5 pt -67.73 -27.41 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.59 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.35 -50.81 72.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.594 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -37.44 85.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.547 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.93 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.569 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.63 -29.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.553 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -64.25 -40.38 88.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.463 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 721' ' ' VAL . 1.4 mp -67.4 -26.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.475 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 16.0 m -78.96 -29.13 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.617 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -26.86 67.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -173.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.2 m -62.6 -26.11 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.481 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.87 -35.43 69.78 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.53 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 174.191 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.557 0.217 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 703' ' ' ILE . 17.3 tt -55.57 -37.03 44.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 13.6 mt -69.16 -39.7 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.67 12.95 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.52 -36.28 69.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.511 0.196 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 18.8 ttp -63.56 -54.67 32.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.411 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 710' ' ' VAL . 61.7 t -71.87 -43.49 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.35 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.59 -4.94 62.53 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.27 16.13 35.8 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.0 t -70.46 -47.61 64.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 110.579 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -44.44 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.604 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.64 -25.22 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.14 -53.12 61.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 76.5 p -61.71 -33.37 73.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.65 -46.18 86.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.518 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 -32.02 36.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 81.0 t -73.52 -41.33 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.36 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.22 -44.17 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 13.4 p -64.26 -31.96 73.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.607 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -31.73 73.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.683 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.87 -46.53 93.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 10.8 ttt -67.91 -36.71 80.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.781 -176.491 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 701' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 705' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 110.832 -0.062 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.75 -42.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.449 -173.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.65 -30.21 37.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.591 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.5 -24.5 72.67 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 701' ' ' ALA . 80.4 mt -61.4 -34.03 74.68 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.936 -0.155 . . . . 0.0 110.933 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.18 -38.4 35.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.55 -54.25 37.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.349 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -83.79 -29.63 31.52 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 709' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -65.27 -33.06 85.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -169.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.69 -47.15 87.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 110.632 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.96 -48.68 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.506 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 28.7 mt -62.66 -30.77 50.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.649 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -56.41 -53.51 56.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.443 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 66.8 p -61.47 -33.25 73.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.625 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.69 -51.89 29.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.416 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.35 -33.33 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.416 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 713' ' ' ALA . 22.6 t -63.26 -43.97 98.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.303 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.88 -32.09 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.464 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -29.59 55.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.61 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -32.63 74.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.623 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.18 -35.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.428 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 ttm -72.0 -33.39 68.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.723 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.564 177.478 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.692 0.282 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.04 -32.93 51.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.581 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.36 -43.95 91.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.89 -40.9 24.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 47.3 mt -72.49 -21.64 61.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.792 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -25.74 62.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.47 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.57 -40.76 87.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.412 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.23 1.99 83.15 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.14 26.23 8.03 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -43.09 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.729 0.3 . . . . 0.0 110.64 173.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -71.98 -38.38 63.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.449 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 712' ' ' ILE . 8.2 tt -78.22 -25.02 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.41 73.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.515 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.43 -38.44 80.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 711' ' ' VAL . 63.1 t -65.64 -51.0 67.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.459 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.45 -37.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.579 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 721' ' ' VAL . 41.4 t -69.53 -39.01 77.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.32 -175.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.9 mt -65.91 -33.85 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.346 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -34.51 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.775 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.3 -31.73 72.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.654 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 717' ' ' VAL . 41.1 t -67.47 -27.23 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.531 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 6.3 mmt -80.52 -31.65 37.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.514 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.423 175.902 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.466 0.174 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.3 pt -58.89 -28.28 37.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.492 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.93 -46.94 81.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.426 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.73 -33.99 59.95 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.86 -21.42 51.4 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.839 -0.212 . . . . 0.0 110.997 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.29 -43.08 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.67 -29.27 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -101.32 9.13 57.46 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.52 12.3 40.83 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.7 -30.4 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.686 0.279 . . . . 0.0 110.724 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 715' ' ' VAL . 64.8 t -76.81 -46.46 30.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 22.3 pt -67.41 -25.85 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.594 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.52 -52.58 62.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 6.1 p -62.19 -31.98 72.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.666 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 711' ' ' VAL . 70.4 t -67.28 -46.83 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 34.9 mt -71.67 -33.5 49.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.4 t -68.54 -40.27 81.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 718' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 721' ' ' VAL . 3.8 mm -62.66 -32.93 57.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -23.82 41.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.787 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.37 -24.75 64.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.703 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.5 m -63.87 -26.12 39.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -69.48 -36.68 76.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.893 176.788 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.475 0.179 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -54.6 -32.79 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.589 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.88 -31.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -178.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.68 -39.37 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 705' ' ' LEU . 63.9 mt -63.85 -43.56 95.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.587 0.232 . . . . 0.0 110.781 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.0 ttt -62.17 -53.64 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.412 -174.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 710' ' ' VAL . 87.4 t -72.51 -44.06 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.405 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.22 3.44 46.75 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.17 20.07 23.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 707' ' ' VAL . 87.8 t -64.5 -49.97 78.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 110.601 174.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.86 -43.91 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.445 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.2 -23.73 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.411 -176.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -63.3 -49.99 71.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.562 176.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 70.8 p -66.14 -30.27 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.417 -175.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.02 -34.91 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.641 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 70.2 mt -77.49 -32.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.5 t -64.75 -47.27 89.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.437 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 39.4 pt -67.27 -28.96 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.629 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 719' ' ' THR . . . . . 0.626 HG22 HD12 ' A' ' 723' ' ' LEU . 28.1 m -71.78 -36.26 70.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -25.2 59.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.586 -178.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 717' ' ' VAL . 55.9 t -64.64 -47.83 87.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 722' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 722' ' ' MET . 0.0 OUTLIER -81.98 -23.22 36.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.41 -176.569 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 719' ' ' THR . 98.6 mt . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.705 175.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.483 0.182 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -53.5 -26.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.779 -173.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.97 -46.53 78.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.561 177.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.78 -32.55 32.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.35 -25.06 64.9 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.895 -0.179 . . . . 0.0 111.091 177.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 ttt -63.55 -30.91 71.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.719 -179.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.72 -44.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.58 2.88 78.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.43 23.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -177.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 3.1 m -86.65 -35.87 9.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -45.46 78.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.443 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.4 pt -70.37 -26.63 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 -179.007 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.18 -50.37 73.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.47 177.076 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 3.0 m -61.67 -36.31 80.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.572 -178.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.44 -48.72 79.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.08 -38.34 79.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.414 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 721' ' ' VAL . 54.1 t -67.24 -47.19 82.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.362 -176.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 43.2 mt -56.67 -42.29 76.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.524 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 93.5 m -67.13 -37.16 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.79 -30.11 69.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.656 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 717' ' ' VAL . 26.0 t -67.35 -40.77 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 176.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 21.0 mtp -74.29 -24.71 59.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.9 -179.168 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.408 -178.896 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -65.7 -26.08 38.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.43 -177.66 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.08 -29.22 45.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.684 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -84.4 -33.2 20.52 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.82 -21.32 51.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.852 174.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.9 tpp -71.26 -47.96 53.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.497 -174.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 22.1 m -68.32 -31.11 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.652 174.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -89.83 11.28 70.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 177.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.32 13.88 56.2 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.52 -43.83 96.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.456 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.5 p -74.23 -40.21 50.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.57 -177.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.426 ' N ' HG13 ' A' ' 711' ' ' VAL . 16.2 mt -73.73 -28.68 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -57.08 -51.01 70.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.579 174.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -33.3 75.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.544 -176.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.92 -45.28 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.541 178.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.33 -36.92 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.424 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 713' ' ' ALA . 97.1 t -67.73 -47.98 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 tp -69.4 -26.42 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.42 -174.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 57.0 m -75.67 -41.87 52.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.553 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.71 -35.68 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.486 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.4 mtt -78.7 -30.1 45.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.5 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.644 176.886 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.03 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.99 -32.56 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.632 -174.281 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.57 -44.79 93.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 175.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.74 -29.39 57.63 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 75.2 mt -68.02 -24.62 65.13 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.911 -0.17 . . . . 0.0 110.923 177.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.2 ttm -66.57 -29.27 69.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.705 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.45 -38.67 81.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.89 -0.91 71.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.7 12.86 39.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -175.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -68.92 -46.37 79.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.625 -178.909 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 715' ' ' VAL . 44.1 t -67.43 -47.49 80.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 -177.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.66 -40.29 78.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.669 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.87 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -38.71 87.21 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.485 -178.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 711' ' ' VAL . 65.3 t -61.89 -52.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.44 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.49 -39.29 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.562 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 73.6 t -68.34 -41.72 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.356 -175.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.99 -36.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -72.98 -32.55 65.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.04 -33.41 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.01 -42.19 78.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 176.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -36.66 76.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.649 177.406 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.474 HD13 HD12 ' A' ' 705' ' ' LEU . 3.4 mm -60.36 -24.4 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.576 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 12.3 tt -57.51 -31.59 39.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -86.29 -33.07 14.99 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 702' ' ' ILE . 86.8 mt -66.45 -23.38 66.27 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.827 -0.219 . . . . 0.0 110.86 174.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.6 ttm -68.55 -25.57 64.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.719 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 710' ' ' VAL . 46.2 t -66.0 -39.19 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.605 176.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.6 -7.14 88.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.38 23.18 10.31 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 707' ' ' VAL . 90.0 t -82.35 -37.8 14.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.715 0.293 . . . . 0.0 110.489 175.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 711' ' ' VAL . 0.9 OUTLIER -74.27 -41.0 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.373 -174.852 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.4 -26.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.681 177.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -51.84 67.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.9 p -61.9 -34.37 75.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.76 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.31 -51.46 58.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 178.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.1 -39.98 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.452 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.3 t -69.32 -45.18 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 -174.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.47 -40.68 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.504 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.1 m -67.27 -39.29 86.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.479 176.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.614 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 717' ' ' VAL . 98.7 t -60.15 -44.54 95.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.453 177.017 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 52.7 mmm -70.83 -33.85 71.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.481 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.681 177.842 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.594 0.235 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 9.7 mm -51.02 -33.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.602 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.17 -47.01 89.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.422 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.13 -36.48 24.41 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -176.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.99 -28.64 69.17 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.53 0.205 . . . . 0.0 110.857 176.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -31.12 70.46 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -46.19 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.44 -5.63 89.37 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 178.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.91 12.19 54.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.017 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 71.6 t -71.57 -46.49 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.758 0.313 . . . . 0.0 110.536 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 715' ' ' VAL . 2.8 t -67.52 -42.34 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.407 -176.194 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.38 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.648 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.59 -52.5 65.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 178.355 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 69.7 p -62.94 -33.63 75.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.653 -177.143 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.3 t -65.35 -49.04 80.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.54 -31.82 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.49 -178.167 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.8 t -73.21 -39.6 56.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.442 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.07 -32.22 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.426 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -45.38 90.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 174.387 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.48 -30.26 70.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.778 -176.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.607 176.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.3 tpt -82.65 -22.43 34.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 175.581 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.506 0.193 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.01 -34.53 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.544 176.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 707' ' ' VAL . 20.0 mt -70.29 -48.87 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.233 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.92 -25.62 75.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 177.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.25 -43.85 80.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.589 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.4 mmt -70.04 -31.19 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.408 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 703' ' ' ILE . 77.7 t -67.13 -48.45 78.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.503 -178.526 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.9 1.95 78.87 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 178.453 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -93.22 16.93 59.4 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.81 -33.58 16.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.517 0.198 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -72.44 -43.64 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 -179.523 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.66 -25.58 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.32 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -64.08 -54.11 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 178.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.4 p -57.74 -36.64 72.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.84 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 711' ' ' VAL . 90.7 t -65.81 -49.54 76.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.472 -179.181 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -65.36 -40.48 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.4 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -68.92 -42.22 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.194 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.68 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 90.4 m -65.58 -31.24 72.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -25.95 64.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.733 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.27 -33.87 65.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 176.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.32 -29.13 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.423 -178.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.852 177.677 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.594 0.235 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.4 tp -65.58 -21.43 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.641 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.22 -24.7 35.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -178.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.88 -35.22 19.49 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.69 -24.23 63.56 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 122.877 -0.19 . . . . 0.0 110.714 178.188 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 9.4 ttp -67.63 -25.7 65.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.24 -41.51 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -87.16 -0.83 84.88 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.42 9.38 55.22 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 710' ' ' VAL . 0.2 OUTLIER -64.91 -44.75 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 -177.782 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 715' ' ' VAL . 84.1 t -71.99 -36.96 59.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.45 -176.645 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.15 -27.94 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.529 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -54.2 47.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.555 175.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 28.0 p -62.29 -29.17 70.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.629 -175.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.1 t -70.17 -48.3 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.49 177.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.44 -30.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.469 -178.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 721' ' ' VAL . 70.2 t -76.81 -39.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.292 -177.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.78 -42.18 93.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.321 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.7 p -72.62 -29.39 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.579 -177.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 720' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 723' ' ' LEU . 37.8 tp -67.46 -34.81 77.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.606 177.026 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 717' ' ' VAL . 63.5 t -64.89 -31.13 52.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.485 178.298 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.3 ttt -72.63 -31.17 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.613 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 723' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 720' ' ' LEU . 94.7 mt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.762 178.031 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.79 -29.11 25.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.02 -48.65 78.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.495 -179.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.66 -34.76 48.28 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.67 -33.61 75.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.025 -179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.4 ttm -50.66 -25.14 3.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 710' ' ' VAL . 52.1 t -64.91 -50.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.564 174.058 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.83 -4.25 85.05 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.67 13.37 56.27 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 707' ' ' VAL . 94.2 t -72.06 -49.18 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.457 -177.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 715' ' ' VAL . 26.6 t -61.26 -47.29 94.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.471 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.2 mm -68.25 -34.13 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.465 -176.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.78 -52.5 64.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 175.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -33.06 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.589 -176.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -68.11 -51.54 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.404 179.055 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.4 -38.17 81.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.449 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -69.89 -43.55 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.457 -175.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.01 -34.28 52.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.559 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.3 m -70.61 -36.32 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.451 178.079 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 -30.16 70.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.685 -176.234 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.33 -39.67 81.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 2.8 ttt -73.71 -30.39 62.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.559 -176.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.758 174.65 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.073 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.6 mm -57.18 -32.92 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.635 -178.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.88 -43.32 79.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.524 178.174 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 704' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 707' ' ' VAL . . . -78.67 -21.66 68.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -177.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.55 -24.71 49.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 174.887 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -21.51 66.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.522 -173.04 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 707' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 704' ' ' GLY . 4.8 m -68.79 -31.31 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 -179.086 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.17 0.16 63.83 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.32 13.39 33.85 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.18 -50.25 37.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.626 0.25 . . . . 0.0 110.489 -178.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 711' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -59.25 -48.14 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.593 177.738 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.471 -178.012 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.31 -50.82 72.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.577 177.134 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 85.2 m -60.24 -35.7 76.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.645 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -67.31 -45.7 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.65 -29.16 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.521 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 717' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.5 t -77.2 -42.27 31.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.414 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.12 -43.51 89.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.491 176.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 39.5 p -68.03 -31.31 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.545 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -28.9 67.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.578 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 721' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 717' ' ' VAL . 60.4 t -63.47 -34.98 70.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 175.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 9.0 mtm -79.36 -15.98 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.618 -177.767 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.53 0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.638 174.005 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.55 0.214 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 684' ' ' HIS . . . . . 0.402 ' CG ' ' H ' ' A' ' 685' ' ' HIS . 5.0 t-80 -96.51 -179.52 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.614 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 685' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 684' ' ' HIS . 32.3 p-80 -119.48 176.13 5.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -151.03 77.89 1.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.09 19.48 11.63 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.32 -15.52 62.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.33 -0.34 4.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.861 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -71.76 -27.98 63.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -82.88 8.88 11.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.799 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.22 61.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.51 -3.43 14.63 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.16 -16.32 62.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.46 -21.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -72.18 -156.73 3.03 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 53.1 m -137.45 -85.96 0.3 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.455 0.169 . . . . 0.0 110.608 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 699' ' ' LYS . 14.6 p-10 -151.54 -111.34 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.515 ' H ' ' CG ' ' A' ' 698' ' ' ASN . 0.4 OUTLIER -54.28 -40.93 68.31 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.918 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.24 -18.4 71.21 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.08 60.72 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.805 -0.233 . . . . 0.0 110.895 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 699' ' ' LYS . 7.8 tt -57.34 -37.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.533 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 17.1 mt -69.18 -38.44 77.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.312 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.77 -45.55 64.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.04 -29.19 68.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.788 -0.206 . . . . 0.0 110.701 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 3.9 mmt -70.9 -51.28 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.49 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.04 -40.15 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.543 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.37 -6.77 87.97 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.53 5.25 78.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.03 -35.29 63.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.614 0.245 . . . . 0.0 110.688 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 715' ' ' VAL . 6.7 t -77.8 -38.02 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.371 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.51 -32.52 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.491 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.48 -53.12 61.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 35.0 p -64.32 -30.67 71.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.6 t -68.26 -49.8 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.87 -33.87 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.329 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.0 t -72.27 -45.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.433 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.9 mm -54.57 -41.3 54.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 15.7 m -65.87 -36.34 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.537 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -28.95 69.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.634 -176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.74 -47.52 88.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.413 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 57.6 mtt -77.26 -29.35 53.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.486 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.41 -16.26 56.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.775 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.2 pttp 26.29 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.604 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -60.68 130.28 45.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.749 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 45.4 mttt 51.81 68.67 0.77 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.802 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 54.48 -141.67 0.85 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.443 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.577 172.19 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.706 0.289 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -98.79 -156.41 0.54 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.653 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.26 95.23 10.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -91.09 12.99 18.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.13 -165.28 1.16 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.37 5.35 4.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.944 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 83.9 t -75.79 -6.08 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.564 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -30.39 12.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.466 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.76 -56.13 3.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.306 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.36 -17.2 64.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.54 -17.89 63.28 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.773 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 92.3 t -60.32 -39.12 79.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 64.49 -129.35 36.64 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.63 -50.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ASN . . . . . 0.546 ' H ' ' HB3' ' A' ' 701' ' ' ALA . 0.2 OUTLIER -166.79 171.29 11.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.447 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.5 -47.21 66.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.755 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.26 -24.34 76.03 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.546 ' HB3' ' H ' ' A' ' 698' ' ' ASN . . . -64.74 -40.87 96.04 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.789 175.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 12.9 mm -58.16 -31.95 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.6 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 703' ' ' ILE . 1.8 mp -74.65 -43.02 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.373 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.51 -31.41 56.71 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.2 -25.48 66.94 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.839 -0.213 . . . . 0.0 110.834 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -30.54 69.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.96 -48.3 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.524 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -84.43 -3.22 88.71 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.16 11.34 55.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 714' ' ' THR . 7.7 p -73.53 -42.91 55.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.492 0.187 . . . . 0.0 110.538 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 715' ' ' VAL . 24.6 t -66.99 -45.65 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.372 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.0 -34.92 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.91 -51.13 70.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.533 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 710' ' ' VAL . 45.6 p -62.93 -36.77 84.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.619 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 711' ' ' VAL . 66.6 t -61.77 -54.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.502 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.62 -38.36 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.362 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.3 t -66.38 -42.17 90.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.507 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.12 -29.63 46.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.512 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -34.78 68.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' LEU . . . . . 0.488 HD13 HD12 ' A' ' 723' ' ' LEU . 1.6 mm? -65.52 -31.2 72.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.515 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.0 t -61.12 -38.12 78.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 5.4 mmt -76.54 -28.14 56.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.571 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 720' ' ' LEU . 84.4 mt -64.45 -24.8 67.74 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.778 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt 71.95 155.5 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -148.19 -72.01 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.447 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -166.7 97.14 0.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.445 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -167.34 -102.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.435 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.477 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.703 0.287 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 64.83 19.04 11.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -102.14 -62.82 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -168.96 144.6 3.35 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.534 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -101.93 103.23 13.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.502 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.17 -16.41 4.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 10.3 p -64.2 -13.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.758 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -54.63 44.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.679 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -75.42 -31.69 60.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.612 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 695' ' ' VAL . . . -66.67 -13.3 61.07 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -60.24 -17.5 42.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.08 -10.61 59.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.918 -171.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 692' ' ' ALA . 17.0 m -70.25 -4.56 4.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.805 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -51.28 143.24 16.53 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 7.6 t -128.68 -165.38 1.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.18 146.58 0.06 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -83.92 -50.56 7.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.491 -178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -64.98 -13.67 57.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.48 -24.97 68.05 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.788 -0.242 . . . . 0.0 110.966 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 699' ' ' LYS . 2.1 pp -56.68 -29.91 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.811 -175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 4.4 mm -63.44 -50.86 76.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.89 -34.77 29.73 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.79 -29.11 70.46 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.825 -0.22 . . . . 0.0 110.964 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -30.54 71.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.658 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.79 -40.51 85.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.59 1.62 64.11 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.73 14.06 32.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.1 OUTLIER -70.52 -46.99 67.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.564 0.221 . . . . 0.0 110.624 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -67.76 -42.24 85.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.467 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.3 mt -66.47 -36.86 78.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.517 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.55 -51.41 70.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -38.73 83.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.707 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 711' ' ' VAL . 88.3 t -63.06 -50.4 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.477 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -36.83 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 70.0 t -69.32 -42.42 81.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.446 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.93 -29.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.548 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -71.44 -36.16 71.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.578 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.74 -30.69 71.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.5 -36.65 65.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.505 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -32.74 68.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.537 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.8 -37.62 70.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -68.54 154.42 41.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 35.3 mttm 55.99 90.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.762 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.6 -54.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.439 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -79.18 161.21 26.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.642 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.482 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -91.41 171.84 8.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.525 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -71.35 -88.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.486 -168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 51.15 -113.14 0.69 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.798 164.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -116.06 176.34 5.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.587 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.76 -48.32 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.542 173.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.28 -44.85 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -34.28 78.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.582 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -96.05 21.08 9.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.409 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.65 58.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.81 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.07 -27.16 65.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -53.81 15.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.569 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.63 -54.62 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 92.1 59.62 1.3 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 1.1 p -94.34 175.06 6.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.662 0.268 . . . . 0.0 110.575 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -130.44 172.76 11.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.742 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -34.83 75.0 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.653 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.04 -32.24 76.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -73.54 -30.78 63.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.496 0.188 . . . . 0.0 110.651 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.58 -33.78 49.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.496 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 15.3 mm -66.58 -36.54 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.368 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.11 -31.97 41.01 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -70.93 -21.14 62.39 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.781 -0.246 . . . . 0.0 110.941 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.5 ttm -66.13 -25.8 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.17 -42.05 95.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.99 80.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.17 11.58 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.65 -37.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.589 0.233 . . . . 0.0 110.609 -174.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.8 OUTLIER -76.15 -37.87 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.42 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.14 -28.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.4 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.45 -54.29 42.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.573 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.47 -37.46 75.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 711' ' ' VAL . 94.1 t -63.8 -52.7 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.356 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 45.0 mt -66.85 -37.81 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.485 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -70.44 -40.29 77.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.408 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 42.3 mt -63.72 -32.95 58.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.44 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.5 m -69.73 -32.38 70.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -69.28 -29.43 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.07 -34.88 71.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.464 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 -37.09 86.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.707 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.27 -60.59 3.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.431 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -133.99 151.29 51.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -76.1 -174.33 2.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.531 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -60.69 -72.93 0.1 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.505 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -165.41 83.53 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.348 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.562 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--O 1.232 0.18 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.44 25.97 0.4 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.57 158.05 18.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.387 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -83.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.515 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -133.27 -152.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.07 -4.79 1.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.838 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 13.1 m -79.11 -0.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -52.45 65.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.58 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.6 -26.37 41.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.503 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.494 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -69.95 -9.17 54.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -78.52 -17.32 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.93 -6.94 53.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 21.3 m -65.77 -12.24 13.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.067 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -48.03 121.27 6.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 75.2 p -128.21 -155.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.31 116.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.802 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -34.69 66.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.743 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -61.34 -53.01 47.86 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.04 -32.95 72.81 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.841 -0.211 . . . . 0.0 110.642 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.8 mm -55.48 -39.2 52.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.61 -43.82 95.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.36 -37.09 37.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.12 -25.4 67.75 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.842 -0.21 . . . . 0.0 110.989 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.48 -28.72 69.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -42.83 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.35 -3.22 88.52 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.99 24.49 7.85 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.79 -34.39 7.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.633 0.254 . . . . 0.0 110.6 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 715' ' ' VAL . 22.1 t -76.51 -42.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.468 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -26.07 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -62.14 -51.55 67.4 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 2.2 p -61.04 -33.75 73.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.703 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 711' ' ' VAL . 67.4 t -68.17 -46.45 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.43 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 82.8 mt -73.86 -31.23 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.4 t -74.19 -42.83 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.391 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.7 mt -61.89 -37.6 78.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 10.7 p -72.22 -30.63 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.598 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.1 t -60.39 -33.89 55.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.514 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.2 mmt -73.03 -32.84 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.0 -30.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.746 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.7 pttt 35.17 37.16 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.594 0.559 . . . . 0.0 111.482 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm 44.13 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.086 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 11.5 tttp 68.28 104.11 0.05 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 -44.23 0.15 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.661 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.462 0.153 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.465 176.521 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.552 0.215 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -102.04 -87.52 0.4 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.495 -174.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 20.9 m80 52.62 -161.23 0.1 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.794 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 74.45 -67.02 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.672 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -101.67 165.95 10.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.2 tp 70.3 1.25 3.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.874 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.89 -11.73 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -8.22 43.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.929 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -83.86 39.02 0.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.667 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -75.01 -10.95 59.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.724 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.43 -30.39 71.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.701 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.74 -55.8 6.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 35.7 m -74.32 0.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -69.8 -166.17 5.28 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 1.1 p 63.28 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.569 0.223 . . . . 0.0 110.857 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ASN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 701' ' ' ALA . 3.0 m-20 -172.16 103.61 0.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.479 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -67.66 -41.47 83.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.58 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.34 96.88 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 698' ' ' ASN . . . -63.93 -41.34 97.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.636 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 20.4 mt -55.75 -41.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.513 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.33 -48.36 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -67.08 -28.24 73.71 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.24 -21.55 39.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.118 . . . . 0.0 110.717 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 11.3 tpt -67.31 -49.12 65.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.362 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 707' ' ' VAL . 14.3 m -66.79 -33.82 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.1 5.89 82.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.86 17.24 42.12 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.65 -43.59 61.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.643 0.258 . . . . 0.0 110.416 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.4 p -69.45 -42.51 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.1 tt -75.82 -26.58 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.49 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.5 -46.94 88.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.8 m -67.85 -35.54 78.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.61 -43.82 91.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.536 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.7 mm -69.75 -38.15 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.482 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.6 t -60.18 -46.24 94.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.444 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.35 -28.78 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.415 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 3.9 m -75.69 -38.52 58.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.441 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -65.33 -31.33 72.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 717' ' ' VAL . 87.7 t -61.0 -28.85 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.571 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -81.12 -24.47 37.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 720' ' ' LEU . 85.5 mt -60.89 -18.68 57.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -74.87 -40.96 60.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 17.8 tttt 69.9 102.24 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.64 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -100.07 -60.25 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.587 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -135.32 -39.96 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.448 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.506 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.546 0.212 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -81.96 164.87 21.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.92 75.07 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.388 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 150.33 26.37 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.463 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 689' ' ' VAL . 19.2 mttp -96.87 -168.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.41 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.91 -12.49 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.849 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 687' ' ' LYS . 12.2 p -69.5 -13.15 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.499 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -64.6 -61.06 2.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.687 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -71.97 -32.74 67.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.79 -16.03 62.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.69 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.2 -25.43 59.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.729 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -8.62 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.8 -41.56 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.593 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 66.57 -147.93 50.2 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.7 m -168.05 -90.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -109.75 -164.97 0.97 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -46.05 60.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.488 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.5 -19.72 69.11 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.09 62.35 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.679 -0.307 . . . . 0.0 110.819 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.2 tt -53.98 -33.77 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.84 -40.58 88.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.317 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.21 62.67 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.19 -31.05 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.602 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.3 ttm -72.18 -50.94 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.81 -34.46 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.435 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.37 -4.29 86.18 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.24 18.01 30.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.3 m -76.53 -34.06 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.93 -45.91 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.545 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.28 -25.38 31.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.14 -51.23 68.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 37.0 p -64.0 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.596 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.88 -45.12 84.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.46 -36.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.456 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.2 t -70.97 -47.77 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.393 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.12 -26.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.483 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 68.9 m -70.01 -46.1 65.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.594 171.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.03 -32.74 74.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.58 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.51 -40.33 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.508 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.3 mmm -79.56 -27.99 41.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.484 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 723' ' ' LEU . 89.8 mt -68.04 -20.95 65.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -88.77 25.61 1.72 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 173.4 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.653 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -140.36 107.1 5.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.418 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -55.55 102.61 0.07 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.526 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 -174.584 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.595 0.236 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.13 -9.47 0.16 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -68.89 -7.4 34.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.592 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -61.27 -82.76 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.663 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -76.2 95.82 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.1 -43.48 1.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.093 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.69 -33.7 26.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.619 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.87 -24.16 59.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.542 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.71 16.31 26.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.595 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.73 44.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.667 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -7.58 14.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -15.28 63.58 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.61 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.97 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.077 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -90.65 157.89 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.42 168.3 22.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.853 0.358 . . . . 0.0 110.948 172.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 64.82 -175.33 0.17 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.679 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.88 71.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.743 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.6 65.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.21 65.8 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.798 -0.237 . . . . 0.0 110.912 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 5.8 tt -55.9 -36.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.575 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 707' ' ' VAL . 82.9 mt -64.96 -36.86 78.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.41 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -71.28 -33.63 64.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.02 -32.11 63.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.503 0.192 . . . . 0.0 110.77 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 13.5 tpp -71.79 -51.71 21.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 703' ' ' ILE . 12.4 p -73.05 -37.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.428 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -82.97 -2.25 90.66 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -80.46 2.82 76.23 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 20.9 m -65.39 -40.15 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.404 0.145 . . . . 0.0 110.707 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 711' ' ' VAL . 0.0 OUTLIER -76.28 -41.28 36.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.503 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 68.6 mt -71.12 -30.17 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.65 -50.73 72.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -39.51 94.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.49 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.4 -51.15 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.516 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.16 -36.92 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.8 t -58.49 -46.99 89.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.457 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.48 -32.0 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -43.2 82.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.63 -29.48 66.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.599 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.02 -41.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.406 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.0 tpt -75.21 -31.82 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.475 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.91 -65.94 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.0 tttp 69.98 -53.62 0.62 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.79 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -62.76 142.69 58.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.571 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 155.35 46.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.84 -125.85 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.415 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 41.7 t80 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.936 0.398 . . . . 0.0 110.622 178.047 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.647 0.26 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -67.06 119.44 12.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -151.85 -40.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.953 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -57.95 -22.24 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -136.06 -171.64 2.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.665 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 688' ' ' LEU . 0.9 OUTLIER 80.15 -45.4 0.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.705 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.24 -25.08 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -72.09 -44.52 63.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -73.63 -49.57 25.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.74 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.634 ' O ' HG22 ' A' ' 695' ' ' VAL . . . -61.26 -17.02 51.38 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.034 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -54.55 -21.7 11.0 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -19.4 62.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.603 -168.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 692' ' ' ALA . 27.2 m -61.92 -25.16 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.78 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 71.73 -143.86 35.89 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 27.6 t -169.23 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.604 0.24 . . . . 0.0 110.374 169.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.67 149.36 14.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.123 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -54.62 -40.07 68.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.55 -42.5 93.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.53 89.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.722 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.03 -32.46 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 -173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.53 -48.03 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.623 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.29 66.98 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.48 -24.16 65.57 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 122.944 -0.151 . . . . 0.0 110.778 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 26.4 ttm -65.58 -30.53 71.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.11 -40.24 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.14 0.48 75.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.25 12.34 45.29 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -67.47 -49.0 75.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 110.664 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 715' ' ' VAL . 93.7 t -65.01 -46.51 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.37 -36.0 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.588 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.59 -47.89 83.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 714' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 718' ' ' ILE . 18.5 m -64.3 -36.77 85.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.6 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 711' ' ' VAL . 86.0 t -63.25 -31.69 53.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.525 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 73.8 mt -80.16 -30.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 713' ' ' ALA . 62.3 t -64.68 -39.27 85.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.58 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 714' ' ' THR . 1.1 pt -65.23 -26.07 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 1.1 m -79.92 -30.48 40.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.33 -29.23 70.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -31.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -26.14 60.48 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.568 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.21 -10.85 60.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.711 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 36.3 tttp 72.03 129.1 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -161.96 109.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.353 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt 53.96 61.78 2.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.703 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -159.33 111.05 2.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.344 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.539 179.306 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.492 0.187 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -125.6 -79.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -162.77 169.17 20.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.787 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -87.11 178.1 7.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.454 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -146.16 -77.54 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.251 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.94 -67.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.114 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.44 -12.04 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -72.24 -55.32 7.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.542 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.35 -10.51 59.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.701 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.01 -30.3 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.83 -39.08 73.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.576 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.92 -52.19 66.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.556 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.23 -57.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.416 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 77.64 27.26 59.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -10.41 59.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 68.9 159.94 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.709 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.431 ' O ' HG22 ' A' ' 702' ' ' ILE . 1.2 mptm? -76.83 -9.03 58.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.697 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.65 -22.33 76.67 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -72.88 -13.42 61.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.566 0.222 . . . . 0.0 110.78 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 699' ' ' LYS . 10.1 tt -65.12 -26.62 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -42.26 84.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.2 98.37 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.16 -22.76 59.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.835 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -47.65 69.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.339 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 710' ' ' VAL . 61.2 t -67.04 -37.6 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.323 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.65 7.98 60.51 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.66 12.52 56.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 707' ' ' VAL . 29.1 m -68.31 -39.9 81.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.504 0.192 . . . . 0.0 110.678 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -75.0 -43.19 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.63 -31.05 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.362 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.97 -53.09 62.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.615 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -39.59 82.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 60.2 t -61.4 -51.6 71.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.495 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.21 -35.15 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.339 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.4 t -67.46 -36.34 76.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.438 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 721' ' ' VAL . 52.0 mt -69.96 -26.94 31.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -25.83 48.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.698 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.37 -20.83 62.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.4 m -67.22 -26.53 36.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 tpt -70.41 -37.21 74.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.437 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.04 -37.64 54.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.646 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.2 tttt 56.21 -170.8 0.08 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.687 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -132.54 172.28 12.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.497 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.11 143.54 39.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.672 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 65.84 170.08 0.22 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.855 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.676 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 61.33 111.77 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.1 78.46 8.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 -176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -103.57 100.81 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.57 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 51.66 79.78 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.35 -13.95 44.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.644 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 33.3 m -83.46 -30.4 8.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.767 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.78 -24.39 67.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -92.39 41.45 1.07 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.717 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -82.18 7.25 14.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.667 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.23 -20.58 51.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -33.78 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 10.6 m -76.7 -6.99 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -60.9 63.12 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 37.5 m -105.82 151.78 24.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.803 -0.199 . . . . 0.0 110.528 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 111.91 0.02 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -26.72 67.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.522 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.2 -37.01 80.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -62.03 -41.43 98.09 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.584 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 46.0 mt -57.07 -31.49 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.482 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 9.9 mm -68.22 -44.69 83.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.85 41.45 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.94 -24.37 67.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.222 . . . . 0.0 111.045 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 25.4 ttm -61.96 -28.74 69.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.49 -40.25 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -88.19 -1.95 81.01 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.47 14.9 48.89 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.91 -49.57 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.632 0.254 . . . . 0.0 110.445 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 78.2 t -60.26 -47.39 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.519 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.27 -34.37 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.535 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.14 -48.98 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.39 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -33.17 74.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.527 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 57.3 t -70.3 -46.4 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.363 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 11.9 mm -72.21 -31.76 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 721' ' ' VAL . 45.6 t -74.33 -45.91 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.429 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.8 -41.28 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.406 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 32.2 p -73.42 -27.53 61.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.697 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.86 -31.13 69.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 717' ' ' VAL . 93.9 t -65.32 -28.74 45.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.558 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' MET . . . . . 0.478 ' SD ' ' N ' ' A' ' 722' ' ' MET . 0.9 OUTLIER -82.28 -24.85 34.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.706 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.5 -55.46 30.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.444 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -102.63 179.92 4.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.489 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.37 174.83 10.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.466 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -77.77 -119.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.541 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -137.64 16.2 2.91 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.445 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.685 0.278 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 116.86 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.365 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -133.49 148.35 51.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.541 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -70.47 145.82 50.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.644 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.47 172.43 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.091 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.4 tp 75.64 -11.32 1.13 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.928 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.3 t -86.7 9.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.445 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.03 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.36 35.7 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -75.01 -13.89 60.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.15 -38.65 80.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.608 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -77.95 -45.18 24.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.574 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.21 -34.15 52.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.567 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -64.42 102.99 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 92.7 p -140.48 -49.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.234 . . . . 0.0 110.455 -175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -69.71 120.23 15.16 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.575 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -75.22 -43.25 52.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.577 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.22 -30.68 78.39 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.93 70.8 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.815 -0.226 . . . . 0.0 110.798 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.473 ' O ' HD13 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -59.09 -31.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.674 -175.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.47 -47.41 86.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.555 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.05 -37.61 37.54 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.29 -26.01 68.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.496 0.189 . . . . 0.0 110.705 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 14.2 ttp -60.54 -32.5 71.55 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.28 -46.01 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.504 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.86 -3.53 85.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.77 13.57 47.32 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.71 -36.41 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 110.658 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 715' ' ' VAL . 35.2 m -73.7 -40.15 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.452 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 711' ' ' VAL . 3.5 mm -65.9 -36.77 78.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.92 -52.87 63.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -35.45 78.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.736 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 711' ' ' VAL . 92.0 t -63.49 -51.4 71.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.471 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 95.7 mt -68.14 -37.08 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.2 t -67.4 -41.05 85.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.444 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 718' ' ' ILE . . . . . 0.597 ' O ' HG22 ' A' ' 721' ' ' VAL . 36.3 mt -63.51 -26.09 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.84 -27.48 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.671 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' LEU . . . . . 1.002 HD13 HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -62.18 -27.61 69.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 718' ' ' ILE . 2.7 m -65.81 -21.17 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.511 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 12.9 mtt -78.68 -22.57 46.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.659 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 1.002 HD12 HD13 ' A' ' 720' ' ' LEU . 97.4 mt -69.67 -4.37 19.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.802 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -76.19 45.89 0.38 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.574 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -145.73 82.11 1.62 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.345 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 123.67 26.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.682 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -138.8 149.41 44.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.467 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.164 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.7 0.286 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -97.88 144.41 27.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -79.96 91.89 5.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.402 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -56.68 129.4 40.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.633 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.77 57.88 1.71 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.469 -175.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 9.9 mp -95.76 -20.32 18.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.499 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.95 -11.05 11.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.86 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.58 -33.58 10.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.77 -49.83 6.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.633 -173.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.39 -6.72 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.8 -11.02 60.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.934 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -64.61 -18.69 65.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.19 -32.71 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -92.23 99.04 2.49 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 701' ' ' ALA . 22.0 t -142.75 -123.28 0.09 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.36 125.78 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.855 0.359 . . . . 0.0 110.637 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.648 ' HA ' HD12 ' A' ' 702' ' ' ILE . 6.6 tttp -58.64 -26.44 63.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.12 38.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 697' ' ' SER . . . -73.67 -21.03 60.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.646 0.26 . . . . 0.0 110.749 -174.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 699' ' ' LYS . 23.9 mt -63.2 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 703' ' ' ILE . 0.9 OUTLIER -63.03 -22.65 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.347 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.21 38.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.844 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -63.01 -46.78 86.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.618 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.54 -31.7 43.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.33 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.66 13.38 66.84 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.45 37.27 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 711' ' ' VAL . 7.1 p -67.95 -39.86 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.551 0.215 . . . . 0.0 110.656 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.476 HG23 HG13 ' A' ' 710' ' ' VAL . 33.7 t -75.82 -42.71 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.4 -27.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.438 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.81 -49.94 75.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.584 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 88.0 m -62.09 -41.2 97.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 91.5 t -56.8 -42.19 77.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.462 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -74.24 -35.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 713' ' ' ALA . 76.3 t -60.12 -47.64 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.28 -30.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.452 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 5.3 m -72.64 -39.1 67.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.528 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 720' ' ' LEU . . . . . 0.431 HD13 HD12 ' A' ' 723' ' ' LEU . 0.6 OUTLIER -64.83 -30.51 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -32.21 56.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.402 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.67 -32.36 57.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 -172.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 720' ' ' LEU . 85.6 mt -55.43 -40.47 71.56 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.808 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm 59.21 162.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.5 tttt 63.56 92.45 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.807 174.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -101.15 126.94 47.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 63.58 159.23 0.08 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.859 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 174.869 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -152.02 101.51 2.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.3 -68.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.433 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.43 104.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.873 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -139.13 156.8 46.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.683 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 2.1 tt -166.65 -39.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.245 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.11 -18.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.819 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -80.54 -48.17 13.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.643 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.91 -29.73 44.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.25 -10.07 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.63 -7.4 38.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.17 -8.94 57.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.838 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.24 -24.33 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -73.37 97.47 0.86 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.3 p -138.35 94.63 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.554 0.216 . . . . 0.0 110.489 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.53 136.36 3.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.352 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -59.48 -38.52 81.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.21 -44.1 77.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.73 84.51 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 121.391 -0.123 . . . . 0.0 110.697 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 26.1 mt -54.69 -34.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.31 -47.57 80.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.582 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.42 59.47 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.66 -26.74 68.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.425 -0.11 . . . . 0.0 110.823 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -27.64 66.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.01 -43.35 99.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.513 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.11 -2.99 90.71 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -87.79 24.74 9.79 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.89 -47.04 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.56 0.219 . . . . 0.0 110.465 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.1 p -62.87 -44.25 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -177.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.494 ' N ' HG13 ' A' ' 711' ' ' VAL . 17.7 tt -70.6 -28.23 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.24 -49.08 78.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.541 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -30.72 70.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.467 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.7 t -76.37 -49.09 25.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.405 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.92 -23.58 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.703 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 713' ' ' ALA . 16.2 t -66.6 -44.93 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.72 -36.75 62.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.539 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -41.5 97.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.447 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -31.14 69.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.759 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.455 HG13 ' HD2' ' A' ' 725' ' ' LYS . 58.3 t -65.05 -31.71 55.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 174.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 14.8 ttm -80.28 -26.04 39.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.95 -64.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.661 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -145.01 -92.48 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.118 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.455 ' HD2' HG13 ' A' ' 721' ' ' VAL . 14.6 tttm 44.22 65.5 1.03 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.637 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -61.95 100.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.489 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -73.47 177.35 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.614 0.245 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -89.11 -27.36 20.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 11.2 m170 58.94 -179.26 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -143.15 25.5 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.614 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 689' ' ' VAL . 4.3 tptp -69.02 -58.81 3.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.496 177.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 71.56 -41.67 0.51 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.967 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 2.8 t -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.564 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.44 -54.15 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -79.55 -37.87 35.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.604 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -63.81 -15.73 59.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.708 -177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.05 -29.84 62.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.759 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -15.66 59.09 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.95 -45.38 98.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.759 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 705' ' ' LEU . . . 73.53 -156.24 50.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' SER . . . . . 0.402 ' H ' ' CB ' ' A' ' 701' ' ' ALA . 31.0 t -168.15 -111.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -165.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.46 -162.17 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.434 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 702' ' ' ILE . 19.9 pttm -61.53 -42.91 99.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.737 177.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.17 -11.4 58.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.402 ' CB ' ' H ' ' A' ' 697' ' ' SER . . . -68.43 -18.3 64.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.822 -0.189 . . . . 0.0 110.894 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 699' ' ' LYS . 35.9 pt -58.23 -27.95 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.483 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.3 mt -70.34 -44.03 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.21 -35.33 49.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.475 HD11 ' HA3' ' A' ' 696' ' ' GLY . 94.0 mt -71.28 -34.75 70.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.89 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.1 tpp -62.89 -55.17 28.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.392 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 708' ' ' GLY . 12.5 p -73.87 -38.57 50.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.458 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -75.54 -5.98 79.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.49 16.69 17.32 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 711' ' ' VAL . 7.9 p -68.55 -40.96 82.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.64 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 710' ' ' VAL . 7.4 p -75.8 -38.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.512 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.4 ' N ' HG13 ' A' ' 711' ' ' VAL . 7.3 mt -75.6 -26.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.19 -50.83 72.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.509 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 67.7 p -63.66 -34.75 78.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.579 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.03 -48.18 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.54 -36.86 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.458 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 713' ' ' ALA . 64.7 t -70.47 -44.12 77.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.406 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.28 -38.49 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.5 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 20.8 m -68.16 -32.86 73.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.599 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.61 -32.24 73.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.606 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.66 -41.24 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.476 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.08 -31.2 55.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.524 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.92 -12.52 58.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -109.45 144.14 38.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.469 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -76.35 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.561 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -71.77 168.65 17.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.67 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.96 -143.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.6 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -59.93 -31.51 69.91 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -75.08 128.11 34.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.589 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -167.28 165.03 15.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.437 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -156.2 27.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.57 -30.77 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.527 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.52 -10.43 13.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.714 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.46 -60.23 3.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.703 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -82.12 -27.21 32.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.72 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.76 -23.12 64.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.774 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -75.12 -16.52 60.54 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.51 14.28 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.261 176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.4 -62.91 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.625 162.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 71.41 178.21 28.43 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 66.2 m -152.44 162.55 41.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.455 0.169 . . . . 0.0 110.901 173.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.47 165.86 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -62.17 -25.61 67.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.94 -18.61 66.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.53 -23.62 67.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 122.866 -0.197 . . . . 0.0 110.837 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.58 -30.69 22.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.652 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.39 -42.11 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.493 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.72 -43.68 17.7 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.61 -34.43 69.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.379 0.133 . . . . 0.0 110.89 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.8 ttt -64.9 -53.08 52.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.405 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 710' ' ' VAL . 39.7 t -73.87 -42.28 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.49 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.85 -6.61 82.43 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.53 18.74 40.5 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.2 t -75.76 -35.34 30.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 91.1 t -71.14 -49.14 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 18.5 pt -67.73 -27.41 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.59 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.35 -50.81 72.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.594 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -37.44 85.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.547 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.93 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.569 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.63 -29.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.553 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -64.25 -40.38 88.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.463 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 721' ' ' VAL . 1.4 mp -67.4 -26.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.475 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 16.0 m -78.96 -29.13 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.617 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -26.86 67.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -173.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.2 m -62.6 -26.11 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.481 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.87 -35.43 69.78 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.53 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.0 mt -80.45 -53.96 6.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -156.88 144.81 19.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.546 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -72.97 -50.81 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.533 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -101.08 177.32 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.607 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -104.47 -93.84 0.34 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.5 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.145 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.52 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.603 0.239 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 14.3 m80 63.09 176.57 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.755 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' HIS . . . . . 0.475 ' H ' ' NZ ' ' A' ' 687' ' ' LYS . 5.0 m-70 -117.51 -150.01 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.288 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.49 -69.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.671 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.475 ' NZ ' ' H ' ' A' ' 685' ' ' HIS . 20.8 mttp 49.07 -105.49 0.16 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.773 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.5 mp -52.37 -23.68 6.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.047 -174.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 689' ' ' VAL . 61.7 t -70.76 2.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 690' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 1.0 OUTLIER -91.31 -39.71 11.89 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.487 174.223 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 691' ' ' PHE . . . . . 0.468 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 21.5 t80 -76.78 -55.21 5.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.357 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.81 -9.72 40.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.819 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.31 -23.37 56.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -60.79 -15.81 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.109 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.84 -49.46 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 170.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 66.91 -150.54 52.02 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 4.0 m -166.16 -96.06 0.02 OUTLIER 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -164.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 -157.42 0.61 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.485 -172.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 702' ' ' ILE . 34.4 mttt -57.27 -45.28 84.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.772 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.78 -18.0 67.88 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.87 62.08 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.745 -0.268 . . . . 0.0 110.843 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 699' ' ' LYS . 17.3 tt -55.57 -37.03 44.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 13.6 mt -69.16 -39.7 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.67 12.95 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.52 -36.28 69.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.511 0.196 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 18.8 ttp -63.56 -54.67 32.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.411 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 710' ' ' VAL . 61.7 t -71.87 -43.49 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.35 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.59 -4.94 62.53 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.27 16.13 35.8 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.0 t -70.46 -47.61 64.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 110.579 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -44.44 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.604 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.64 -25.22 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.14 -53.12 61.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 76.5 p -61.71 -33.37 73.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.65 -46.18 86.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.518 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 -32.02 36.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 81.0 t -73.52 -41.33 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.36 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.22 -44.17 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 13.4 p -64.26 -31.96 73.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.607 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -31.73 73.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.683 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.87 -46.53 93.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 10.8 ttt -67.91 -36.71 80.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.66 3.66 31.98 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.781 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -142.67 112.22 6.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.39 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -164.45 140.48 6.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -77.63 80.29 4.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.425 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -89.43 122.33 32.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.498 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -171.396 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.607 0.241 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 54.03 -148.86 0.44 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.61 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 57.06 37.47 28.69 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -69.79 -45.4 68.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.53 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -86.52 -117.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.562 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.6 -50.05 0.7 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.883 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.58 -9.39 11.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -70.13 -59.32 2.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.627 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 175.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.72 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.572 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.22 -38.67 75.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.86 -33.75 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.629 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.64 -25.78 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.552 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 161.72 -89.59 0.11 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 38.2 t -165.12 172.68 12.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.832 0.348 . . . . 0.0 110.661 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -35.65 64.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.713 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -57.76 -32.83 67.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.758 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.56 -40.72 96.22 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 705' ' ' LEU . . . -60.31 -36.79 78.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.75 -42.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.449 -173.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.65 -30.21 37.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.591 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.5 -24.5 72.67 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 701' ' ' ALA . 80.4 mt -61.4 -34.03 74.68 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.936 -0.155 . . . . 0.0 110.933 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.18 -38.4 35.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.55 -54.25 37.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.349 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -83.79 -29.63 31.52 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 709' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -65.27 -33.06 85.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -169.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.69 -47.15 87.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 110.632 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.96 -48.68 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.506 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 28.7 mt -62.66 -30.77 50.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.649 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -56.41 -53.51 56.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.443 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 66.8 p -61.47 -33.25 73.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.625 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.69 -51.89 29.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.416 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.35 -33.33 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.416 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 713' ' ' ALA . 22.6 t -63.26 -43.97 98.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.303 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.88 -32.09 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.464 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -29.59 55.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.61 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -32.63 74.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.623 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.18 -35.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.428 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 ttm -72.0 -33.39 68.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.723 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.68 -62.06 1.99 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.564 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.08 144.62 5.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.21 -56.43 2.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.562 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -76.59 -84.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -73.42 131.54 41.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.526 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.521 -170.921 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 685' ' ' HIS . 59.5 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -29.79 66.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.618 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 685' ' ' HIS . . . . . 0.425 ' H ' HG12 ' A' ' 683' ' ' VAL . 1.6 t60 68.52 112.68 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.649 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -68.76 101.42 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.434 -172.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -66.78 122.62 18.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.661 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.16 -58.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.339 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -29.68 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.462 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.2 -26.48 64.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.616 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -47.14 4.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 172.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -88.77 1.51 55.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.885 -163.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.47 -22.96 64.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -66.69 -24.7 66.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.444 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.59 -37.49 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.568 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -179.64 161.03 26.66 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 9.3 t -154.17 8.92 0.35 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.618 0.246 . . . . 0.0 110.477 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.52 138.39 46.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.48 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.676 -176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.8 -23.04 65.02 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -67.03 -22.63 65.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.692 0.282 . . . . 0.0 110.79 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.04 -32.93 51.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.581 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.36 -43.95 91.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.89 -40.9 24.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 47.3 mt -72.49 -21.64 61.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.792 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -25.74 62.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.47 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.57 -40.76 87.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.412 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.23 1.99 83.15 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.14 26.23 8.03 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -43.09 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.729 0.3 . . . . 0.0 110.64 173.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -71.98 -38.38 63.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.449 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 712' ' ' ILE . 8.2 tt -78.22 -25.02 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.41 73.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.515 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.43 -38.44 80.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 711' ' ' VAL . 63.1 t -65.64 -51.0 67.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.459 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.45 -37.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.579 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 721' ' ' VAL . 41.4 t -69.53 -39.01 77.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.32 -175.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.9 mt -65.91 -33.85 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.346 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -34.51 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.775 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.3 -31.73 72.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.654 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 717' ' ' VAL . 41.1 t -67.47 -27.23 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.531 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 6.3 mmt -80.52 -31.65 37.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.514 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.68 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.423 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -97.81 176.96 5.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.762 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.02 144.64 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -86.04 166.65 15.69 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.668 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.32 -52.24 12.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.447 -170.912 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.589 0.233 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -90.47 -175.11 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.391 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -14.09 0.98 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.605 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.61 -53.59 5.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.545 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -101.13 119.86 39.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.543 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 23.5 mt -100.05 -27.53 13.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.363 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.69 21.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.68 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -61.77 -35.58 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.556 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -95.03 39.36 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.662 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -86.79 24.11 1.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -86.32 -30.69 22.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.628 166.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.09 -29.7 15.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.528 -167.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.1 m -72.46 -8.41 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.537 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -54.41 77.73 0.01 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 83.9 p -82.05 -130.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.3 127.96 33.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.698 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 702' ' ' ILE . 0.3 OUTLIER -70.87 -21.18 62.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.643 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.49 -11.21 40.18 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -64.97 -22.18 66.96 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.466 0.174 . . . . 0.0 110.924 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 699' ' ' LYS . 35.3 pt -58.89 -28.28 37.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.492 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.93 -46.94 81.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.426 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.73 -33.99 59.95 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.86 -21.42 51.4 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.839 -0.212 . . . . 0.0 110.997 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.29 -43.08 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.67 -29.27 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -101.32 9.13 57.46 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.52 12.3 40.83 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.7 -30.4 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.686 0.279 . . . . 0.0 110.724 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 715' ' ' VAL . 64.8 t -76.81 -46.46 30.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 22.3 pt -67.41 -25.85 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.594 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.52 -52.58 62.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 6.1 p -62.19 -31.98 72.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.666 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 711' ' ' VAL . 70.4 t -67.28 -46.83 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 34.9 mt -71.67 -33.5 49.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.4 t -68.54 -40.27 81.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 718' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 721' ' ' VAL . 3.8 mm -62.66 -32.93 57.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -23.82 41.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.787 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.37 -24.75 64.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.703 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.5 m -63.87 -26.12 39.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -69.48 -36.68 76.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt -74.11 -43.73 56.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.893 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -67.34 122.42 17.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm 54.61 87.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.876 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -90.22 -0.41 57.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.731 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.46 169.26 9.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.63 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 179.593 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.509 0.195 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -175.07 5.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -132.78 117.73 18.15 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -90.78 143.66 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.4 ' C ' ' H ' ' A' ' 689' ' ' VAL . 23.3 mttp -78.0 -81.64 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.9 tp 73.54 -12.08 0.86 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.001 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 687' ' ' LYS . 84.9 t -71.35 -12.11 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.392 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -56.99 -57.28 13.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.69 176.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -76.85 -31.49 56.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.613 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.61 -17.19 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.708 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -19.4 58.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.891 175.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.59 11.12 3.29 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.303 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.3 t -82.77 -40.89 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.617 164.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 72.3 -144.12 35.45 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 46.8 t -172.92 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.9 -0.177 . . . . 0.0 110.528 -166.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -93.21 -161.6 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.46 -170.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 702' ' ' ILE . 3.6 ptpt -59.51 -43.75 93.3 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.689 171.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -59.87 -22.26 57.11 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -177.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -72.68 -16.12 61.69 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.682 -0.305 . . . . 0.0 110.955 -174.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 699' ' ' LYS . 2.1 pp -54.6 -32.79 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.589 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.88 -31.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -178.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.68 -39.37 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 705' ' ' LEU . 63.9 mt -63.85 -43.56 95.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.587 0.232 . . . . 0.0 110.781 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.0 ttt -62.17 -53.64 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.412 -174.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 710' ' ' VAL . 87.4 t -72.51 -44.06 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.405 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.22 3.44 46.75 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.17 20.07 23.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 707' ' ' VAL . 87.8 t -64.5 -49.97 78.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 110.601 174.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.86 -43.91 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.445 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.2 -23.73 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.411 -176.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -63.3 -49.99 71.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.562 176.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 70.8 p -66.14 -30.27 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.417 -175.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.02 -34.91 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.641 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 70.2 mt -77.49 -32.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.5 t -64.75 -47.27 89.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.437 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 39.4 pt -67.27 -28.96 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.629 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 719' ' ' THR . . . . . 0.626 HG22 HD12 ' A' ' 723' ' ' LEU . 28.1 m -71.78 -36.26 70.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -25.2 59.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.586 -178.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 717' ' ' VAL . 55.9 t -64.64 -47.83 87.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 722' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 722' ' ' MET . 0.0 OUTLIER -81.98 -23.22 36.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.41 -176.569 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 719' ' ' THR . 98.6 mt -88.84 3.85 49.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.705 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.66 -75.52 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.545 -170.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 53.02 -173.58 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -104.44 170.43 7.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.635 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -73.78 139.11 44.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.828 179.157 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 684' ' ' HIS . 9.7 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 684' ' ' HIS . . . . . 0.413 ' N ' HG12 ' A' ' 683' ' ' VAL . 0.8 OUTLIER -161.49 164.47 29.66 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 110.65 178.186 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.82 166.64 27.9 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.518 -178.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -157.11 161.03 39.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.472 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -165.06 15.98 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -8.9 9.13 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.499 -175.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.532 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 10.1 p -68.72 -12.38 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.72 177.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.15 -68.94 0.16 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.29 -40.15 85.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 176.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -66.51 -12.3 56.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -174.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.99 -13.28 24.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.937 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -8.75 57.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -171.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.15 -4.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.834 177.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -50.49 97.02 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 87.0 p -83.15 -168.49 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.608 0.242 . . . . 0.0 110.676 -175.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.53 144.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.7 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 702' ' ' ILE . 24.0 tptt -81.42 -51.75 7.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.493 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.36 -10.04 56.27 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -175.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.86 69.31 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.76 -0.259 . . . . 0.0 110.939 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 699' ' ' LYS . 2.1 pp -53.5 -26.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.779 -173.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.97 -46.53 78.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.561 177.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.78 -32.55 32.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.35 -25.06 64.9 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.895 -0.179 . . . . 0.0 111.091 177.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 ttt -63.55 -30.91 71.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.719 -179.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.72 -44.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.58 2.88 78.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.43 23.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -177.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 3.1 m -86.65 -35.87 9.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -45.46 78.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.443 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.4 pt -70.37 -26.63 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 -179.007 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.18 -50.37 73.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.47 177.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 3.0 m -61.67 -36.31 80.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.572 -178.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.44 -48.72 79.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.08 -38.34 79.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.414 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 721' ' ' VAL . 54.1 t -67.24 -47.19 82.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.362 -176.182 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 43.2 mt -56.67 -42.29 76.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.524 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 93.5 m -67.13 -37.16 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.79 -30.11 69.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.656 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 717' ' ' VAL . 26.0 t -67.35 -40.77 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 176.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 21.0 mtp -74.29 -24.71 59.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.9 -179.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.44 -41.69 97.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.408 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -159.04 -67.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.641 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 725' ' ' LYS . 1.3 mtpt -69.29 95.6 0.79 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.16 -166.024 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -83.71 131.09 34.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.55 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.32 -118.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 172.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.803 0.335 . . . . 0.0 110.74 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.706 0.289 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -139.09 15.78 2.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.603 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -73.31 -9.44 58.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.443 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -141.9 103.09 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -87.65 155.86 19.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.36 -21.2 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.07 -10.43 9.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.751 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.84 -13.43 62.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.815 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -90.45 34.27 0.89 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.657 176.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.49 55.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 176.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -65.41 -20.88 66.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.756 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.66 -38.7 64.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.781 178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.09 -62.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.415 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 60.6 -157.55 29.49 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 174.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 19.9 m 55.06 42.62 30.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 165.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -126.36 9.69 7.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.458 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -48.93 77.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.568 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.62 92.41 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.41 -11.29 60.82 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.771 -0.252 . . . . 0.0 110.801 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 702' ' ' ILE . 0.4 OUTLIER -65.7 -26.08 38.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.43 -177.66 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.08 -29.22 45.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.684 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -84.4 -33.2 20.52 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.82 -21.32 51.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.852 174.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.9 tpp -71.26 -47.96 53.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.497 -174.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 22.1 m -68.32 -31.11 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.652 174.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -89.83 11.28 70.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 177.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.32 13.88 56.2 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.52 -43.83 96.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.456 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.5 p -74.23 -40.21 50.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.57 -177.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.426 ' N ' HG13 ' A' ' 711' ' ' VAL . 16.2 mt -73.73 -28.68 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -57.08 -51.01 70.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.579 174.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -33.3 75.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.544 -176.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.92 -45.28 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.541 178.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.33 -36.92 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.424 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 713' ' ' ALA . 97.1 t -67.73 -47.98 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 tp -69.4 -26.42 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.42 -174.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 57.0 m -75.67 -41.87 52.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.553 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.71 -35.68 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.486 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.4 mtt -78.7 -30.1 45.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.5 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.55 -49.83 36.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.644 176.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -103.11 120.76 41.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.626 -176.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.15 108.59 5.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.342 -175.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -98.47 39.54 1.24 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.593 -177.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 52.23 71.27 0.48 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.61 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.74 0.305 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -147.84 -173.3 4.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 2.3 m80 59.27 102.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.35 -67.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.476 -170.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -84.57 -157.05 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.383 172.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 17.1 mt 70.8 -2.21 2.36 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 70.0 t -71.91 -16.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 177.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -49.87 75.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.63 -21.68 35.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.709 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -74.73 -1.08 20.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.62 -14.23 62.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 173.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -65.57 -16.24 63.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.739 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.88 -40.9 74.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.639 174.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -83.71 118.83 4.76 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.87 107.06 2.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.575 0.226 . . . . 0.0 110.509 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.58 142.86 6.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 175.229 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' A' ' 702' ' ' ILE . 16.1 mmtt -62.86 -35.67 80.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.26 -47.95 74.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 175.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.33 83.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.823 -0.222 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 699' ' ' LYS . 22.7 mt -58.99 -32.56 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.632 -174.281 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.57 -44.79 93.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 175.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.74 -29.39 57.63 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 75.2 mt -68.02 -24.62 65.13 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.911 -0.17 . . . . 0.0 110.923 177.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.2 ttm -66.57 -29.27 69.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.705 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.45 -38.67 81.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.89 -0.91 71.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.7 12.86 39.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -175.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -68.92 -46.37 79.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.625 -178.909 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 715' ' ' VAL . 44.1 t -67.43 -47.49 80.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 -177.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.66 -40.29 78.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.669 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.87 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -38.71 87.21 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.485 -178.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 711' ' ' VAL . 65.3 t -61.89 -52.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.44 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.49 -39.29 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.562 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 73.6 t -68.34 -41.72 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.356 -175.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.99 -36.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -72.98 -32.55 65.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.04 -33.41 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.01 -42.19 78.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 176.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -36.66 76.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.44 -39.76 77.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.649 177.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -90.96 -160.4 0.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 726' ' ' LYS . 39.9 pttt -163.02 -20.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.356 -172.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 725' ' ' LYS . 8.7 mmtp -97.46 99.35 10.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.91 138.87 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.614 176.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.425 173.332 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.516 0.198 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.35 144.4 49.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.649 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -97.09 70.08 2.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.425 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -90.43 -19.16 24.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.65 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -76.17 158.76 31.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.43 -31.22 2.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.436 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.72 -28.95 41.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.47 -54.6 26.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 -175.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -61.99 -30.0 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.644 175.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.25 73.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.654 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.36 -35.68 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.38 -39.64 85.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.587 -171.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.72 -12.66 8.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.677 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 97.3 -48.66 1.54 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 172.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 17.5 t -161.83 96.09 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.604 -0.35 . . . . 0.0 110.449 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -95.61 -30.17 13.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.862 176.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -59.68 -28.09 66.98 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.554 -167.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -60.13 -62.13 6.39 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.67 -21.52 63.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.771 0.319 . . . . 0.0 110.737 -171.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.474 HD13 HD12 ' A' ' 705' ' ' LEU . 3.4 mm -60.36 -24.4 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.576 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 12.3 tt -57.51 -31.59 39.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -86.29 -33.07 14.99 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 702' ' ' ILE . 86.8 mt -66.45 -23.38 66.27 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.827 -0.219 . . . . 0.0 110.86 174.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.6 ttm -68.55 -25.57 64.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.719 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 710' ' ' VAL . 46.2 t -66.0 -39.19 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.605 176.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.6 -7.14 88.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.38 23.18 10.31 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 707' ' ' VAL . 90.0 t -82.35 -37.8 14.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.715 0.293 . . . . 0.0 110.489 175.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 711' ' ' VAL . 0.9 OUTLIER -74.27 -41.0 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.373 -174.852 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.4 -26.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.681 177.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -51.84 67.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.9 p -61.9 -34.37 75.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.76 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.31 -51.46 58.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 178.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.1 -39.98 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.452 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.3 t -69.32 -45.18 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 -174.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.47 -40.68 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.504 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.1 m -67.27 -39.29 86.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.479 176.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.614 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 717' ' ' VAL . 98.7 t -60.15 -44.54 95.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.453 177.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 52.7 mmm -70.83 -33.85 71.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.481 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.89 -28.77 60.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.681 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 100.32 6.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.388 -175.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -133.31 -41.63 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.523 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 20.3 mttt 55.77 30.78 16.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.98 -178.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -143.82 -71.13 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.371 -178.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -178.259 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.837 0.351 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 128.92 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 -176.023 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.82 174.65 7.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.617 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -93.01 -179.7 5.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.67 178.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.49 56.15 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.546 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.6 -15.41 6.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.538 178.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 689' ' ' VAL . 2.3 t -67.6 -10.67 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 -178.423 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 690' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 0.0 OUTLIER -77.74 -53.5 7.45 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.346 177.527 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 691' ' ' PHE . . . . . 0.402 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 66.1 t80 -74.16 -39.72 63.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.474 -177.836 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.36 -13.16 49.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.891 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.0 -19.91 63.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.745 175.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -65.26 -12.11 48.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 -176.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.95 -48.98 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 171.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 73.37 -149.87 42.8 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 99.3 p -161.99 -127.45 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.468 0.175 . . . . 0.0 110.555 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.56 -179.88 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.906 -177.199 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -77.07 -50.18 13.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.607 -177.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.32 -21.88 62.61 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.25 64.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.594 0.235 . . . . 0.0 110.788 177.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 9.7 mm -51.02 -33.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.602 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.17 -47.01 89.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.422 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.13 -36.48 24.41 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -176.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.99 -28.64 69.17 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.53 0.205 . . . . 0.0 110.857 176.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -31.12 70.46 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -46.19 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.44 -5.63 89.37 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 178.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.91 12.19 54.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.017 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 71.6 t -71.57 -46.49 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.758 0.313 . . . . 0.0 110.536 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 715' ' ' VAL . 2.8 t -67.52 -42.34 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.407 -176.194 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.38 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.648 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.59 -52.5 65.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 178.355 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 69.7 p -62.94 -33.63 75.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.653 -177.143 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.3 t -65.35 -49.04 80.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.54 -31.82 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.49 -178.167 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.8 t -73.21 -39.6 56.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.442 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.07 -32.22 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.426 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -45.38 90.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 174.387 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.48 -30.26 70.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.778 -176.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.607 176.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.3 tpt -82.65 -22.43 34.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.94 4.23 5.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 175.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -54.54 158.51 2.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.897 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -98.49 41.05 1.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.55 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 10.0 tttp 67.26 161.47 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.868 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 54.7 -148.53 0.47 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.589 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.274 178.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 683' ' ' VAL . 13.2 p . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.925 0.393 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -100.32 135.7 41.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.565 178.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 685' ' ' HIS . . . . . 0.422 ' CG ' ' N ' ' A' ' 686' ' ' GLN . 14.1 p-80 -146.66 -125.61 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.337 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 686' ' ' GLN . . . . . 0.422 ' N ' ' CG ' ' A' ' 685' ' ' HIS . 4.2 tt0 71.6 49.67 0.28 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.042 0.449 . . . . 0.0 110.568 176.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -136.8 38.61 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.442 -174.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.75 -26.85 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.742 -176.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 0.0 OUTLIER -78.74 9.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.701 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 690' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 0.0 OUTLIER -58.59 -54.96 41.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.63 177.978 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 691' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 7.4 t80 -81.23 -31.51 33.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 176.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -82.25 14.7 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.513 -178.025 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.68 -10.22 22.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.941 162.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.82 -11.58 56.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.545 -171.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 4.7 m -77.09 -0.33 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -61.48 148.53 46.89 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -173.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.0 m -127.92 -26.84 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.455 -0.373 . . . . 0.0 110.208 -160.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -57.61 155.49 9.72 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 178.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 699' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 702' ' ' ILE . 11.9 ptmt -58.97 -31.36 68.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 -173.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -76.96 -18.54 78.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.57 -13.97 62.31 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.828 -0.219 . . . . 0.0 110.923 176.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 699' ' ' LYS . 13.1 tt -60.01 -34.53 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.544 176.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 707' ' ' VAL . 20.0 mt -70.29 -48.87 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.233 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.92 -25.62 75.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 177.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.25 -43.85 80.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.4 mmt -70.04 -31.19 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.408 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 703' ' ' ILE . 77.7 t -67.13 -48.45 78.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.503 -178.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.9 1.95 78.87 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 178.453 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -93.22 16.93 59.4 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.81 -33.58 16.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.517 0.198 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -72.44 -43.64 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 -179.523 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.66 -25.58 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.32 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -64.08 -54.11 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 178.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.4 p -57.74 -36.64 72.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.84 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 711' ' ' VAL . 90.7 t -65.81 -49.54 76.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.472 -179.181 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -65.36 -40.48 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.4 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -68.92 -42.22 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.194 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.68 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 90.4 m -65.58 -31.24 72.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -25.95 64.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.733 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.27 -33.87 65.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 176.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.32 -29.13 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.423 -178.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.5 mt -70.42 -38.06 74.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.852 177.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -105.95 128.12 53.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.687 -175.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -91.05 -176.99 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.634 -178.025 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -148.73 171.49 16.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.839 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -101.52 -63.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.421 -177.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.465 0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.916 176.837 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.485 0.183 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 152.26 25.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 -176.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.8 t60 50.53 54.29 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.581 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -94.37 -22.45 18.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.579 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -90.4 165.57 13.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.605 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.5 tp -117.13 -36.64 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.179 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.96 -18.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.59 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -78.47 -50.97 10.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.452 -175.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -13.81 62.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.66 177.308 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.99 67.34 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.82 -39.0 83.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.56 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.36 -47.08 24.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.467 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.55 -38.64 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 -176.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 137.64 -106.51 0.54 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 13.2 t -176.25 78.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 175.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -140.96 89.27 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -83.14 -19.39 36.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.94 -36.81 92.57 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 175.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.99 -8.8 52.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.594 0.235 . . . . 0.0 110.751 -170.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.4 tp -65.58 -21.43 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.641 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.22 -24.7 35.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -178.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.88 -35.22 19.49 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.69 -24.23 63.56 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 122.877 -0.19 . . . . 0.0 110.714 178.188 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 9.4 ttp -67.63 -25.7 65.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.24 -41.51 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -87.16 -0.83 84.88 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.42 9.38 55.22 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 710' ' ' VAL . 0.2 OUTLIER -64.91 -44.75 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 -177.782 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 715' ' ' VAL . 84.1 t -71.99 -36.96 59.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.45 -176.645 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.15 -27.94 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.529 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -54.2 47.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.555 175.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 28.0 p -62.29 -29.17 70.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.629 -175.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.1 t -70.17 -48.3 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.49 177.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.44 -30.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.469 -178.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 721' ' ' VAL . 70.2 t -76.81 -39.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.292 -177.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.78 -42.18 93.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.321 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.7 p -72.62 -29.39 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.579 -177.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 720' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 723' ' ' LEU . 37.8 tp -67.46 -34.81 77.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.606 177.026 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 717' ' ' VAL . 63.5 t -64.89 -31.13 52.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.485 178.298 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.3 ttt -72.63 -31.17 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.613 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 723' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 720' ' ' LEU . 94.7 mt -69.28 -16.2 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.762 178.031 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.3 tttp 66.72 132.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.746 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -143.0 165.87 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.722 -178.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -71.55 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.427 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -141.34 -63.39 0.46 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 -174.103 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.406 179.455 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -81.16 115.33 20.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.517 176.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -151.49 -9.83 0.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.586 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.49 77.68 1.94 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 -176.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 689' ' ' VAL . 36.1 mttp -132.07 -77.14 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.571 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.2 -47.2 0.62 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.926 -176.188 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 689' ' ' VAL . 2.7 t -57.39 -38.58 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 -177.278 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.51 -41.44 19.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.63 177.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -37.04 67.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -63.56 -30.51 71.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.748 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.24 -41.79 56.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -38.62 75.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.533 -171.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.07 -21.61 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 175.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -42.94 -38.66 3.4 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 172.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 697' ' ' SER . . . . . 0.482 ' HB3' HD11 ' A' ' 705' ' ' LEU . 0.5 OUTLIER -174.73 140.94 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.741 170.363 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -77.8 169.2 18.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.821 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -60.09 -52.26 66.11 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.16 -23.86 64.55 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.55 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.764 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.79 -29.11 25.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.02 -48.65 78.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.495 -179.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.66 -34.76 48.28 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 697' ' ' SER . 16.8 mt -67.67 -33.61 75.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.025 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.4 ttm -50.66 -25.14 3.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 710' ' ' VAL . 52.1 t -64.91 -50.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.564 174.058 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.83 -4.25 85.05 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.67 13.37 56.27 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 707' ' ' VAL . 94.2 t -72.06 -49.18 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.457 -177.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 715' ' ' VAL . 26.6 t -61.26 -47.29 94.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.471 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.2 mm -68.25 -34.13 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.465 -176.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.78 -52.5 64.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 175.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -33.06 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.589 -176.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -68.11 -51.54 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.404 179.055 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.4 -38.17 81.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.449 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -69.89 -43.55 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.457 -175.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.01 -34.28 52.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.559 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.3 m -70.61 -36.32 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.451 178.079 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 -30.16 70.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.685 -176.234 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.33 -39.67 81.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 2.8 ttt -73.71 -30.39 62.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.559 -176.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.89 -17.01 63.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.758 174.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.18 171.74 7.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -143.92 24.71 1.65 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.448 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 tttm 67.31 143.22 0.03 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.852 -178.127 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.57 133.44 39.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.677 174.451 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.49 171.088 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.618 0.247 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 70.3 1.79 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.371 -178.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -140.0 -61.24 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.518 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 52.68 -101.39 0.11 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt 49.88 -112.9 0.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.852 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 67.93 3.06 3.37 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.41 -17.63 20.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.439 176.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -78.31 -37.84 43.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.47 176.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -46.09 12.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.646 -178.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 692' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 695' ' ' VAL . . . -71.7 -0.71 11.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.721 -177.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.01 -14.32 60.11 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 176.441 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.28 -7.16 59.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.68 -170.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 692' ' ' ALA . 28.8 m -65.97 -18.83 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -133.81 83.26 0.29 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 174.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 35.0 p -111.0 57.03 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 175.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.49 132.56 37.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.504 177.003 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -56.36 -40.28 74.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.83 -36.14 81.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.75 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.733 178.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.6 mm -57.18 -32.92 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.635 -178.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.88 -43.32 79.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.524 178.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 704' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 707' ' ' VAL . . . -78.67 -21.66 68.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -177.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.55 -24.71 49.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 174.887 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -21.51 66.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.522 -173.04 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 707' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 704' ' ' GLY . 4.8 m -68.79 -31.31 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 -179.086 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.17 0.16 63.83 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.32 13.39 33.85 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.18 -50.25 37.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.626 0.25 . . . . 0.0 110.489 -178.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 711' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -59.25 -48.14 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.593 177.738 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.471 -178.012 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.31 -50.82 72.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.577 177.134 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 85.2 m -60.24 -35.7 76.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.645 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -67.31 -45.7 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.65 -29.16 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.521 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.5 t -77.2 -42.27 31.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.414 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.12 -43.51 89.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.491 176.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 39.5 p -68.03 -31.31 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.545 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -28.9 67.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.578 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 721' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 717' ' ' VAL . 60.4 t -63.47 -34.98 70.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 175.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 9.0 mtm -79.36 -15.98 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.618 -177.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.34 17.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.638 174.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -7.39 41.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.907 174.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 29.3 mttp 64.39 -167.3 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.726 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -98.4 -30.07 12.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -79.61 -2.91 44.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.642 177.688 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.444 0.164 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 703' ' ' ILE . 7.8 tt -57.34 -37.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.533 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 17.1 mt -69.18 -38.44 77.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.312 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.77 -45.55 64.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.04 -29.19 68.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.788 -0.206 . . . . 0.0 110.701 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 3.9 mmt -70.9 -51.28 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.49 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.04 -40.15 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.543 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.37 -6.77 87.97 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.53 5.25 78.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.03 -35.29 63.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.614 0.245 . . . . 0.0 110.688 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 715' ' ' VAL . 6.7 t -77.8 -38.02 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.371 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.51 -32.52 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.491 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.48 -53.12 61.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 35.0 p -64.32 -30.67 71.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.6 t -68.26 -49.8 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.87 -33.87 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.329 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.0 t -72.27 -45.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.433 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.9 mm -54.57 -41.3 54.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 15.7 m -65.87 -36.34 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.537 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -28.95 69.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.634 -176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.74 -47.52 88.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.413 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 57.6 mtt -77.26 -29.35 53.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.486 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.775 177.283 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 120.371 0.129 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 12.9 mm -58.16 -31.95 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.6 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 703' ' ' ILE . 1.8 mp -74.65 -43.02 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.373 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.51 -31.41 56.71 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.2 -25.48 66.94 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.839 -0.213 . . . . 0.0 110.834 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -30.54 69.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.96 -48.3 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.524 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -84.43 -3.22 88.71 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.16 11.34 55.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 714' ' ' THR . 7.7 p -73.53 -42.91 55.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.492 0.187 . . . . 0.0 110.538 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 715' ' ' VAL . 24.6 t -66.99 -45.65 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.372 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.0 -34.92 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.91 -51.13 70.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.533 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 710' ' ' VAL . 45.6 p -62.93 -36.77 84.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.619 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 711' ' ' VAL . 66.6 t -61.77 -54.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.502 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.62 -38.36 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.362 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.3 t -66.38 -42.17 90.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.507 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.12 -29.63 46.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.512 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -34.78 68.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . 0.488 HD13 HD12 ' A' ' 723' ' ' LEU . 1.6 mm? -65.52 -31.2 72.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.515 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.0 t -61.12 -38.12 78.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 5.4 mmt -76.54 -28.14 56.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.571 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 720' ' ' LEU . 84.4 mt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.778 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.68 -29.91 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 4.4 mm -63.44 -50.86 76.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.89 -34.77 29.73 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.79 -29.11 70.46 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.825 -0.22 . . . . 0.0 110.964 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -30.54 71.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.658 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.79 -40.51 85.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.59 1.62 64.11 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.73 14.06 32.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.1 OUTLIER -70.52 -46.99 67.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.564 0.221 . . . . 0.0 110.624 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -67.76 -42.24 85.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.467 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.3 mt -66.47 -36.86 78.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.517 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.55 -51.41 70.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -38.73 83.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.707 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 711' ' ' VAL . 88.3 t -63.06 -50.4 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.477 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -36.83 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 70.0 t -69.32 -42.42 81.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.446 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.93 -29.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.548 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -71.44 -36.16 71.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.578 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.74 -30.69 71.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.5 -36.65 65.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.505 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -32.74 68.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.537 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 177.247 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.496 0.188 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.58 -33.78 49.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.496 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 15.3 mm -66.58 -36.54 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.368 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.11 -31.97 41.01 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -70.93 -21.14 62.39 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.781 -0.246 . . . . 0.0 110.941 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.5 ttm -66.13 -25.8 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.17 -42.05 95.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.99 80.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.17 11.58 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.65 -37.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.589 0.233 . . . . 0.0 110.609 -174.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.8 OUTLIER -76.15 -37.87 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.42 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.14 -28.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.4 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.45 -54.29 42.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.573 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.47 -37.46 75.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 711' ' ' VAL . 94.1 t -63.8 -52.7 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.356 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 45.0 mt -66.85 -37.81 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.485 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -70.44 -40.29 77.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.408 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 42.3 mt -63.72 -32.95 58.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.44 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.5 m -69.73 -32.38 70.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -69.28 -29.43 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.07 -34.88 71.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.464 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 -37.09 86.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.707 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.431 -179.426 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.419 0.152 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.8 mm -55.48 -39.2 52.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.61 -43.82 95.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.36 -37.09 37.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.12 -25.4 67.75 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.842 -0.21 . . . . 0.0 110.989 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.48 -28.72 69.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -42.83 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.35 -3.22 88.52 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.99 24.49 7.85 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.79 -34.39 7.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.633 0.254 . . . . 0.0 110.6 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 715' ' ' VAL . 22.1 t -76.51 -42.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.468 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -26.07 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -62.14 -51.55 67.4 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 2.2 p -61.04 -33.75 73.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.703 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 711' ' ' VAL . 67.4 t -68.17 -46.45 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.43 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 82.8 mt -73.86 -31.23 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.4 t -74.19 -42.83 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.391 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.7 mt -61.89 -37.6 78.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 10.7 p -72.22 -30.63 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.598 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.1 t -60.39 -33.89 55.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.514 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.2 mmt -73.03 -32.84 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.746 176.184 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.032 0 CA-C-O 120.479 0.18 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 20.4 mt -55.75 -41.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.513 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.33 -48.36 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -67.08 -28.24 73.71 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.24 -21.55 39.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.118 . . . . 0.0 110.717 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 11.3 tpt -67.31 -49.12 65.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.362 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 707' ' ' VAL . 14.3 m -66.79 -33.82 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.1 5.89 82.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.86 17.24 42.12 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.65 -43.59 61.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.643 0.258 . . . . 0.0 110.416 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.4 p -69.45 -42.51 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.1 tt -75.82 -26.58 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.49 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.5 -46.94 88.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.8 m -67.85 -35.54 78.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.61 -43.82 91.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.536 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.7 mm -69.75 -38.15 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.482 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.6 t -60.18 -46.24 94.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.444 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.35 -28.78 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.415 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 3.9 m -75.69 -38.52 58.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.441 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -65.33 -31.33 72.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 717' ' ' VAL . 87.7 t -61.0 -28.85 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.571 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -81.12 -24.47 37.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 720' ' ' LEU . 85.5 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.495 0.188 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.2 tt -53.98 -33.77 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.84 -40.58 88.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.317 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.21 62.67 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.19 -31.05 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.602 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.3 ttm -72.18 -50.94 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.81 -34.46 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.435 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.37 -4.29 86.18 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.24 18.01 30.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.3 m -76.53 -34.06 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.93 -45.91 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.545 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.28 -25.38 31.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.14 -51.23 68.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 37.0 p -64.0 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.596 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.88 -45.12 84.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.46 -36.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.456 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.2 t -70.97 -47.77 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.393 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.12 -26.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.483 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 68.9 m -70.01 -46.1 65.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.594 171.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.03 -32.74 74.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.58 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.51 -40.33 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.508 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.3 mmm -79.56 -27.99 41.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.484 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 723' ' ' LEU . 89.8 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.52 0.2 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 5.8 tt -55.9 -36.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.575 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 707' ' ' VAL . 82.9 mt -64.96 -36.86 78.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.41 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -71.28 -33.63 64.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.02 -32.11 63.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.503 0.192 . . . . 0.0 110.77 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 13.5 tpp -71.79 -51.71 21.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 703' ' ' ILE . 12.4 p -73.05 -37.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.428 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -82.97 -2.25 90.66 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -80.46 2.82 76.23 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 20.9 m -65.39 -40.15 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.404 0.145 . . . . 0.0 110.707 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 711' ' ' VAL . 0.0 OUTLIER -76.28 -41.28 36.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.503 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 68.6 mt -71.12 -30.17 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.65 -50.73 72.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -39.51 94.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.49 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.4 -51.15 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.516 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.16 -36.92 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.8 t -58.49 -46.99 89.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.457 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.48 -32.0 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -43.2 82.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.63 -29.48 66.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.599 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.02 -41.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.406 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.0 tpt -75.21 -31.82 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.475 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.092 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.34 0.114 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.03 -32.46 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 -173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.53 -48.03 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.623 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.29 66.98 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.48 -24.16 65.57 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 122.944 -0.151 . . . . 0.0 110.778 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 26.4 ttm -65.58 -30.53 71.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.11 -40.24 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.14 0.48 75.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.25 12.34 45.29 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -67.47 -49.0 75.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 110.664 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 715' ' ' VAL . 93.7 t -65.01 -46.51 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.37 -36.0 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.588 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.59 -47.89 83.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 718' ' ' ILE . 18.5 m -64.3 -36.77 85.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.6 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 711' ' ' VAL . 86.0 t -63.25 -31.69 53.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.525 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 73.8 mt -80.16 -30.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 713' ' ' ALA . 62.3 t -64.68 -39.27 85.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.58 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 714' ' ' THR . 1.1 pt -65.23 -26.07 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 1.1 m -79.92 -30.48 40.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.33 -29.23 70.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -31.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -26.14 60.48 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.568 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.711 175.865 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.566 0.222 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.12 -26.62 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -42.26 84.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.2 98.37 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.16 -22.76 59.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.835 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -47.65 69.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.339 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 710' ' ' VAL . 61.2 t -67.04 -37.6 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.323 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.65 7.98 60.51 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.66 12.52 56.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 707' ' ' VAL . 29.1 m -68.31 -39.9 81.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.504 0.192 . . . . 0.0 110.678 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -75.0 -43.19 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.63 -31.05 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.362 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.97 -53.09 62.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.615 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -39.59 82.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 60.2 t -61.4 -51.6 71.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.495 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.21 -35.15 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.339 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.4 t -67.46 -36.34 76.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.438 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 721' ' ' VAL . 52.0 mt -69.96 -26.94 31.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -25.83 48.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.698 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.37 -20.83 62.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.4 m -67.22 -26.53 36.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 tpt -70.41 -37.21 74.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.437 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.646 174.664 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.037 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 46.0 mt -57.07 -31.49 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.482 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 9.9 mm -68.22 -44.69 83.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.85 41.45 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.94 -24.37 67.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.222 . . . . 0.0 111.045 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 25.4 ttm -61.96 -28.74 69.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.49 -40.25 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -88.19 -1.95 81.01 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.47 14.9 48.89 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.91 -49.57 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.632 0.254 . . . . 0.0 110.445 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 78.2 t -60.26 -47.39 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.519 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.27 -34.37 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.535 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.14 -48.98 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.39 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -33.17 74.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.527 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 57.3 t -70.3 -46.4 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.363 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 11.9 mm -72.21 -31.76 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 721' ' ' VAL . 45.6 t -74.33 -45.91 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.429 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.8 -41.28 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.406 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 32.2 p -73.42 -27.53 61.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.697 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.86 -31.13 69.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 717' ' ' VAL . 93.9 t -65.32 -28.74 45.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.558 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 722' ' ' MET . 0.9 OUTLIER -82.28 -24.85 34.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.706 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.444 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.359 0.124 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 702' ' ' ILE . 0.4 OUTLIER -59.09 -31.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.674 -175.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.47 -47.41 86.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.555 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.05 -37.61 37.54 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.29 -26.01 68.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.496 0.189 . . . . 0.0 110.705 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 14.2 ttp -60.54 -32.5 71.55 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.28 -46.01 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.504 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.86 -3.53 85.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.77 13.57 47.32 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.71 -36.41 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 110.658 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 715' ' ' VAL . 35.2 m -73.7 -40.15 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.452 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 711' ' ' VAL . 3.5 mm -65.9 -36.77 78.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.92 -52.87 63.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -35.45 78.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.736 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 711' ' ' VAL . 92.0 t -63.49 -51.4 71.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.471 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 95.7 mt -68.14 -37.08 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.2 t -67.4 -41.05 85.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.444 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . 0.597 ' O ' HG22 ' A' ' 721' ' ' VAL . 36.3 mt -63.51 -26.09 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.84 -27.48 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.671 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . 1.002 HD13 HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -62.18 -27.61 69.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 718' ' ' ILE . 2.7 m -65.81 -21.17 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.511 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 12.9 mtt -78.68 -22.57 46.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.659 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 1.002 HD12 HD13 ' A' ' 720' ' ' LEU . 97.4 mt . . . . . 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.802 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.646 0.26 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.9 mt -63.2 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 703' ' ' ILE . 0.9 OUTLIER -63.03 -22.65 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.347 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.21 38.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.844 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -63.01 -46.78 86.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.618 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.54 -31.7 43.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.33 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.66 13.38 66.84 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.45 37.27 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 711' ' ' VAL . 7.1 p -67.95 -39.86 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.551 0.215 . . . . 0.0 110.656 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.476 HG23 HG13 ' A' ' 710' ' ' VAL . 33.7 t -75.82 -42.71 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.4 -27.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.438 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.81 -49.94 75.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.584 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 88.0 m -62.09 -41.2 97.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 91.5 t -56.8 -42.19 77.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.462 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -74.24 -35.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 713' ' ' ALA . 76.3 t -60.12 -47.64 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.28 -30.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.452 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 5.3 m -72.64 -39.1 67.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.528 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . 0.431 HD13 HD12 ' A' ' 723' ' ' LEU . 0.6 OUTLIER -64.83 -30.51 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -32.21 56.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.402 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.67 -32.36 57.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 -172.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 720' ' ' LEU . 85.6 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.808 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.087 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 26.1 mt -54.69 -34.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.31 -47.57 80.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.582 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.42 59.47 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.66 -26.74 68.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.425 -0.11 . . . . 0.0 110.823 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -27.64 66.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.01 -43.35 99.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.513 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.11 -2.99 90.71 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -87.79 24.74 9.79 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.89 -47.04 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.56 0.219 . . . . 0.0 110.465 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.1 p -62.87 -44.25 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -177.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.494 ' N ' HG13 ' A' ' 711' ' ' VAL . 17.7 tt -70.6 -28.23 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.24 -49.08 78.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.541 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -30.72 70.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.467 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.7 t -76.37 -49.09 25.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.405 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.92 -23.58 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.703 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 713' ' ' ALA . 16.2 t -66.6 -44.93 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.72 -36.75 62.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.539 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -41.5 97.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.447 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -31.14 69.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.759 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 -31.71 55.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 14.8 ttm -80.28 -26.04 39.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.661 177.109 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.388 0.137 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.23 -27.95 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.483 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.3 mt -70.34 -44.03 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.21 -35.33 49.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 705' ' ' LEU . 94.0 mt -71.28 -34.75 70.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.89 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.1 tpp -62.89 -55.17 28.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.392 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 708' ' ' GLY . 12.5 p -73.87 -38.57 50.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.458 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -75.54 -5.98 79.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.49 16.69 17.32 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 711' ' ' VAL . 7.9 p -68.55 -40.96 82.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.64 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 710' ' ' VAL . 7.4 p -75.8 -38.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.512 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.4 ' N ' HG13 ' A' ' 711' ' ' VAL . 7.3 mt -75.6 -26.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.19 -50.83 72.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.509 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 67.7 p -63.66 -34.75 78.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.579 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.03 -48.18 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.54 -36.86 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.458 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 713' ' ' ALA . 64.7 t -70.47 -44.12 77.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.406 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.28 -38.49 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.5 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 20.8 m -68.16 -32.86 73.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.599 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.61 -32.24 73.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.606 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.66 -41.24 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.476 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.08 -31.2 55.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.524 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 178.184 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 120.433 0.158 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.58 -30.69 22.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.652 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.39 -42.11 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.493 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.72 -43.68 17.7 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.61 -34.43 69.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.379 0.133 . . . . 0.0 110.89 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.8 ttt -64.9 -53.08 52.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.405 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 710' ' ' VAL . 39.7 t -73.87 -42.28 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.49 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.85 -6.61 82.43 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.53 18.74 40.5 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.2 t -75.76 -35.34 30.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 91.1 t -71.14 -49.14 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 18.5 pt -67.73 -27.41 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.59 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.35 -50.81 72.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.594 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -37.44 85.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.547 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.93 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.569 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.63 -29.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.553 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -64.25 -40.38 88.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.463 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 721' ' ' VAL . 1.4 mp -67.4 -26.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.475 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 16.0 m -78.96 -29.13 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.617 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -26.86 67.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -173.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.2 m -62.6 -26.11 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.481 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.87 -35.43 69.78 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.53 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 174.191 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.557 0.217 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 703' ' ' ILE . 17.3 tt -55.57 -37.03 44.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 13.6 mt -69.16 -39.7 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.67 12.95 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.52 -36.28 69.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.511 0.196 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 18.8 ttp -63.56 -54.67 32.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.411 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 710' ' ' VAL . 61.7 t -71.87 -43.49 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.35 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.59 -4.94 62.53 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.27 16.13 35.8 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.0 t -70.46 -47.61 64.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 110.579 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -44.44 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.604 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.64 -25.22 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.14 -53.12 61.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 76.5 p -61.71 -33.37 73.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.65 -46.18 86.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.518 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 -32.02 36.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 81.0 t -73.52 -41.33 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.36 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.22 -44.17 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 13.4 p -64.26 -31.96 73.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.607 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -31.73 73.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.683 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.87 -46.53 93.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 10.8 ttt -67.91 -36.71 80.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.781 -176.491 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 705' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 110.832 -0.062 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.75 -42.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.449 -173.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.65 -30.21 37.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.591 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.5 -24.5 72.67 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 701' ' ' ALA . 80.4 mt -61.4 -34.03 74.68 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.936 -0.155 . . . . 0.0 110.933 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.18 -38.4 35.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.55 -54.25 37.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.349 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -83.79 -29.63 31.52 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -65.27 -33.06 85.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -169.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.69 -47.15 87.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 110.632 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.96 -48.68 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.506 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 28.7 mt -62.66 -30.77 50.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.649 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -56.41 -53.51 56.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.443 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 66.8 p -61.47 -33.25 73.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.625 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.69 -51.89 29.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.416 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.35 -33.33 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.416 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 713' ' ' ALA . 22.6 t -63.26 -43.97 98.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.303 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.88 -32.09 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.464 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -29.59 55.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.61 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -32.63 74.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.623 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.18 -35.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.428 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 ttm -72.0 -33.39 68.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.723 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.564 177.478 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.692 0.282 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.04 -32.93 51.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.581 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.36 -43.95 91.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.89 -40.9 24.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 47.3 mt -72.49 -21.64 61.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.792 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -25.74 62.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.47 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.57 -40.76 87.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.412 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.23 1.99 83.15 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.14 26.23 8.03 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -43.09 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.729 0.3 . . . . 0.0 110.64 173.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -71.98 -38.38 63.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.449 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 712' ' ' ILE . 8.2 tt -78.22 -25.02 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.41 73.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.515 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.43 -38.44 80.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 711' ' ' VAL . 63.1 t -65.64 -51.0 67.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.459 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.45 -37.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.579 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 721' ' ' VAL . 41.4 t -69.53 -39.01 77.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.32 -175.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.9 mt -65.91 -33.85 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.346 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -34.51 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.775 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.3 -31.73 72.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.654 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 717' ' ' VAL . 41.1 t -67.47 -27.23 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.531 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 6.3 mmt -80.52 -31.65 37.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.514 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.423 175.902 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.466 0.174 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 35.3 pt -58.89 -28.28 37.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.492 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.93 -46.94 81.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.426 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.73 -33.99 59.95 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.86 -21.42 51.4 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.839 -0.212 . . . . 0.0 110.997 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.29 -43.08 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.67 -29.27 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -101.32 9.13 57.46 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.52 12.3 40.83 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.7 -30.4 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.686 0.279 . . . . 0.0 110.724 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 715' ' ' VAL . 64.8 t -76.81 -46.46 30.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 22.3 pt -67.41 -25.85 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.594 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.52 -52.58 62.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 6.1 p -62.19 -31.98 72.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.666 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 711' ' ' VAL . 70.4 t -67.28 -46.83 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 34.9 mt -71.67 -33.5 49.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.4 t -68.54 -40.27 81.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 721' ' ' VAL . 3.8 mm -62.66 -32.93 57.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -23.82 41.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.787 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.37 -24.75 64.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.703 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.5 m -63.87 -26.12 39.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -69.48 -36.68 76.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.893 176.788 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.475 0.179 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -54.6 -32.79 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.589 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.88 -31.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -178.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.68 -39.37 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 705' ' ' LEU . 63.9 mt -63.85 -43.56 95.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.587 0.232 . . . . 0.0 110.781 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.0 ttt -62.17 -53.64 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.412 -174.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 710' ' ' VAL . 87.4 t -72.51 -44.06 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.405 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.22 3.44 46.75 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.17 20.07 23.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 707' ' ' VAL . 87.8 t -64.5 -49.97 78.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 110.601 174.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.86 -43.91 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.445 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.2 -23.73 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.411 -176.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -63.3 -49.99 71.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.562 176.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 70.8 p -66.14 -30.27 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.417 -175.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.02 -34.91 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.641 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 70.2 mt -77.49 -32.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.5 t -64.75 -47.27 89.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.437 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 39.4 pt -67.27 -28.96 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.629 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . 0.626 HG22 HD12 ' A' ' 723' ' ' LEU . 28.1 m -71.78 -36.26 70.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -25.2 59.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.586 -178.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 717' ' ' VAL . 55.9 t -64.64 -47.83 87.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 722' ' ' MET . 0.0 OUTLIER -81.98 -23.22 36.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.41 -176.569 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 719' ' ' THR . 98.6 mt . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.705 175.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.483 0.182 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.1 pp -53.5 -26.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.779 -173.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.97 -46.53 78.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.561 177.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.78 -32.55 32.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.35 -25.06 64.9 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.895 -0.179 . . . . 0.0 111.091 177.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 ttt -63.55 -30.91 71.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.719 -179.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.72 -44.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.58 2.88 78.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.43 23.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -177.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 3.1 m -86.65 -35.87 9.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -45.46 78.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.443 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.4 pt -70.37 -26.63 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 -179.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.18 -50.37 73.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.47 177.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 3.0 m -61.67 -36.31 80.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.572 -178.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.44 -48.72 79.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.08 -38.34 79.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.414 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 721' ' ' VAL . 54.1 t -67.24 -47.19 82.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.362 -176.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 43.2 mt -56.67 -42.29 76.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.524 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 93.5 m -67.13 -37.16 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.79 -30.11 69.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.656 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 717' ' ' VAL . 26.0 t -67.35 -40.77 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 176.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 21.0 mtp -74.29 -24.71 59.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.9 -179.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.408 -178.896 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 702' ' ' ILE . 0.4 OUTLIER -65.7 -26.08 38.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.43 -177.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.08 -29.22 45.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.684 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -84.4 -33.2 20.52 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.82 -21.32 51.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.852 174.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.9 tpp -71.26 -47.96 53.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.497 -174.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 22.1 m -68.32 -31.11 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.652 174.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -89.83 11.28 70.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 177.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.32 13.88 56.2 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.52 -43.83 96.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.456 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.5 p -74.23 -40.21 50.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.57 -177.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.426 ' N ' HG13 ' A' ' 711' ' ' VAL . 16.2 mt -73.73 -28.68 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -57.08 -51.01 70.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.579 174.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -33.3 75.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.544 -176.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.92 -45.28 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.541 178.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.33 -36.92 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.424 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 713' ' ' ALA . 97.1 t -67.73 -47.98 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 tp -69.4 -26.42 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.42 -174.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 57.0 m -75.67 -41.87 52.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.553 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.71 -35.68 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.486 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.4 mtt -78.7 -30.1 45.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.5 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.644 176.886 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.03 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.99 -32.56 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.632 -174.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.57 -44.79 93.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 175.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.74 -29.39 57.63 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 75.2 mt -68.02 -24.62 65.13 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.911 -0.17 . . . . 0.0 110.923 177.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.2 ttm -66.57 -29.27 69.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.705 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.45 -38.67 81.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.89 -0.91 71.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.7 12.86 39.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -175.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -68.92 -46.37 79.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.625 -178.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 715' ' ' VAL . 44.1 t -67.43 -47.49 80.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 -177.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.66 -40.29 78.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.669 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.87 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -38.71 87.21 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.485 -178.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 711' ' ' VAL . 65.3 t -61.89 -52.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.44 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.49 -39.29 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.562 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 73.6 t -68.34 -41.72 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.356 -175.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.99 -36.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -72.98 -32.55 65.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.04 -33.41 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.01 -42.19 78.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 176.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -36.66 76.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.649 177.406 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.771 0.319 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.474 HD13 HD12 ' A' ' 705' ' ' LEU . 3.4 mm -60.36 -24.4 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.576 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 12.3 tt -57.51 -31.59 39.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -86.29 -33.07 14.99 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 702' ' ' ILE . 86.8 mt -66.45 -23.38 66.27 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.827 -0.219 . . . . 0.0 110.86 174.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.6 ttm -68.55 -25.57 64.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.719 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 710' ' ' VAL . 46.2 t -66.0 -39.19 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.605 176.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.6 -7.14 88.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.38 23.18 10.31 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 707' ' ' VAL . 90.0 t -82.35 -37.8 14.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.715 0.293 . . . . 0.0 110.489 175.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 711' ' ' VAL . 0.9 OUTLIER -74.27 -41.0 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.373 -174.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.4 -26.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.681 177.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -51.84 67.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.9 p -61.9 -34.37 75.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.76 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.31 -51.46 58.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 178.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.1 -39.98 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.452 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.3 t -69.32 -45.18 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 -174.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.47 -40.68 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.504 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.1 m -67.27 -39.29 86.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.479 176.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.614 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 717' ' ' VAL . 98.7 t -60.15 -44.54 95.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.453 177.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 52.7 mmm -70.83 -33.85 71.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.481 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.681 177.842 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.594 0.235 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 9.7 mm -51.02 -33.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.602 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.17 -47.01 89.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.422 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.13 -36.48 24.41 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -176.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.99 -28.64 69.17 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.53 0.205 . . . . 0.0 110.857 176.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -31.12 70.46 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -46.19 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.44 -5.63 89.37 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 178.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.91 12.19 54.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 71.6 t -71.57 -46.49 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.758 0.313 . . . . 0.0 110.536 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 715' ' ' VAL . 2.8 t -67.52 -42.34 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.407 -176.194 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.38 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.648 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.59 -52.5 65.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 178.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 69.7 p -62.94 -33.63 75.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.653 -177.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.3 t -65.35 -49.04 80.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.54 -31.82 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.49 -178.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.8 t -73.21 -39.6 56.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.442 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.07 -32.22 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.426 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -45.38 90.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 174.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.48 -30.26 70.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.778 -176.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.607 176.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.3 tpt -82.65 -22.43 34.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 175.581 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.506 0.193 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.01 -34.53 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.544 176.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 707' ' ' VAL . 20.0 mt -70.29 -48.87 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.233 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.92 -25.62 75.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 177.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.25 -43.85 80.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.4 mmt -70.04 -31.19 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.408 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 703' ' ' ILE . 77.7 t -67.13 -48.45 78.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.503 -178.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.9 1.95 78.87 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 178.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -93.22 16.93 59.4 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.81 -33.58 16.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.517 0.198 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -72.44 -43.64 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 -179.523 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.66 -25.58 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -64.08 -54.11 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 178.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.4 p -57.74 -36.64 72.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.84 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 711' ' ' VAL . 90.7 t -65.81 -49.54 76.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.472 -179.181 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -65.36 -40.48 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.4 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -68.92 -42.22 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.68 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 90.4 m -65.58 -31.24 72.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -25.95 64.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.733 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.27 -33.87 65.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 176.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.32 -29.13 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.423 -178.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.852 177.677 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.594 0.235 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.4 tp -65.58 -21.43 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.641 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.22 -24.7 35.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -178.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.88 -35.22 19.49 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.69 -24.23 63.56 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 122.877 -0.19 . . . . 0.0 110.714 178.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 9.4 ttp -67.63 -25.7 65.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.24 -41.51 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -87.16 -0.83 84.88 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.42 9.38 55.22 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 710' ' ' VAL . 0.2 OUTLIER -64.91 -44.75 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 -177.782 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 715' ' ' VAL . 84.1 t -71.99 -36.96 59.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.45 -176.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.15 -27.94 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.529 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -54.2 47.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.555 175.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 28.0 p -62.29 -29.17 70.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.629 -175.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.1 t -70.17 -48.3 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.49 177.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.44 -30.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.469 -178.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 721' ' ' VAL . 70.2 t -76.81 -39.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.292 -177.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.78 -42.18 93.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.321 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.7 p -72.62 -29.39 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.579 -177.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 723' ' ' LEU . 37.8 tp -67.46 -34.81 77.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.606 177.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 717' ' ' VAL . 63.5 t -64.89 -31.13 52.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.485 178.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.3 ttt -72.63 -31.17 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.613 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 720' ' ' LEU . 94.7 mt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.762 178.031 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.79 -29.11 25.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.02 -48.65 78.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.495 -179.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.66 -34.76 48.28 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.67 -33.61 75.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.025 -179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.4 ttm -50.66 -25.14 3.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 710' ' ' VAL . 52.1 t -64.91 -50.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.564 174.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.83 -4.25 85.05 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.67 13.37 56.27 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 707' ' ' VAL . 94.2 t -72.06 -49.18 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.457 -177.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 715' ' ' VAL . 26.6 t -61.26 -47.29 94.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.471 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.2 mm -68.25 -34.13 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.465 -176.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.78 -52.5 64.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 175.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -33.06 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.589 -176.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -68.11 -51.54 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.404 179.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.4 -38.17 81.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.449 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -69.89 -43.55 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.457 -175.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.01 -34.28 52.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.559 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.3 m -70.61 -36.32 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.451 178.079 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 -30.16 70.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.685 -176.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.33 -39.67 81.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 2.8 ttt -73.71 -30.39 62.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.559 -176.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.758 174.65 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.073 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.6 mm -57.18 -32.92 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.635 -178.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.88 -43.32 79.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.524 178.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 707' ' ' VAL . . . -78.67 -21.66 68.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -177.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.55 -24.71 49.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 174.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -21.51 66.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.522 -173.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 707' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 704' ' ' GLY . 4.8 m -68.79 -31.31 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 -179.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.17 0.16 63.83 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.32 13.39 33.85 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.18 -50.25 37.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.626 0.25 . . . . 0.0 110.489 -178.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -59.25 -48.14 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.593 177.738 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.471 -178.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.31 -50.82 72.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.577 177.134 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 85.2 m -60.24 -35.7 76.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.645 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -67.31 -45.7 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.65 -29.16 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.521 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 717' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.5 t -77.2 -42.27 31.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.414 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.12 -43.51 89.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.491 176.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 39.5 p -68.03 -31.31 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.545 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -28.9 67.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.578 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 721' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 717' ' ' VAL . 60.4 t -63.47 -34.98 70.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 175.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 9.0 mtm -79.36 -15.98 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.618 -177.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.53 0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.638 174.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.55 0.214 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . 0.402 ' CG ' ' H ' ' A' ' 685' ' ' HIS . 5.0 t-80 -96.51 -179.52 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.614 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 684' ' ' HIS . 32.3 p-80 -119.48 176.13 5.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.763 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.03 77.89 1.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.09 19.48 11.63 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.32 -15.52 62.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.33 -0.34 4.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.861 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -71.76 -27.98 63.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -82.88 8.88 11.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.799 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -73.62 -15.22 61.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.51 -3.43 14.63 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.16 -16.32 62.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.46 -21.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -72.18 -156.73 3.03 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 53.1 m -137.45 -85.96 0.3 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.455 0.169 . . . . 0.0 110.608 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 699' ' ' LYS . 14.6 p-10 -151.54 -111.34 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.515 ' H ' ' CG ' ' A' ' 698' ' ' ASN . 0.4 OUTLIER -54.28 -40.93 68.31 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.918 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.24 -18.4 71.21 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.08 60.72 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.805 -0.233 . . . . 0.0 110.895 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 699' ' ' LYS . 7.8 tt -57.34 -37.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.533 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 17.1 mt -69.18 -38.44 77.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.312 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.77 -45.55 64.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.04 -29.19 68.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.788 -0.206 . . . . 0.0 110.701 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 3.9 mmt -70.9 -51.28 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.49 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.04 -40.15 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.543 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.37 -6.77 87.97 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.53 5.25 78.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.03 -35.29 63.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.614 0.245 . . . . 0.0 110.688 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 715' ' ' VAL . 6.7 t -77.8 -38.02 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.371 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.51 -32.52 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.491 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.48 -53.12 61.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 35.0 p -64.32 -30.67 71.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.6 t -68.26 -49.8 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.87 -33.87 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.329 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.0 t -72.27 -45.66 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.433 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.9 mm -54.57 -41.3 54.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 15.7 m -65.87 -36.34 83.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.537 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -28.95 69.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.634 -176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.74 -47.52 88.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.413 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 57.6 mtt -77.26 -29.35 53.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.486 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.41 -16.26 56.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.775 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.2 pttp 26.29 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.604 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -60.68 130.28 45.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.749 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 45.4 mttt 51.81 68.67 0.77 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.802 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 54.48 -141.67 0.85 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.443 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.577 172.19 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.706 0.289 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -98.79 -156.41 0.54 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.653 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.26 95.23 10.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -91.09 12.99 18.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.13 -165.28 1.16 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.37 5.35 4.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.944 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 83.9 t -75.79 -6.08 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.564 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -30.39 12.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.466 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.76 -56.13 3.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.306 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.694 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.36 -17.2 64.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.54 -17.89 63.28 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.773 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 92.3 t -60.32 -39.12 79.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.543 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 64.49 -129.35 36.64 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.63 -50.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . 0.546 ' H ' ' HB3' ' A' ' 701' ' ' ALA . 0.2 OUTLIER -166.79 171.29 11.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.447 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.5 -47.21 66.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.755 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.26 -24.34 76.03 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.546 ' HB3' ' H ' ' A' ' 698' ' ' ASN . . . -64.74 -40.87 96.04 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.789 175.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 12.9 mm -58.16 -31.95 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.6 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 703' ' ' ILE . 1.8 mp -74.65 -43.02 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.373 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.51 -31.41 56.71 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.2 -25.48 66.94 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.839 -0.213 . . . . 0.0 110.834 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -30.54 69.92 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.96 -48.3 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.524 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -84.43 -3.22 88.71 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.16 11.34 55.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 714' ' ' THR . 7.7 p -73.53 -42.91 55.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.492 0.187 . . . . 0.0 110.538 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 715' ' ' VAL . 24.6 t -66.99 -45.65 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.372 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.0 -34.92 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.91 -51.13 70.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.533 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 710' ' ' VAL . 45.6 p -62.93 -36.77 84.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.619 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 711' ' ' VAL . 66.6 t -61.77 -54.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.502 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.62 -38.36 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.362 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.3 t -66.38 -42.17 90.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.507 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.12 -29.63 46.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.512 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -34.78 68.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . 0.488 HD13 HD12 ' A' ' 723' ' ' LEU . 1.6 mm? -65.52 -31.2 72.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.515 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 63.0 t -61.12 -38.12 78.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.515 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 5.4 mmt -76.54 -28.14 56.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.571 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 720' ' ' LEU . 84.4 mt -64.45 -24.8 67.74 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.778 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt 71.95 155.5 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -148.19 -72.01 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.447 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -166.7 97.14 0.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.445 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . 0.536 HE21 ' H ' ' A' ' 728' ' ' TYR . 0.1 OUTLIER -167.34 -102.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.435 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . 0.536 ' H ' HE21 ' A' ' 727' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.477 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.703 0.287 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 64.83 19.04 11.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.824 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -102.14 -62.82 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -168.96 144.6 3.35 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.534 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -101.93 103.23 13.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.502 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.17 -16.41 4.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 10.3 p -64.2 -13.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.758 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -54.63 44.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.679 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -75.42 -31.69 60.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.612 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 695' ' ' VAL . . . -66.67 -13.3 61.07 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -60.24 -17.5 42.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.807 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.08 -10.61 59.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.918 -171.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 692' ' ' ALA . 17.0 m -70.25 -4.56 4.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.805 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -51.28 143.24 16.53 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 7.6 t -128.68 -165.38 1.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.18 146.58 0.06 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -83.92 -50.56 7.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.491 -178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -64.98 -13.67 57.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.48 -24.97 68.05 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.788 -0.242 . . . . 0.0 110.966 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 699' ' ' LYS . 2.1 pp -56.68 -29.91 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.811 -175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 4.4 mm -63.44 -50.86 76.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.89 -34.77 29.73 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.79 -29.11 70.46 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.825 -0.22 . . . . 0.0 110.964 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -30.54 71.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.658 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.79 -40.51 85.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.59 1.62 64.11 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.73 14.06 32.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.1 OUTLIER -70.52 -46.99 67.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.564 0.221 . . . . 0.0 110.624 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -67.76 -42.24 85.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.467 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.3 mt -66.47 -36.86 78.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.517 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.55 -51.41 70.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -38.73 83.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.707 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 711' ' ' VAL . 88.3 t -63.06 -50.4 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.477 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -36.83 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 70.0 t -69.32 -42.42 81.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.446 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.93 -29.5 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.548 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -71.44 -36.16 71.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.578 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.74 -30.69 71.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.5 -36.65 65.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.505 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -32.74 68.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.537 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.8 -37.62 70.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -68.54 154.42 41.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 35.3 mttm 55.99 90.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.762 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.6 -54.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.439 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -79.18 161.21 26.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.642 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.482 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -91.41 171.84 8.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.525 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -71.35 -88.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.486 -168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 51.15 -113.14 0.69 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.798 164.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -116.06 176.34 5.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.587 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.76 -48.32 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.542 173.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.28 -44.85 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -168.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -34.28 78.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.582 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -96.05 21.08 9.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.409 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.65 58.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.81 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.07 -27.16 65.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -53.81 15.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.569 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.63 -54.62 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.534 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 92.1 59.62 1.3 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 1.1 p -94.34 175.06 6.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.662 0.268 . . . . 0.0 110.575 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -130.44 172.76 11.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.742 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -34.83 75.0 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.653 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.04 -32.24 76.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -73.54 -30.78 63.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.496 0.188 . . . . 0.0 110.651 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.9 mm -58.58 -33.78 49.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.496 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 15.3 mm -66.58 -36.54 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.368 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -79.11 -31.97 41.01 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 71.1 mt -70.93 -21.14 62.39 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 122.781 -0.246 . . . . 0.0 110.941 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.5 ttm -66.13 -25.8 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.17 -42.05 95.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.99 80.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.17 11.58 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.65 -37.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.589 0.233 . . . . 0.0 110.609 -174.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.8 OUTLIER -76.15 -37.87 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.42 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -74.14 -28.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.4 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.45 -54.29 42.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.573 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.47 -37.46 75.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 711' ' ' VAL . 94.1 t -63.8 -52.7 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.356 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 45.0 mt -66.85 -37.81 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.485 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -70.44 -40.29 77.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.408 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 42.3 mt -63.72 -32.95 58.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.44 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.5 m -69.73 -32.38 70.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -69.28 -29.43 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.07 -34.88 71.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.464 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 -37.09 86.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.707 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.27 -60.59 3.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.431 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -133.99 151.29 51.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -76.1 -174.33 2.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.531 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -60.69 -72.93 0.1 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.505 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -165.41 83.53 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.348 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.562 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--O 1.232 0.18 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.44 25.97 0.4 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.57 158.05 18.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.387 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -83.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.515 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -133.27 -152.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.07 -4.79 1.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.838 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 13.1 m -79.11 -0.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -52.45 65.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.58 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.6 -26.37 41.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.503 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.494 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -69.95 -9.17 54.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -78.52 -17.32 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.93 -6.94 53.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 21.3 m -65.77 -12.24 13.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.067 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -48.03 121.27 6.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 75.2 p -128.21 -155.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.31 116.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.802 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -34.69 66.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.743 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -61.34 -53.01 47.86 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.04 -32.95 72.81 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.841 -0.211 . . . . 0.0 110.642 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 2.8 mm -55.48 -39.2 52.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.61 -43.82 95.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.36 -37.09 37.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.12 -25.4 67.75 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.842 -0.21 . . . . 0.0 110.989 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.48 -28.72 69.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -42.83 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.35 -3.22 88.52 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.99 24.49 7.85 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.79 -34.39 7.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.633 0.254 . . . . 0.0 110.6 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 715' ' ' VAL . 22.1 t -76.51 -42.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.468 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -26.07 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -62.14 -51.55 67.4 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 2.2 p -61.04 -33.75 73.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.703 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 711' ' ' VAL . 67.4 t -68.17 -46.45 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.43 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 82.8 mt -73.86 -31.23 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.4 t -74.19 -42.83 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.391 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.7 mt -61.89 -37.6 78.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 10.7 p -72.22 -30.63 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.598 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -36.41 84.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.1 t -60.39 -33.89 55.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.514 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.2 mmt -73.03 -32.84 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.613 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.0 -30.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.746 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.7 pttt 35.17 37.16 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.594 0.559 . . . . 0.0 111.482 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm 44.13 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.086 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 11.5 tttp 68.28 104.11 0.05 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 -44.23 0.15 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.661 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.462 0.153 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.465 176.521 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.552 0.215 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -102.04 -87.52 0.4 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.495 -174.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 20.9 m80 52.62 -161.23 0.1 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.794 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 74.45 -67.02 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.672 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -101.67 165.95 10.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.2 tp 70.3 1.25 3.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.874 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.89 -11.73 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -8.22 43.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.929 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -83.86 39.02 0.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.667 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -75.01 -10.95 59.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.724 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.43 -30.39 71.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.701 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.74 -55.8 6.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 35.7 m -74.32 0.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.869 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -69.8 -166.17 5.28 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 1.1 p 63.28 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.569 0.223 . . . . 0.0 110.857 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 701' ' ' ALA . 3.0 m-20 -172.16 103.61 0.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.479 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -67.66 -41.47 83.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.58 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.34 96.88 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 698' ' ' ASN . . . -63.93 -41.34 97.66 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.636 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 20.4 mt -55.75 -41.96 67.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.513 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.33 -48.36 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -67.08 -28.24 73.71 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.24 -21.55 39.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.118 . . . . 0.0 110.717 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 11.3 tpt -67.31 -49.12 65.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.362 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 707' ' ' VAL . 14.3 m -66.79 -33.82 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.1 5.89 82.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.86 17.24 42.12 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.65 -43.59 61.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.643 0.258 . . . . 0.0 110.416 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.4 p -69.45 -42.51 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 711' ' ' VAL . 8.1 tt -75.82 -26.58 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.49 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.5 -46.94 88.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 176.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.8 m -67.85 -35.54 78.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.328 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.61 -43.82 91.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.536 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.7 mm -69.75 -38.15 75.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.482 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.6 t -60.18 -46.24 94.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.444 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.35 -28.78 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.415 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 3.9 m -75.69 -38.52 58.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.441 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -65.33 -31.33 72.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 717' ' ' VAL . 87.7 t -61.0 -28.85 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.571 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -81.12 -24.47 37.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 720' ' ' LEU . 85.5 mt -60.89 -18.68 57.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -74.87 -40.96 60.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 17.8 tttt 69.9 102.24 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.64 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -100.07 -60.25 1.56 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.587 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -135.32 -39.96 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.448 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.506 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.546 0.212 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -81.96 164.87 21.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -85.92 75.07 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.388 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 150.33 26.37 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.463 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 689' ' ' VAL . 19.2 mttp -96.87 -168.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.41 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.91 -12.49 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.849 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 687' ' ' LYS . 12.2 p -69.5 -13.15 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.499 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -64.6 -61.06 2.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.687 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -71.97 -32.74 67.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.79 -16.03 62.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.69 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.2 -25.43 59.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.729 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -8.62 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.8 -41.56 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.593 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 66.57 -147.93 50.2 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.7 m -168.05 -90.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -109.75 -164.97 0.97 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -46.05 60.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.488 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.5 -19.72 69.11 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.09 62.35 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.679 -0.307 . . . . 0.0 110.819 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 14.2 tt -53.98 -33.77 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.84 -40.58 88.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.317 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.36 -32.21 62.67 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.19 -31.05 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.602 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.3 ttm -72.18 -50.94 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.81 -34.46 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.435 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.37 -4.29 86.18 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -85.24 18.01 30.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.3 m -76.53 -34.06 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.93 -45.91 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.545 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.28 -25.38 31.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.14 -51.23 68.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.557 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 37.0 p -64.0 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.596 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.88 -45.12 84.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.46 -36.31 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.456 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.2 t -70.97 -47.77 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.393 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.12 -26.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.483 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 68.9 m -70.01 -46.1 65.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.594 171.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.03 -32.74 74.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.58 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.51 -40.33 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.508 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.3 mmm -79.56 -27.99 41.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.484 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 723' ' ' LEU . 89.8 mt -68.04 -20.95 65.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -88.77 25.61 1.72 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.565 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 173.4 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.653 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -140.36 107.1 5.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.418 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -55.55 102.61 0.07 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.526 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 -174.584 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.595 0.236 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.13 -9.47 0.16 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -68.89 -7.4 34.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.592 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -61.27 -82.76 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.663 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -76.2 95.82 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.1 -43.48 1.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.093 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.69 -33.7 26.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.619 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.87 -24.16 59.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.542 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.71 16.31 26.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.595 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.73 44.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.667 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -7.58 14.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -15.28 63.58 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.61 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.97 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.077 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -90.65 157.89 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.42 168.3 22.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.853 0.358 . . . . 0.0 110.948 172.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . 0.497 ' ND2' ' H ' ' A' ' 699' ' ' LYS . 4.9 t30 64.82 -175.33 0.17 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.679 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.497 ' H ' ' ND2' ' A' ' 698' ' ' ASN . 0.1 OUTLIER -61.98 -30.88 71.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.743 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.6 65.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.21 65.8 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.798 -0.237 . . . . 0.0 110.912 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 5.8 tt -55.9 -36.58 44.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.575 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 707' ' ' VAL . 82.9 mt -64.96 -36.86 78.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.41 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -71.28 -33.63 64.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.02 -32.11 63.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.503 0.192 . . . . 0.0 110.77 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 13.5 tpp -71.79 -51.71 21.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.394 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 703' ' ' ILE . 12.4 p -73.05 -37.46 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.428 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -82.97 -2.25 90.66 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -80.46 2.82 76.23 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 20.9 m -65.39 -40.15 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.404 0.145 . . . . 0.0 110.707 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 711' ' ' VAL . 0.0 OUTLIER -76.28 -41.28 36.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.503 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 68.6 mt -71.12 -30.17 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.476 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.65 -50.73 72.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -39.51 94.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.49 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.4 -51.15 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.516 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.16 -36.92 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 713' ' ' ALA . 56.8 t -58.49 -46.99 89.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.457 -177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.48 -32.0 56.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.32 -43.2 82.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 175.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.63 -29.48 66.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.599 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.02 -41.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.406 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.0 tpt -75.21 -31.82 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.475 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.91 -65.94 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.594 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.0 tttp 69.98 -53.62 0.62 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.79 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -62.76 142.69 58.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.571 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.41 155.35 46.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.755 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.84 -125.85 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.415 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 41.7 t80 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.936 0.398 . . . . 0.0 110.622 178.047 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.647 0.26 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -67.06 119.44 12.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -151.85 -40.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.953 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -57.95 -22.24 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.749 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -136.06 -171.64 2.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.665 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 688' ' ' LEU . 0.9 OUTLIER 80.15 -45.4 0.29 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.705 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.24 -25.08 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.666 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -72.09 -44.52 63.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -73.63 -49.57 25.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.74 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.634 ' O ' HG22 ' A' ' 695' ' ' VAL . . . -61.26 -17.02 51.38 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.034 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -54.55 -21.7 11.0 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -19.4 62.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.603 -168.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 692' ' ' ALA . 27.2 m -61.92 -25.16 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.78 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 71.73 -143.86 35.89 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 27.6 t -169.23 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.604 0.24 . . . . 0.0 110.374 169.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.67 149.36 14.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.123 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -54.62 -40.07 68.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.55 -42.5 93.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.53 89.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.722 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.03 -32.46 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 -173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 40.9 mt -67.53 -48.03 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.623 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.29 66.98 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.48 -24.16 65.57 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 122.944 -0.151 . . . . 0.0 110.778 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 26.4 ttm -65.58 -30.53 71.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.11 -40.24 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.14 0.48 75.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -82.25 12.34 45.29 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -67.47 -49.0 75.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 110.664 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 715' ' ' VAL . 93.7 t -65.01 -46.51 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.281 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.37 -36.0 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.588 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.59 -47.89 83.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.497 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 718' ' ' ILE . 18.5 m -64.3 -36.77 85.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.6 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 711' ' ' VAL . 86.0 t -63.25 -31.69 53.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.525 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 73.8 mt -80.16 -30.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 713' ' ' ALA . 62.3 t -64.68 -39.27 85.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.58 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 714' ' ' THR . 1.1 pt -65.23 -26.07 38.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 1.1 m -79.92 -30.48 40.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.33 -29.23 70.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -31.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -26.14 60.48 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.568 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.21 -10.85 60.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.711 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 36.3 tttp 72.03 129.1 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -161.96 109.08 1.36 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.353 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt 53.96 61.78 2.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.703 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -159.33 111.05 2.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.344 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.539 179.306 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.492 0.187 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -125.6 -79.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.581 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -162.77 169.17 20.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.787 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -87.11 178.1 7.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.454 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -146.16 -77.54 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.251 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.94 -67.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.114 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.44 -12.04 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -72.24 -55.32 7.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.542 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.35 -10.51 59.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.701 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.01 -30.3 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.83 -39.08 73.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.576 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.92 -52.19 66.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.556 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.23 -57.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.416 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 77.64 27.26 59.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -10.41 59.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.9 159.94 0.18 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.709 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.431 ' O ' HG22 ' A' ' 702' ' ' ILE . 1.2 mptm? -76.83 -9.03 58.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.697 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.65 -22.33 76.67 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -72.88 -13.42 61.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.566 0.222 . . . . 0.0 110.78 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 699' ' ' LYS . 10.1 tt -65.12 -26.62 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -42.26 84.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.2 98.37 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 84.9 mt -74.16 -22.76 59.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.835 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -47.65 69.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.339 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 710' ' ' VAL . 61.2 t -67.04 -37.6 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.323 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.65 7.98 60.51 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.66 12.52 56.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 707' ' ' VAL . 29.1 m -68.31 -39.9 81.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.504 0.192 . . . . 0.0 110.678 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -75.0 -43.19 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.63 -31.05 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.362 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.97 -53.09 62.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.615 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -39.59 82.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 60.2 t -61.4 -51.6 71.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.495 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.21 -35.15 61.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.339 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 713' ' ' ALA . 78.4 t -67.46 -36.34 76.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.438 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 721' ' ' VAL . 52.0 mt -69.96 -26.94 31.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.483 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -25.83 48.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.698 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.37 -20.83 62.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 -173.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.4 m -67.22 -26.53 36.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 tpt -70.41 -37.21 74.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.437 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.04 -37.64 54.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.646 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.2 tttt 56.21 -170.8 0.08 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.687 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -132.54 172.28 12.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.497 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.11 143.54 39.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.672 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 65.84 170.08 0.22 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.855 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.676 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 111.77 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.1 78.46 8.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.479 -176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -103.57 100.81 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.57 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 51.66 79.78 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.35 -13.95 44.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.644 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 33.3 m -83.46 -30.4 8.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.767 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.78 -24.39 67.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -92.39 41.45 1.07 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.717 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -82.18 7.25 14.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.667 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.23 -20.58 51.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -33.78 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.402 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 10.6 m -76.7 -6.99 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -60.9 63.12 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 37.5 m -105.82 151.78 24.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.803 -0.199 . . . . 0.0 110.528 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 111.91 0.02 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -26.72 67.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.522 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -69.2 -37.01 80.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -62.03 -41.43 98.09 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 121.227 -0.189 . . . . 0.0 110.584 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 46.0 mt -57.07 -31.49 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.482 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 9.9 mm -68.22 -44.69 83.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.448 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.85 41.45 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.94 -24.37 67.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.222 . . . . 0.0 111.045 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 25.4 ttm -61.96 -28.74 69.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.49 -40.25 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -88.19 -1.95 81.01 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.47 14.9 48.89 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.91 -49.57 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.632 0.254 . . . . 0.0 110.445 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 715' ' ' VAL . 78.2 t -60.26 -47.39 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.519 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.27 -34.37 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.535 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.14 -48.98 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.39 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -33.17 74.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.527 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 711' ' ' VAL . 57.3 t -70.3 -46.4 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.363 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 11.9 mm -72.21 -31.76 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 721' ' ' VAL . 45.6 t -74.33 -45.91 45.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.429 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 5.2 mm -55.8 -41.28 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.406 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 32.2 p -73.42 -27.53 61.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.697 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.86 -31.13 69.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 717' ' ' VAL . 93.9 t -65.32 -28.74 45.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.558 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 722' ' ' MET . 0.9 OUTLIER -82.28 -24.85 34.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.706 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.5 -55.46 30.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.444 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -102.63 179.92 4.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.489 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.37 174.83 10.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.466 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -77.77 -119.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.541 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -137.64 16.2 2.91 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.576 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.445 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.685 0.278 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 116.86 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.365 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -133.49 148.35 51.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.541 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -70.47 145.82 50.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.644 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.47 172.43 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.091 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.4 tp 75.64 -11.32 1.13 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.928 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.3 t -86.7 9.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.445 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -25.03 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.36 35.7 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -75.01 -13.89 60.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.755 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.15 -38.65 80.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.608 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -77.95 -45.18 24.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.574 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.21 -34.15 52.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.567 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -64.42 102.99 0.67 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 92.7 p -140.48 -49.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.234 . . . . 0.0 110.455 -175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -69.71 120.23 15.16 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.575 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -75.22 -43.25 52.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.577 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.22 -30.68 78.39 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.93 70.8 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.815 -0.226 . . . . 0.0 110.798 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 702' ' ' ILE . 0.4 OUTLIER -59.09 -31.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.674 -175.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.47 -47.41 86.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.555 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.05 -37.61 37.54 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.29 -26.01 68.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.496 0.189 . . . . 0.0 110.705 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 14.2 ttp -60.54 -32.5 71.55 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.28 -46.01 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.504 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.86 -3.53 85.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.77 13.57 47.32 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.71 -36.41 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 110.658 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.647 ' O ' HG23 ' A' ' 715' ' ' VAL . 35.2 m -73.7 -40.15 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.452 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 711' ' ' VAL . 3.5 mm -65.9 -36.77 78.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.92 -52.87 63.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -35.45 78.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.736 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 711' ' ' VAL . 92.0 t -63.49 -51.4 71.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.471 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 95.7 mt -68.14 -37.08 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.2 t -67.4 -41.05 85.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.444 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . 0.597 ' O ' HG22 ' A' ' 721' ' ' VAL . 36.3 mt -63.51 -26.09 39.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.84 -27.48 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.671 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . 1.002 HD13 HD12 ' A' ' 723' ' ' LEU . 0.4 OUTLIER -62.18 -27.61 69.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 718' ' ' ILE . 2.7 m -65.81 -21.17 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.511 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 12.9 mtt -78.68 -22.57 46.54 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.659 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 1.002 HD12 HD13 ' A' ' 720' ' ' LEU . 97.4 mt -69.67 -4.37 19.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.802 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -76.19 45.89 0.38 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.672 0.272 . . . . 0.0 110.574 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -145.73 82.11 1.62 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.345 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 123.67 26.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.682 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -138.8 149.41 44.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.467 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.164 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.7 0.286 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -97.88 144.41 27.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.301 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -79.96 91.89 5.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.402 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -56.68 129.4 40.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.633 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.77 57.88 1.71 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.469 -175.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 9.9 mp -95.76 -20.32 18.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.499 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.95 -11.05 11.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.86 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.58 -33.58 10.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.722 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.77 -49.83 6.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.633 -173.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.39 -6.72 26.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.8 -11.02 60.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.934 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -64.61 -18.69 65.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.19 -32.71 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -92.23 99.04 2.49 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 701' ' ' ALA . 22.0 t -142.75 -123.28 0.09 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.36 125.78 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.855 0.359 . . . . 0.0 110.637 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.648 ' HA ' HD12 ' A' ' 702' ' ' ILE . 6.6 tttp -58.64 -26.44 63.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.12 38.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 697' ' ' SER . . . -73.67 -21.03 60.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.646 0.26 . . . . 0.0 110.749 -174.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 699' ' ' LYS . 23.9 mt -63.2 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 703' ' ' ILE . 0.9 OUTLIER -63.03 -22.65 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.347 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.21 38.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.41 -26.56 63.74 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.844 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -63.01 -46.78 86.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.618 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.54 -31.7 43.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.33 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.66 13.38 66.84 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.45 37.27 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 711' ' ' VAL . 7.1 p -67.95 -39.86 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.551 0.215 . . . . 0.0 110.656 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.476 HG23 HG13 ' A' ' 710' ' ' VAL . 33.7 t -75.82 -42.71 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.459 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.4 -27.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.438 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -59.81 -49.94 75.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.584 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 88.0 m -62.09 -41.2 97.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 91.5 t -56.8 -42.19 77.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.462 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -74.24 -35.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 713' ' ' ALA . 76.3 t -60.12 -47.64 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.28 -30.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.452 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 5.3 m -72.64 -39.1 67.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.528 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . 0.431 HD13 HD12 ' A' ' 723' ' ' LEU . 0.6 OUTLIER -64.83 -30.51 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.554 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.82 -32.21 56.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.402 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.67 -32.36 57.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 -172.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 720' ' ' LEU . 85.6 mt -55.43 -40.47 71.56 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.808 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm 59.21 162.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.5 tttt 63.56 92.45 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.807 174.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -101.15 126.94 47.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 63.58 159.23 0.08 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.859 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 174.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -152.02 101.51 2.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.3 -68.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.433 175.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.43 104.69 0.02 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.873 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -139.13 156.8 46.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.683 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 2.1 tt -166.65 -39.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.245 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.11 -18.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.819 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -80.54 -48.17 13.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.643 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.91 -29.73 44.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -71.25 -10.07 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -69.63 -7.4 38.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.17 -8.94 57.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.838 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.24 -24.33 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -73.37 97.47 0.86 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.3 p -138.35 94.63 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.554 0.216 . . . . 0.0 110.489 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.53 136.36 3.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.352 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -59.48 -38.52 81.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.21 -44.1 77.27 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.73 84.51 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 121.391 -0.123 . . . . 0.0 110.697 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 26.1 mt -54.69 -34.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.31 -47.57 80.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.582 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -73.63 -32.42 59.47 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.66 -26.74 68.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.425 -0.11 . . . . 0.0 110.823 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -27.64 66.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.01 -43.35 99.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.513 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.11 -2.99 90.71 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -87.79 24.74 9.79 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.89 -47.04 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.56 0.219 . . . . 0.0 110.465 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.1 p -62.87 -44.25 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -177.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.494 ' N ' HG13 ' A' ' 711' ' ' VAL . 17.7 tt -70.6 -28.23 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.24 -49.08 78.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.541 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -30.72 70.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.467 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.7 t -76.37 -49.09 25.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.405 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.92 -23.58 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.703 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 713' ' ' ALA . 16.2 t -66.6 -44.93 89.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.72 -36.75 62.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.539 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -41.5 97.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.447 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -31.14 69.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.759 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.455 HG13 ' HD2' ' A' ' 725' ' ' LYS . 58.3 t -65.05 -31.71 55.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 174.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 14.8 ttm -80.28 -26.04 39.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.95 -64.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.661 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -145.01 -92.48 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.118 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.455 ' HD2' HG13 ' A' ' 721' ' ' VAL . 14.6 tttm 44.22 65.5 1.03 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.637 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -61.95 100.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.489 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -73.47 177.35 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.618 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.614 0.245 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -89.11 -27.36 20.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 11.2 m170 58.94 -179.26 0.08 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -143.15 25.5 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.614 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 689' ' ' VAL . 4.3 tptp -69.02 -58.81 3.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.496 177.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 71.56 -41.67 0.51 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.967 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 2.8 t -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.564 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.44 -54.15 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.759 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -79.55 -37.87 35.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.604 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -63.81 -15.73 59.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.708 -177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -74.05 -29.84 62.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.759 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -15.66 59.09 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.95 -45.38 98.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.759 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 705' ' ' LEU . . . 73.53 -156.24 50.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . 0.402 ' H ' ' CB ' ' A' ' 701' ' ' ALA . 31.0 t -168.15 -111.98 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -165.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -80.46 -162.17 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.434 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 702' ' ' ILE . 19.9 pttm -61.53 -42.91 99.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.737 177.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.17 -11.4 58.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.402 ' CB ' ' H ' ' A' ' 697' ' ' SER . . . -68.43 -18.3 64.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.822 -0.189 . . . . 0.0 110.894 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.679 HG23 ' O ' ' A' ' 699' ' ' LYS . 35.9 pt -58.23 -27.95 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.483 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 55.3 mt -70.34 -44.03 77.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.21 -35.33 49.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.475 HD11 ' HA3' ' A' ' 696' ' ' GLY . 94.0 mt -71.28 -34.75 70.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.89 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.1 tpp -62.89 -55.17 28.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.392 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 708' ' ' GLY . 12.5 p -73.87 -38.57 50.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.458 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 707' ' ' VAL . . . -75.54 -5.98 79.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.49 16.69 17.32 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 711' ' ' VAL . 7.9 p -68.55 -40.96 82.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.64 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 710' ' ' VAL . 7.4 p -75.8 -38.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.512 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.4 ' N ' HG13 ' A' ' 711' ' ' VAL . 7.3 mt -75.6 -26.41 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.503 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.19 -50.83 72.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.509 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 67.7 p -63.66 -34.75 78.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.579 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.03 -48.18 80.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.54 -36.86 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.458 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 713' ' ' ALA . 64.7 t -70.47 -44.12 77.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.406 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.28 -38.49 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.5 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 20.8 m -68.16 -32.86 73.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.599 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.61 -32.24 73.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.606 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.66 -41.24 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.476 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.08 -31.2 55.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.524 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.92 -12.52 58.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -109.45 144.14 38.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.469 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -76.35 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.561 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -71.77 168.65 17.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.67 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.96 -143.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.343 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.6 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.775 0.321 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -59.93 -31.51 69.91 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -75.08 128.11 34.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.589 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -167.28 165.03 15.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.437 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -156.2 27.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.57 -30.77 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.527 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.52 -10.43 13.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.714 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.46 -60.23 3.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.703 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -82.12 -27.21 32.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.72 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -68.76 -23.12 64.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.774 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -75.12 -16.52 60.54 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.51 14.28 1.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.261 176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.4 -62.91 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.625 162.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 71.41 178.21 28.43 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 66.2 m -152.44 162.55 41.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.455 0.169 . . . . 0.0 110.901 173.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.47 165.86 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -62.17 -25.61 67.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.94 -18.61 66.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -63.53 -23.62 67.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 122.866 -0.197 . . . . 0.0 110.837 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.58 -30.69 22.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.652 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.39 -42.11 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.493 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.72 -43.68 17.7 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.61 -34.43 69.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.379 0.133 . . . . 0.0 110.89 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.8 ttt -64.9 -53.08 52.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.405 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 710' ' ' VAL . 39.7 t -73.87 -42.28 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.49 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.85 -6.61 82.43 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.53 18.74 40.5 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.2 t -75.76 -35.34 30.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 91.1 t -71.14 -49.14 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 18.5 pt -67.73 -27.41 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.59 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.35 -50.81 72.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.594 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -37.44 85.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.547 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.93 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.569 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 71.7 mt -77.63 -29.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.553 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 713' ' ' ALA . 53.0 t -64.25 -40.38 88.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.463 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 721' ' ' VAL . 1.4 mp -67.4 -26.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.475 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 16.0 m -78.96 -29.13 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.617 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -26.86 67.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.614 -173.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.2 m -62.6 -26.11 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.481 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.87 -35.43 69.78 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.53 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 84.0 mt -80.45 -53.96 6.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -156.88 144.81 19.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.546 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -72.97 -50.81 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.533 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -101.08 177.32 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.607 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -104.47 -93.84 0.34 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.5 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.145 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.52 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.603 0.239 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 14.3 m80 63.09 176.57 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.755 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . 0.475 ' H ' ' NZ ' ' A' ' 687' ' ' LYS . 5.0 m-70 -117.51 -150.01 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.288 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.49 -69.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.671 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.475 ' NZ ' ' H ' ' A' ' 685' ' ' HIS . 20.8 mttp 49.07 -105.49 0.16 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.773 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.5 mp -52.37 -23.68 6.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.047 -174.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 689' ' ' VAL . 61.7 t -70.76 2.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 1.0 OUTLIER -91.31 -39.71 11.89 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.487 174.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . 0.468 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 21.5 t80 -76.78 -55.21 5.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.357 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.81 -9.72 40.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.819 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.31 -23.37 56.29 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -60.79 -15.81 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.109 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.84 -49.46 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.527 170.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 66.91 -150.54 52.02 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 4.0 m -166.16 -96.06 0.02 OUTLIER 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -164.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 -157.42 0.61 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.485 -172.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 702' ' ' ILE . 34.4 mttt -57.27 -45.28 84.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.772 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -66.78 -18.0 67.88 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.87 62.08 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.745 -0.268 . . . . 0.0 110.843 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 699' ' ' LYS . 17.3 tt -55.57 -37.03 44.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.401 ' N ' HG23 ' A' ' 702' ' ' ILE . 13.6 mt -69.16 -39.7 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.67 12.95 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.52 -36.28 69.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.511 0.196 . . . . 0.0 110.827 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 18.8 ttp -63.56 -54.67 32.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.411 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 710' ' ' VAL . 61.7 t -71.87 -43.49 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.35 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.59 -4.94 62.53 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -84.27 16.13 35.8 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 707' ' ' VAL . 55.0 t -70.46 -47.61 64.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 110.579 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -44.44 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.604 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.64 -25.22 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -60.14 -53.12 61.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 76.5 p -61.71 -33.37 73.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.608 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.65 -46.18 86.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.518 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 -32.02 36.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 81.0 t -73.52 -41.33 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.36 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.22 -44.17 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 13.4 p -64.26 -31.96 73.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.607 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -31.73 73.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.683 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.87 -46.53 93.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 10.8 ttt -67.91 -36.71 80.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.66 3.66 31.98 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.781 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -142.67 112.22 6.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.39 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -164.45 140.48 6.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -77.63 80.29 4.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.425 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -89.43 122.33 32.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.498 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -171.396 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.607 0.241 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 54.03 -148.86 0.44 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.61 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 57.06 37.47 28.69 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -69.79 -45.4 68.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.53 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -86.52 -117.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.562 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.6 -50.05 0.7 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.883 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.58 -9.39 11.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -70.13 -59.32 2.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.627 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 175.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.72 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.572 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.22 -38.67 75.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.86 -33.75 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.629 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.64 -25.78 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.552 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 161.72 -89.59 0.11 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 38.2 t -165.12 172.68 12.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.832 0.348 . . . . 0.0 110.661 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -35.65 64.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.713 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -57.76 -32.83 67.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.758 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.56 -40.72 96.22 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 705' ' ' LEU . . . -60.31 -36.79 78.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 23.4 mm -60.75 -42.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.449 -173.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 51.0 mt -71.65 -30.21 37.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.591 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -74.5 -24.5 72.67 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 701' ' ' ALA . 80.4 mt -61.4 -34.03 74.68 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.936 -0.155 . . . . 0.0 110.933 -178.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.18 -38.4 35.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.55 -54.25 37.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.349 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -83.79 -29.63 31.52 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 713' ' ' ALA . . . -65.27 -33.06 85.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -169.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.69 -47.15 87.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 110.632 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.96 -48.68 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.506 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 28.7 mt -62.66 -30.77 50.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.649 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 709' ' ' GLY . . . -56.41 -53.51 56.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.443 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 66.8 p -61.47 -33.25 73.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.625 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.69 -51.89 29.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.416 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.35 -33.33 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.416 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 713' ' ' ALA . 22.6 t -63.26 -43.97 98.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.303 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.88 -32.09 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.464 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -29.59 55.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.61 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -32.63 74.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.623 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.18 -35.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.428 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.4 ttm -72.0 -33.39 68.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.723 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.68 -62.06 1.99 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.564 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.08 144.62 5.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.21 -56.43 2.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.562 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -76.59 -84.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -73.42 131.54 41.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.526 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.521 -170.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 685' ' ' HIS . 59.5 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -29.79 66.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.618 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . 0.425 ' H ' HG12 ' A' ' 683' ' ' VAL . 1.6 t60 68.52 112.68 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.649 174.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -68.76 101.42 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.434 -172.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -66.78 122.62 18.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.661 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.16 -58.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.339 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -29.68 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.462 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.2 -26.48 64.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.616 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -47.14 4.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 172.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -88.77 1.51 55.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.885 -163.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.47 -22.96 64.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -66.69 -24.7 66.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.444 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.59 -37.49 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.568 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -179.64 161.03 26.66 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 9.3 t -154.17 8.92 0.35 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.618 0.246 . . . . 0.0 110.477 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.52 138.39 46.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.48 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -75.73 -32.06 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.676 -176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.8 -23.04 65.02 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -67.03 -22.63 65.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.692 0.282 . . . . 0.0 110.79 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.04 -32.93 51.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.581 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.36 -43.95 91.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.89 -40.9 24.51 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 47.3 mt -72.49 -21.64 61.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.792 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -25.74 62.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.47 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.57 -40.76 87.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.412 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -81.23 1.99 83.15 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -88.14 26.23 8.03 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -43.09 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.729 0.3 . . . . 0.0 110.64 173.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 715' ' ' VAL . 7.1 p -71.98 -38.38 63.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.449 -174.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 712' ' ' ILE . 8.2 tt -78.22 -25.02 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.41 73.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.515 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.43 -38.44 80.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.487 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 711' ' ' VAL . 63.1 t -65.64 -51.0 67.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.459 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.45 -37.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.579 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 721' ' ' VAL . 41.4 t -69.53 -39.01 77.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.32 -175.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 36.9 mt -65.91 -33.85 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.346 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -34.51 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.775 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.3 -31.73 72.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.654 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 717' ' ' VAL . 41.1 t -67.47 -27.23 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.531 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 6.3 mmt -80.52 -31.65 37.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.514 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.68 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.423 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -97.81 176.96 5.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.762 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.02 144.64 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.65 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -86.04 166.65 15.69 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.668 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.32 -52.24 12.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.447 -170.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.589 0.233 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -90.47 -175.11 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.391 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -14.09 0.98 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.605 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -85.61 -53.59 5.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.545 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -101.13 119.86 39.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.543 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 23.5 mt -100.05 -27.53 13.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.363 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.69 21.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.68 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -61.77 -35.58 78.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.556 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -95.03 39.36 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.662 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -86.79 24.11 1.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -86.32 -30.69 22.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.628 166.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.09 -29.7 15.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.528 -167.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.1 m -72.46 -8.41 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.537 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -54.41 77.73 0.01 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 83.9 p -82.05 -130.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.3 127.96 33.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.698 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 702' ' ' ILE . 0.3 OUTLIER -70.87 -21.18 62.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.643 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.49 -11.21 40.18 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -64.97 -22.18 66.96 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.466 0.174 . . . . 0.0 110.924 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 699' ' ' LYS . 35.3 pt -58.89 -28.28 37.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.492 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.93 -46.94 81.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.426 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -72.73 -33.99 59.95 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.86 -21.42 51.4 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.839 -0.212 . . . . 0.0 110.997 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.29 -43.08 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.67 -29.27 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -101.32 9.13 57.46 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.52 12.3 40.83 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.7 -30.4 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.686 0.279 . . . . 0.0 110.724 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 715' ' ' VAL . 64.8 t -76.81 -46.46 30.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 22.3 pt -67.41 -25.85 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.594 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.494 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -62.52 -52.58 62.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 6.1 p -62.19 -31.98 72.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.666 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 711' ' ' VAL . 70.4 t -67.28 -46.83 83.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 34.9 mt -71.67 -33.5 49.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 713' ' ' ALA . 71.4 t -68.54 -40.27 81.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 721' ' ' VAL . 3.8 mm -62.66 -32.93 57.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.583 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -23.82 41.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.787 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.37 -24.75 64.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.703 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 718' ' ' ILE . 3.5 m -63.87 -26.12 39.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -69.48 -36.68 76.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 94.7 mt -74.11 -43.73 56.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.893 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -67.34 122.42 17.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm 54.61 87.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.876 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -90.22 -0.41 57.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.731 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -97.46 169.26 9.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.63 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 179.593 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.509 0.195 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -175.07 5.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.694 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -132.78 117.73 18.15 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.78 143.66 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.709 178.033 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.4 ' C ' ' H ' ' A' ' 689' ' ' VAL . 23.3 mttp -78.0 -81.64 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.9 tp 73.54 -12.08 0.86 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.001 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 687' ' ' LYS . 84.9 t -71.35 -12.11 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.392 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -56.99 -57.28 13.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.69 176.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -76.85 -31.49 56.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.613 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -66.61 -17.19 64.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.708 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -19.4 58.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.891 175.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.59 11.12 3.29 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.303 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.3 t -82.77 -40.89 16.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.617 164.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 72.3 -144.12 35.45 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 46.8 t -172.92 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.9 -0.177 . . . . 0.0 110.528 -166.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -93.21 -161.6 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.46 -170.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 702' ' ' ILE . 3.6 ptpt -59.51 -43.75 93.3 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.689 171.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -59.87 -22.26 57.11 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -177.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -72.68 -16.12 61.69 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.682 -0.305 . . . . 0.0 110.955 -174.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 699' ' ' LYS . 2.1 pp -54.6 -32.79 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.589 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.88 -31.97 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.416 -178.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.68 -39.37 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 705' ' ' LEU . 63.9 mt -63.85 -43.56 95.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.587 0.232 . . . . 0.0 110.781 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 16.0 ttt -62.17 -53.64 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.412 -174.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 710' ' ' VAL . 87.4 t -72.51 -44.06 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.405 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -75.22 3.44 46.75 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.17 20.07 23.31 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 707' ' ' VAL . 87.8 t -64.5 -49.97 78.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 110.601 174.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.86 -43.91 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.445 -178.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.2 -23.73 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.411 -176.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -63.3 -49.99 71.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.562 176.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 70.8 p -66.14 -30.27 70.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.417 -175.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.02 -34.91 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.641 177.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 70.2 mt -77.49 -32.09 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.5 t -64.75 -47.27 89.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.437 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 39.4 pt -67.27 -28.96 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.629 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . 0.626 HG22 HD12 ' A' ' 723' ' ' LEU . 28.1 m -71.78 -36.26 70.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -25.2 59.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.586 -178.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 717' ' ' VAL . 55.9 t -64.64 -47.83 87.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.625 -179.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 722' ' ' MET . 0.0 OUTLIER -81.98 -23.22 36.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.41 -176.569 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 719' ' ' THR . 98.6 mt -88.84 3.85 49.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.705 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -63.66 -75.52 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.545 -170.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 53.02 -173.58 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -104.44 170.43 7.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.635 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -73.78 139.11 44.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.828 179.157 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 684' ' ' HIS . 9.7 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . 0.413 ' N ' HG12 ' A' ' 683' ' ' VAL . 0.8 OUTLIER -161.49 164.47 29.66 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 110.65 178.186 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.82 166.64 27.9 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.518 -178.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -157.11 161.03 39.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.472 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -165.06 15.98 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -8.9 9.13 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.499 -175.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.532 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 10.1 p -68.72 -12.38 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.72 177.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.15 -68.94 0.16 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.29 -40.15 85.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 176.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -66.51 -12.3 56.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -174.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.99 -13.28 24.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.937 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -8.75 57.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -171.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.15 -4.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.834 177.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -50.49 97.02 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 87.0 p -83.15 -168.49 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.608 0.242 . . . . 0.0 110.676 -175.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.53 144.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.7 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 702' ' ' ILE . 24.0 tptt -81.42 -51.75 7.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.493 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -67.36 -10.04 56.27 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -175.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.86 69.31 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.76 -0.259 . . . . 0.0 110.939 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 699' ' ' LYS . 2.1 pp -53.5 -26.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.779 -173.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.97 -46.53 78.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.561 177.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.78 -32.55 32.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.35 -25.06 64.9 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.895 -0.179 . . . . 0.0 111.091 177.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.2 ttt -63.55 -30.91 71.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.719 -179.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.72 -44.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.58 2.88 78.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.43 23.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -177.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 3.1 m -86.65 -35.87 9.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -45.46 78.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.443 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 32.4 pt -70.37 -26.63 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 -179.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.18 -50.37 73.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.47 177.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 3.0 m -61.67 -36.31 80.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.572 -178.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.44 -48.72 79.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.08 -38.34 79.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.414 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 721' ' ' VAL . 54.1 t -67.24 -47.19 82.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.362 -176.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 43.2 mt -56.67 -42.29 76.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.524 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 93.5 m -67.13 -37.16 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.79 -30.11 69.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.656 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 717' ' ' VAL . 26.0 t -67.35 -40.77 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 176.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 21.0 mtp -74.29 -24.71 59.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.9 -179.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.44 -41.69 97.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.408 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -159.04 -67.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.641 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 725' ' ' LYS . 1.3 mtpt -69.29 95.6 0.79 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.16 -166.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -83.71 131.09 34.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.55 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.32 -118.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 172.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.803 0.335 . . . . 0.0 110.74 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.706 0.289 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -139.09 15.78 2.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.603 -177.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -73.31 -9.44 58.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.443 -177.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -141.9 103.09 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.355 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -87.65 155.86 19.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.649 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.36 -21.2 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.62 -178.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.07 -10.43 9.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.751 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.84 -13.43 62.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.815 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -90.45 34.27 0.89 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.657 176.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -76.74 -7.49 55.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 176.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -65.41 -20.88 66.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.756 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.66 -38.7 64.87 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.781 178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.09 -62.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.415 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 60.6 -157.55 29.49 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 174.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 19.9 m 55.06 42.62 30.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 165.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -126.36 9.69 7.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.458 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -48.93 77.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.568 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -63.33 -46.62 92.41 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.41 -11.29 60.82 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.771 -0.252 . . . . 0.0 110.801 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 702' ' ' ILE . 0.4 OUTLIER -65.7 -26.08 38.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.43 -177.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.08 -29.22 45.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.684 -179.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -84.4 -33.2 20.52 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.82 -21.32 51.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.852 174.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.9 tpp -71.26 -47.96 53.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.497 -174.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 22.1 m -68.32 -31.11 50.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.652 174.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -89.83 11.28 70.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 177.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.32 13.88 56.2 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.52 -43.83 96.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.456 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 712' ' ' ILE . 7.5 p -74.23 -40.21 50.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.57 -177.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.426 ' N ' HG13 ' A' ' 711' ' ' VAL . 16.2 mt -73.73 -28.68 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -57.08 -51.01 70.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.579 174.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -33.3 75.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.544 -176.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.92 -45.28 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.541 178.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 87.1 mt -69.33 -36.92 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.424 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 713' ' ' ALA . 97.1 t -67.73 -47.98 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 1.6 tp -69.4 -26.42 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.42 -174.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 57.0 m -75.67 -41.87 52.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.553 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.71 -35.68 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.486 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.4 mtt -78.7 -30.1 45.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.5 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.55 -49.83 36.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.644 176.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -103.11 120.76 41.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.626 -176.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.15 108.59 5.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.342 -175.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -98.47 39.54 1.24 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.593 -177.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 52.23 71.27 0.48 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.61 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.74 0.305 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -147.84 -173.3 4.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 2.3 m80 59.27 102.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.35 -67.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.476 -170.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -84.57 -157.05 0.26 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.383 172.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 17.1 mt 70.8 -2.21 2.36 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 70.0 t -71.91 -16.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.488 177.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -49.87 75.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.63 -21.68 35.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.709 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -74.73 -1.08 20.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.62 -14.23 62.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 173.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -65.57 -16.24 63.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.739 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.88 -40.9 74.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.639 174.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -83.71 118.83 4.76 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.87 107.06 2.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.575 0.226 . . . . 0.0 110.509 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.58 142.86 6.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 175.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' A' ' 702' ' ' ILE . 16.1 mmtt -62.86 -35.67 80.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.26 -47.95 74.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 175.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.33 83.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.823 -0.222 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 699' ' ' LYS . 22.7 mt -58.99 -32.56 47.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.632 -174.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.57 -44.79 93.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 175.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -76.74 -29.39 57.63 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 75.2 mt -68.02 -24.62 65.13 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.911 -0.17 . . . . 0.0 110.923 177.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.2 ttm -66.57 -29.27 69.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.705 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.45 -38.67 81.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -91.89 -0.91 71.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.7 12.86 39.04 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -175.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 710' ' ' VAL . 0.2 OUTLIER -68.92 -46.37 79.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.625 -178.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 715' ' ' VAL . 44.1 t -67.43 -47.49 80.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 -177.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 5.0 mm -58.66 -40.29 78.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.669 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.87 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -38.71 87.21 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.485 -178.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 711' ' ' VAL . 65.3 t -61.89 -52.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.44 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 43.8 mt -64.49 -39.29 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.562 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 713' ' ' ALA . 73.6 t -68.34 -41.72 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.356 -175.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 37.9 mt -61.99 -36.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 4.4 m -72.98 -32.55 65.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.04 -33.41 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.01 -42.19 78.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.473 176.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -36.66 76.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.44 -39.76 77.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.649 177.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -90.96 -160.4 0.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 726' ' ' LYS . 39.9 pttt -163.02 -20.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.356 -172.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 725' ' ' LYS . 8.7 mmtp -97.46 99.35 10.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.91 138.87 31.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.614 176.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.425 173.332 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.516 0.198 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.35 144.4 49.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.649 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -97.09 70.08 2.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.425 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -90.43 -19.16 24.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.65 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -76.17 158.76 31.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.43 -31.22 2.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.436 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.72 -28.95 41.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.47 -54.6 26.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.551 -175.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -61.99 -30.0 70.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.644 175.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.25 73.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.654 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.36 -35.68 68.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.38 -39.64 85.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.587 -171.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.72 -12.66 8.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.677 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 97.3 -48.66 1.54 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 172.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 17.5 t -161.83 96.09 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.604 -0.35 . . . . 0.0 110.449 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.61 -30.17 13.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.862 176.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -59.68 -28.09 66.98 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.554 -167.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -60.13 -62.13 6.39 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.67 -21.52 63.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.771 0.319 . . . . 0.0 110.737 -171.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.474 HD13 HD12 ' A' ' 705' ' ' LEU . 3.4 mm -60.36 -24.4 30.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.576 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 12.3 tt -57.51 -31.59 39.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -86.29 -33.07 14.99 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 702' ' ' ILE . 86.8 mt -66.45 -23.38 66.27 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.827 -0.219 . . . . 0.0 110.86 174.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 4.6 ttm -68.55 -25.57 64.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.719 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 710' ' ' VAL . 46.2 t -66.0 -39.19 83.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.605 176.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.6 -7.14 88.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -86.38 23.18 10.31 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 707' ' ' VAL . 90.0 t -82.35 -37.8 14.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.715 0.293 . . . . 0.0 110.489 175.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 711' ' ' VAL . 0.9 OUTLIER -74.27 -41.0 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.373 -174.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.4 -26.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.681 177.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -51.84 67.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.493 179.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.9 p -61.9 -34.37 75.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.76 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.31 -51.46 58.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 178.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 4.6 mm -64.1 -39.98 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.452 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 713' ' ' ALA . 72.3 t -69.32 -45.18 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 -174.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.47 -40.68 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.504 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.1 m -67.27 -39.29 86.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.479 176.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.614 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 717' ' ' VAL . 98.7 t -60.15 -44.54 95.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.453 177.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 52.7 mmm -70.83 -33.85 71.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.481 -178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.89 -28.77 60.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.681 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.48 100.32 6.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.388 -175.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -133.31 -41.63 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.523 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 20.3 mttt 55.77 30.78 16.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.98 -178.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -143.82 -71.13 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.371 -178.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -178.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.837 0.351 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 128.92 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 -176.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.82 174.65 7.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.617 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -93.01 -179.7 5.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.67 178.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.49 56.15 2.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.546 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.6 -15.41 6.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.538 178.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 689' ' ' VAL . 2.3 t -67.6 -10.67 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 -178.423 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 0.0 OUTLIER -77.74 -53.5 7.45 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.346 177.527 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . 0.402 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 66.1 t80 -74.16 -39.72 63.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.474 -177.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -64.36 -13.16 49.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.891 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.0 -19.91 63.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.745 175.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -65.26 -12.11 48.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 -176.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.95 -48.98 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 171.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 73.37 -149.87 42.8 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 99.3 p -161.99 -127.45 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.468 0.175 . . . . 0.0 110.555 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.56 -179.88 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.906 -177.199 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -77.07 -50.18 13.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.607 -177.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.32 -21.88 62.61 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.25 64.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.594 0.235 . . . . 0.0 110.788 177.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 9.7 mm -51.02 -33.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.602 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.17 -47.01 89.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.422 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -80.13 -36.48 24.41 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -176.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.99 -28.64 69.17 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.53 0.205 . . . . 0.0 110.857 176.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -31.12 70.46 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -46.19 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -82.44 -5.63 89.37 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 178.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -83.91 12.19 54.25 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -176.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 71.6 t -71.57 -46.49 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.758 0.313 . . . . 0.0 110.536 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 715' ' ' VAL . 2.8 t -67.52 -42.34 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.407 -176.194 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.38 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.648 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.59 -52.5 65.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 178.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 69.7 p -62.94 -33.63 75.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.653 -177.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 711' ' ' VAL . 89.3 t -65.35 -49.04 80.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.54 -31.82 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.49 -178.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.8 t -73.21 -39.6 56.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.442 -178.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.07 -32.22 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.426 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -45.38 90.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 174.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.48 -30.26 70.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.778 -176.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.607 176.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 3.3 tpt -82.65 -22.43 34.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.94 4.23 5.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.764 175.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -54.54 158.51 2.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.897 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -98.49 41.05 1.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.55 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 10.0 tttp 67.26 161.47 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.868 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 54.7 -148.53 0.47 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.589 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.274 178.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 683' ' ' VAL . 13.2 p . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.925 0.393 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -100.32 135.7 41.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.565 178.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . 0.422 ' CG ' ' N ' ' A' ' 686' ' ' GLN . 14.1 p-80 -146.66 -125.61 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.337 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . 0.422 ' N ' ' CG ' ' A' ' 685' ' ' HIS . 4.2 tt0 71.6 49.67 0.28 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.042 0.449 . . . . 0.0 110.568 176.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -136.8 38.61 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.442 -174.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.75 -26.85 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.742 -176.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' A' ' 692' ' ' ALA . 0.0 OUTLIER -78.74 9.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.701 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 691' ' ' PHE . 0.0 OUTLIER -58.59 -54.96 41.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.63 177.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' A' ' 690' ' ' PHE . 7.4 t80 -81.23 -31.51 33.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.438 176.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 689' ' ' VAL . . . -82.25 14.7 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.513 -178.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.68 -10.22 22.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.941 162.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.82 -11.58 56.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.545 -171.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 4.7 m -77.09 -0.33 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -61.48 148.53 46.89 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -173.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 2.0 m -127.92 -26.84 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.455 -0.373 . . . . 0.0 110.208 -160.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -57.61 155.49 9.72 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 178.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 702' ' ' ILE . 11.9 ptmt -58.97 -31.36 68.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 -173.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -76.96 -18.54 78.65 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -70.57 -13.97 62.31 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.828 -0.219 . . . . 0.0 110.923 176.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 699' ' ' LYS . 13.1 tt -60.01 -34.53 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.544 176.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 707' ' ' VAL . 20.0 mt -70.29 -48.87 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.233 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -68.92 -25.62 75.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 177.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.25 -43.85 80.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 1.4 mmt -70.04 -31.19 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.408 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 703' ' ' ILE . 77.7 t -67.13 -48.45 78.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.503 -178.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -90.9 1.95 78.87 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 178.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -93.22 16.93 59.4 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.81 -33.58 16.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.517 0.198 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -72.44 -43.64 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.547 -179.523 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.66 -25.58 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -64.08 -54.11 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 178.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 1.4 p -57.74 -36.64 72.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.84 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 711' ' ' VAL . 90.7 t -65.81 -49.54 76.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.472 -179.181 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 5.1 mm -65.36 -40.48 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.4 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -68.92 -42.22 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.68 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 90.4 m -65.58 -31.24 72.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 177.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -25.95 64.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.733 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.27 -33.87 65.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.466 176.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.32 -29.13 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.423 -178.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 97.5 mt -70.42 -38.06 74.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.852 177.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -105.95 128.12 53.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.687 -175.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -91.05 -176.99 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.634 -178.025 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -148.73 171.49 16.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.839 175.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -101.52 -63.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.421 -177.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.465 0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.916 176.837 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.485 0.183 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 152.26 25.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 -176.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 1.8 t60 50.53 54.29 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.581 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -94.37 -22.45 18.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.579 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -90.4 165.57 13.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.605 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.5 tp -117.13 -36.64 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.179 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.96 -18.4 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.59 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -78.47 -50.97 10.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.452 -175.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -13.81 62.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.66 177.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -59.35 -28.99 67.34 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.777 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.82 -39.0 83.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.56 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.36 -47.08 24.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.467 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.55 -38.64 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 -176.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . 137.64 -106.51 0.54 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 13.2 t -176.25 78.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 175.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -140.96 89.27 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.618 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -83.14 -19.39 36.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 177.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -65.94 -36.81 92.57 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 175.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.99 -8.8 52.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.594 0.235 . . . . 0.0 110.751 -170.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.4 tp -65.58 -21.43 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.641 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.22 -24.7 35.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -178.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.88 -35.22 19.49 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.69 -24.23 63.56 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 122.877 -0.19 . . . . 0.0 110.714 178.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 9.4 ttp -67.63 -25.7 65.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.24 -41.51 93.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -87.16 -0.83 84.88 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.42 9.38 55.22 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 710' ' ' VAL . 0.2 OUTLIER -64.91 -44.75 96.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 -177.782 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 715' ' ' VAL . 84.1 t -71.99 -36.96 59.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.45 -176.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.15 -27.94 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.529 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -61.14 -54.2 47.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.555 175.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 28.0 p -62.29 -29.17 70.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.629 -175.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 711' ' ' VAL . 99.1 t -70.17 -48.3 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.49 177.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.44 -30.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.469 -178.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 721' ' ' VAL . 70.2 t -76.81 -39.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.292 -177.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.78 -42.18 93.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.321 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 24.7 p -72.62 -29.39 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.579 -177.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 723' ' ' LEU . 37.8 tp -67.46 -34.81 77.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.606 177.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 717' ' ' VAL . 63.5 t -64.89 -31.13 52.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.485 178.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 17.3 ttt -72.63 -31.17 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.613 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 720' ' ' LEU . 94.7 mt -69.28 -16.2 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.762 178.031 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 12.3 tttp 66.72 132.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.746 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -143.0 165.87 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.722 -178.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -71.55 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.427 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -141.34 -63.39 0.46 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 -174.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.406 179.455 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -81.16 115.33 20.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.517 176.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -151.49 -9.83 0.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.586 178.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.49 77.68 1.94 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 -176.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 689' ' ' VAL . 36.1 mttp -132.07 -77.14 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.571 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.2 -47.2 0.62 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.926 -176.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 689' ' ' VAL . 2.7 t -57.39 -38.58 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 -177.278 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.51 -41.44 19.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.63 177.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.58 -37.04 67.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . . . . . . . . . . . -63.56 -30.51 71.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.748 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.24 -41.79 56.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.606 173.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -38.62 75.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.533 -171.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.07 -21.61 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 175.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -42.94 -38.66 3.4 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 172.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . 0.482 ' HB3' HD11 ' A' ' 705' ' ' LEU . 0.5 OUTLIER -174.73 140.94 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.741 170.363 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -77.8 169.2 18.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.821 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -60.09 -52.26 66.11 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -62.16 -23.86 64.55 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.55 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.764 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 1.9 tp -55.79 -29.11 25.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.02 -48.65 78.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.495 -179.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -75.66 -34.76 48.28 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 697' ' ' SER . 16.8 mt -67.67 -33.61 75.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.025 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 2.4 ttm -50.66 -25.14 3.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 710' ' ' VAL . 52.1 t -64.91 -50.28 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.564 174.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -85.83 -4.25 85.05 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -85.67 13.37 56.27 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 707' ' ' VAL . 94.2 t -72.06 -49.18 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.457 -177.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 715' ' ' VAL . 26.6 t -61.26 -47.29 94.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.471 179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 17.2 mm -68.25 -34.13 64.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.465 -176.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -56.78 -52.5 64.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 175.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -33.06 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.589 -176.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -68.11 -51.54 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.404 179.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 3.8 mm -65.4 -38.17 81.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.449 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 713' ' ' ALA . 74.1 t -69.89 -43.55 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.457 -175.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.1 mm -59.01 -34.28 52.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.559 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 6.3 m -70.61 -36.32 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.451 178.079 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 -30.16 70.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.685 -176.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.33 -39.67 81.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 2.8 ttt -73.71 -30.39 62.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.559 -176.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.89 -17.01 63.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.758 174.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.18 171.74 7.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -143.92 24.71 1.65 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.448 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 tttm 67.31 143.22 0.03 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.852 -178.127 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.57 133.44 39.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.677 174.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.49 171.088 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.618 0.247 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 684' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 70.3 1.79 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.371 -178.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 685' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -140.0 -61.24 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.518 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 686' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 52.68 -101.39 0.11 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.749 178.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt 49.88 -112.9 0.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.852 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 688' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 67.93 3.06 3.37 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.41 -17.63 20.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.439 176.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 690' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -78.31 -37.84 43.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.47 176.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 691' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -46.09 12.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.646 -178.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 692' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 695' ' ' VAL . . . -71.7 -0.71 11.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.721 -177.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 693' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.01 -14.32 60.11 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 176.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 694' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.28 -7.16 59.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.68 -170.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 692' ' ' ALA . 28.8 m -65.97 -18.83 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 696' ' ' GLY . . . . . . . . . . . . . . . -133.81 83.26 0.29 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 174.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 697' ' ' SER . . . . . . . . . . . . . 35.0 p -111.0 57.03 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 175.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 698' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.49 132.56 37.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.504 177.003 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 699' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -56.36 -40.28 74.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -68.83 -36.14 81.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.75 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.733 178.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . . . . . . . . . 7.6 mm -57.18 -32.92 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.635 -178.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.88 -43.32 79.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.524 178.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 707' ' ' VAL . . . -78.67 -21.66 68.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -177.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.55 -24.71 49.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 174.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 706' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -21.51 66.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.522 -173.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 707' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 704' ' ' GLY . 4.8 m -68.79 -31.31 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 -179.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -95.17 0.16 63.83 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 177.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 709' ' ' GLY . . . . . . . . . . . . . . . -81.32 13.39 33.85 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.18 -50.25 37.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.626 0.25 . . . . 0.0 110.489 -178.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -59.25 -48.14 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.593 177.738 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.471 -178.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.525 ' O ' HG23 ' A' ' 717' ' ' VAL . . . -58.31 -50.82 72.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.577 177.134 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 714' ' ' THR . . . . . . . . . . . . . 85.2 m -60.24 -35.7 76.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.645 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 711' ' ' VAL . 58.0 t -67.31 -45.7 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 716' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.65 -29.16 22.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.521 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 713' ' ' ALA . 82.5 t -77.2 -42.27 31.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.414 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 718' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.12 -43.51 89.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.491 176.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 719' ' ' THR . . . . . . . . . . . . . 39.5 p -68.03 -31.31 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.545 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 720' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.23 -28.9 67.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.578 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 721' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 717' ' ' VAL . 60.4 t -63.47 -34.98 70.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 175.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 722' ' ' MET . . . . . . . . . . . . . 9.0 mtm -79.36 -15.98 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.618 -177.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 723' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.34 17.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.638 174.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -7.39 41.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.907 174.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 29.3 mttp 64.39 -167.3 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.726 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -98.4 -30.07 12.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.602 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 727' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -79.61 -2.91 44.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.776 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 728' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.642 177.688 . . . . . . . . 0 0 . 1 stop_ save_